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Abstract
Some dietary studies have been carried out on the metabolism 
of cholesterol and bile acids, in an attempt to elucidate the 
roles of three nutrients, namely, polyunsaturated fats, ascorbic 
acid and iron, which are known to influence the incidence of 
hyperlipidaemia and atherosclerosis. The rate-limiting enzyme 
of bile acid biosynthesis, cholesterol 7<^ “hydroxylase, is a member 
of the mixed function oxidase group of enzymes, in which cytochrome 
P-^50 acts as the terminal oxidase. Thus, the influence of these 
nutrients on some parameters of mixed function oxidase metabolism 
was also examined.
The hypercholesterolaemia and atheroma, induced by feeding 
a diet containing 20$ saturated fat to rabbits, was prevented 
by giving a 20$ polyunsaturated fat diet. However, the mechanism 
of the observed hypocholesterolaemia was shown not to be due to 
the influence of the unsaturated fat on the activity of cholesterol 
ToJL-hydroxylase.
Ascorbic acid deficiency was shown to impair the metabolism 
of both cholesterol and foreign compounds in the guinea pig. 
However, there is apparently a critical threshold level of dietary 
intake required to permit normal metabolism,which shows an inter­
individual and inter-species variability. "Megadose" quantities 
of ascorbic acid did not appear to adversely affect cholesterol 
or foreign compound metabolism.
The administration of an iron-deficient diet to rats was 
shown to influence serum cholesterol concentrations, at least 
partly by an effect on cholesterol 7oL-hydroxylase activity;
however the direction of this effect was not consistent. It is 
possible that the influence of dietary iron deficiency on 
cholesterol and foreign compound metabolism may be dependent 
on the relative depletion of iron stores and/or on an interaction 
with other trace minerals such as copper.
Finally, a hypothesis has been proposed, which suggests 
that cytochrome P-^50 may play a central role in the pathogenesis 
of atherosclerosis.
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Introduction
I Diet, Atherosclerosis and Coronary Heart Disease
Cardiovascular diseases, notably coronary heart disease, 
are considered to be the major cause of death in the Western 
world today. Twenty five percent of all deaths in England and 
Wales (Lancet, 1975) and as many as 5 0 of deaths in the United 
States (Gotto et al., 1976) have been attributed to this cause.
Coronary heart disease results from atherosclerosis of 
the coronary arteries and may present clinically as angina 
pectoris, myocardial infarction or sudden death. The term 
atherosclerosis was introduced by Marchand in 190^. It has been 
defined by WHO (1958) as "a variable combination of changes of 
the intima of arteries, consisting of the focal accumulation 
of lipids, complex carbohydrates, blood and blood products, 
fibrous tissue and calcium deposits and associated with medial 
changes”. The arteries involved in human atherosclerosis are 
the aorta and its immediate large branches, together with the 
coronary and cerebral arteries; in animals the distribution 
of lesions is more variable (Roberts and Straus, 1965)•
Various classifications of the disease process have been 
made, based on the morphology of these lesions . (WHO, 1958;
Haust and More 1972; Strong et al., 1972). It is thus possible 
to define four to six stages in the development of the athero­
matous plaque, each progressing to the next, according to the 
degree of fatty infiltration and subsequent calcification and 
necrosis.
-3-
Whereas in experimental atherosclerosis, a two-stage 
classification of fatty streaks and fibrous plaques suffices 
(Armstrong, 1976), in man, the classification of the early 
lesion as a fatty streak has been questioned (McGill, 1968;
Haust and More, 1972). The fatty streak may be considered as 
a collection of smooth muscle cells assuming a lipid storage 
function i.e "foam cells". Fibrous plaques are a similar 
collection of smooth muscle cells which synthesise large 
amounts of collagen, elastin and various interstitial glycoproteins. 
There would appear to be a gradual transition from one type 
of lesion to the other, occurring in the first two to three 
decades of life. It has thus been suggested that, to be 
effective, any intervention studies should be established prior 
to this (Hermus, 1975)•
Current theories of the pathogenesis of atherosclerosis 
have largely evolved from the original hypothesis of Virchow 
(I856), concerning the imbibition of lipid, and of Rokitansky 
(1852), who considered the initial lesion to result from the 
incorporation of formed elements from the blood. The former 
has undergone modification to become the lipid or infiltration 
hypothesis which suggests that lipids traverse the arterial 
wall from the plasma and subsequently interact with glycoproteins 
within the intima, thus promoting intimal proliferation. There 
is evidence that accumulation of lipid could result from an 
increased uptake of plasma lipids, their decreased elimination, 
or both (Portraan, 1970; Bondjers and Bjorkerund, 1977» Niehaus 
et al., 1977).
Both original theories have been united to form a second
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iraportant hypothesis, the "response-to-injury hypothesis" 
i.e. that atherosclerotic lesions are generated as a result 
of injury to the arterial endothelium (Ross and Glomset, 1976; 
Ross et al., 1977)* The cause of injury may be hyperlipidaemia 
(Ross and Harker, 1976); other factors such as uraemia, infection 
or immunological injury (Minick and Murphy 197^); mechanical 
injury such as the increased shear stress in hypertension or 
arterial dilatation (Ross and Glomset, 1976; Helin <et al.., 1971) 
or a combination of these. Injury to the endothelium may alter 
both its nature as a barrier to blood constituents and also 
endothelial cell-cell or cell-connective tissue attachment, 
such that shear in the blood flow causes focal desquamation 
of the endothelium. Subsequent to this platelets may adhere 
and aggregate at the site of injury. Infiltration of platelet 
factors and other plasma constituents such lipoproteins and 
hormones may then lead to smooth muscle cell proliferation.
A further theory of atherogenesis is that proposed by 
Benditt and Benditt (1973)* This is known as the "monoclpnal 
hypothesis", which suggests that each lesion results from the 
proliferation of a single smooth muscle cell. Each lesion is 
considered to be a benign neoplasm, derived from a cell trans­
formed by a mutagenic stimulus such as a virus, cigarette smoke 
or other environmental contaminant (Benditt, 1977)•
In recent years, it has become apparent that to some 
extent, regression of these atherosclerotic lesions is possible. 
The reversal of atherosclerosis, which has been reviewed by 
Prichard (197*0 and Armstrong (1976), has been demonstrated 
in rabbits, birds, swine and primates (Yesselinovitch et al.,
-5-
1974; Clarkson et al., 1973; Doaud et al., 1974; Friedman et al., 
1976 and Vesselinovitch et al., 1976). Reports based on 
autopsy data and on angiographic evaluation of the coronary 
and peripheral circulation of human subjects indicate regression 
of atherosclerosis after suitable dietary or drug therapy 
(Bamdt, 1977; Wissler and Vesselinovitch, 1977). 'Ibis empha­
sises the importance of elucidating risk factors associated 
with the disease, in the hope that treatment at an early stage 
may enable reversal or retardation of the disease process.
Risk Factors For Coronary Heart Disease
The epidemic increase in coronary heart disease amongst 
young and middle-aged men has led to an immense research 
effort to elucidate its pathogenesis. As a result, the concept 
of the disease as being multifactorial in origin and associated 
with certain risk factors has emerged (Epstein et al.,1965;
Truett et al., 1967). The presence of such factors, or more 
precisely indicators, in an individual or his environment, may 
be used to predict the likelihood of development of clinical 
disease.
There has been much discussion in the literature about 
the relative importance of these risk indicators and their 
classification. Stamler et al. (1972) used the following 
classification:
(aj Those involving social environment and life style 
e.g. diet habitually high in saturated fat, cholesterol and 
calories; cigarette smoking; sedentary living.
(b) Those involving endogenous biochemical - physiological
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regulatory mechanisms, but amenable to exogenous influences 
e.g. diet, pharmaceuticals, hyperlipoproteinaemia, hypertension, 
hyperglycaemia, hyperuricaemia and rapid resting heart rate.
(c) Those involving organ pathology e.g. ECG abnormalities, 
hypothyroidism and renal disease.
(d) Those involving fundamental biology and not generally 
amenable to exogenous influences e.g. age and sex.
The Framingham study, a prospective longitudinal cohort 
study, was established in 19^8 with the aim of observing the 
evolution of cardiovascular disease in a general population 
sample (Kannel et al., 1971)* It is from this study that the 
three primary risk indicators have emergedi elevated serum 
cholesterol, hypertension and cigarette smoking. Factors of 
secondary importance are heredity, sex, hypertriglyceridaemia, 
obesity, diabetes, physical activity, stress and personality 
type, there is also a considerable interrelationship between 
these factors (Gotto et al., 1976). However, the relevance of 
these risk indicators, especially hypercholesterolaemia, to the 
prophylaxis and treatment of cardiovascular disease is still 
widely debated.
The Relationship Between Atherosclerosis, Coronary Heart Disease 
and Lipid Metabolism
There is a well-established relationship between an eleva­
tion in plasma lipid, notably plasma cholesterol concentration 
and the development of atherosclerosis, a s discussed by Kaunitz 
(1977) the number of scientific investigations presenting evidence 
supporting this association is legion, but the evidence may be
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summarized in four main areas.
(i) The atherosclerotic lesion itself has a high choles­
terol content. Windaus (1910) reported that human atheromatous 
aortas contained about six times as much free cholesterol and 
twenty times as much esterified cholesterol as normai aortas.
(ii) Numerous studies in experimental animals have demon­
strated the development of atheroma as a consequence of hyper- 
cholesterolaemia induced by cholesterol feeding, although there 
is considerable inter- and intra- species variation in this 
response (Clarkson et al., 1976).
(iii) Epidemiological studies have demonstrated a definite 
statistical relationship between elevated plasma cholesterol 
concentration and an increased incidence of coronary heart 
disease (Keys et al., 1963; Dayton et al., 1970; Kannel et al.', 
1971; Carlson and Bottiger, 1972).
(iv) Patients suffering from familial hypercholesterolaemia 
have a high risk of developing atherosclerotic complications
(Aldersbergh, 1951; Epstein et al., 1959; Fredrickson et al., 
1967; Olsson, 1975)•
The majority of lipids circulate in the plasma associated 
with specific proteins in the form of soluble lipoproteins.
These complexes contain a core of non polar lipid (triglycerides 
and cholesterol esters), a surface layer of more polar lipid 
(free cholesterol and phospholipids), together with the 
apoproteins (Morrisett et al., 1975; Jackson et al., 1976). 
Lipoproteins can be classified according to density, a property 
determined by the relative ratios of lipid to protein in the 
molecule. Two schemes of nomenclature which are used inter­
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changeably have been derived from their principal methods of 
separation i.e. ultracentrifugation and electrophoresis on 
paper or cellulose acetate. In order to understand the role 
of these lipoproteins in lipid transport as related to atheros­
clerosis, their structure and function will be briefly described; 
the subject has been reviewed in detail by Jackson and his 
colleagues (1976).
The properties of these lipoproteins are summarized in 
Table 1.1. Their chemical composition has been extensively 
investigated (Lindgren et al., 1955; Ewing et al., 1965; Levy 
et al., 1967)* Chylomicrons are the largest lipoproteins, 
composed mainly of exogenous triglyceride in transit from the 
small intestine to the liver and adipose tissue. Endogenous 
triglycerides comprise 50#-70# of the very low density lipo­
proteins together with 10-25# cholesterol. Their role is to 
transport this triglyceride from the liver and to some extent 
the intestine to other tissues such as adipose tissue and 
muscle. During their breakdown, there is an interchange of 
apoprotein with other lipoproteins. The remnant particles, 
known as intermediate density lipoproteins, deliver the bulk of 
their cholesterol to the liver and are subsequently degraded 
into low density lipoproteins. These are largely composed 
of cholesterol (40-^5#) and are thus the major vehicle for 
cholesterol transport in plasma. High density lipoproteins 
comprise 50$ protein, 35# phospholipid and only 15-20# 
cholesterol. Nevertheless, it has become apparent that these 
particles play an important role in transport of cholesterol 
to the liver for subsequent catabolism and excretion, as they
Ta
bl
e 
1.
1 
Ch
ar
ac
te
ri
st
ic
s 
an
d 
No
me
nc
la
tu
re
 
of 
Hu
ma
n 
Pl
as
ma
 
Li
po
pr
ot
ei
n 
Cl
as
se
s
-9-
to
to
0
Po
£
•H
0
P
O
£
ftO
ft•H
i—j
-p•H
TO
£0
Q
,£W)•H
S£
>5
-PrH
ra
£o
Q
o
pi
>j
p
•Hm
£
0
n
o
Pi
> 3
£0
>
o•H
P
TO
•H
£
0
p
o
0
£a
&o
P £o £ •H
VO 0
CM B TO rH• ' •H £ Eft •d rH O
0 -3- £ i—! tUD
1 TO M 0 0
Ov W) £ CO
CO » VO o TO vO
VO CO 'd SO O
o £ •• I ft H
rH
o 1
co
VO Yv?
O TO• O £
P CM P o
CM £ P
1 1 *• 0 0
O W) £
VO O O TO
O 'd So
O £• ft
H
VO
o
O o TO■ •
P
o £
O
1 CO £ P0 1 1 •• 0 0
£ CM W) £
ft -3- o Cv o TO
o\ CM 'd to
• £o ft
TO TO o
£ £ oo o o CM TO£ £ vo ' » •« .TO P
O o O VO oo £ 0
•H •H o P Cv O . 0
B B • £ So o rH 1 1 0
p P fcJD £
>3 >3 o P o 0
,£ ,£ o M X PO O -3- OV ft <HC\ <
o
•H0-3 
0 0 
£ £ 
O £
X PPi 0 
O P £ O 
P £ o 0 
0 B 
P o 
ft £
i—!
rH \
0 to bJ3 
W) o £ *H 0 
W)P W
•H TO C 
£ *H 0 
P  £ ft 
£
0 -P > 3  
OOP  
0 0 *H 
£ £  TO
P cd £ 
0£> O Q
ft
CO
o
•H
P
0
ft
£
•H
0
PO
£
ft\'d
•H
ft
•H
Pi
£•H
W)
•H
£
O
n
o
oi—i
ft
£
•H
0O
£
0
TO
0
£
ft
vo
O
O
•
rH
> 3
P
•H
TO
£
0
'd
p
0
TO
P
•H
£
So
t»o
£
0
ft
'd
0
>
co
£
•H
P
£
0
•H
O
•H
<H
<H
0
O
o
£
o
•H
P
0
P
£
0
B
•H
•d
0
w
0
> •
•H o
P o
0 VO
SD CM
0
£ P
0
0
,£ £
P o
•H
TO P
0 £
P P
O o
£ TO
0
'd P
O
ft 0
CO s
ju
■V
Ad
ap
te
d 
fr
om
 
Sk
ip
sk
i 
(1
97
2)
- 10-
interact with lecithin* cholesterol acyl transferase in plasma, 
taking.up cholesterol in the ester form (Glomset, 1968).
Early studies linking circulatory lipid to coronary heart 
disease, emphasised the importance of elevation of the low and 
very low density lipoprotein fractions. Thus, Fredrickson 
et al. (1967) in their classification of the hyperlipoprotein- 
aemias noted that in both Type II (elevated low density) and 
Type IV (elevated very low density) there was an increased 
incidence of coronary heart disease. Similarly, an increased 
concentration of low density lipoproteins and their subsequent 
filtration to the arterial intima have been implicated as 
pathogenetic in the disease, possibly as a result of low 
density lipoprotein receptor deficiency (Brown and Goldstein, 
197^; Brown and Goldstein, 1976).
In recent years however, the emphasis has changed to the 
association of high density lipoprotein with the incidence of 
coronary heart disease,as the two are apparently inversely 
correlated. This observation was made several years ago (Barr 
et al., 1951; Nikkila et al., 1953; Jencks et. al., 1956;
Brunner et al., 1962) but was not considered important until 
1975»when Miller and Miller proposed that a reduction in high 
density lipoprotein was likely to accelerate the development 
of atherosclerosis by impairing the clearance of cholesterol 
from the arterial wall. Thus, a decrease in high density 
lipoprotein levels may be considered as an additional and 
independent risk factor in coronary heart disease (Castelli 
et al., 1977, Cooperative Lipoprotein Phenotyping Study;
Gordon et al., 1977> Framingham Study). Similarly, the findings
- 11-
of the Troms^ Heart Study indicate that high density lipoprotein 
concentrations may be a better predictor of coronary heart 
disease than serum cholesterol itself (Miller et al., 1977).
Diet in Relation to Hyoerlipidaemia and Atherosclerosis
The observed association between atherosclerosis and serum 
lipids has made them the focus of attempts to limit the disease. 
Results from numerous animal experiments, epidemiological inves­
tigations and studies of populations subjected to changes in 
their habitual diets, have emphasised the role of diet as a 
major determinant of serum lipid concentration. The majority 
of these investigations have been concerned with the influence 
of dietary lipid. Thus, the "lipid theory1* of coronary heart 
disease, whereby a reduction in serum cholesterol concentration 
in an individual by modification of dietary fat intake is 
thought to diminish the risk of a coronary event, has become 
widely accepted (Ahrens, 1976). The importance of dietary 
lipid will be further considered in Chapter 2. However, may 
it suffice to say that on the basis of existing experimental 
and epidemiological data, despite considerable scepticism and 
uncertainty on the part of some of the leading investigators 
(Ahrens, 1976; Mann, 1977)» recommendations have been made 
both in this country and the United States for an overall 
modification in diet, particularly with respect to dietary 
lipid (D.H.S.S. 197^;Royal College of Physicians, London, 1976; 
Select Committee on Nutrition and Human Needs, U.S. Senate,1977)•
In addition to lipid, certain other dietary components 
such as carbohydrate, protein and fibre are known to influence
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serum lipid concentration. Deficiencies of some vitamins, 
notably ascorbic acid, and minerals may affect the degree of 
lipidaemia* their importance will be discussed in Chapters 3 
and 4 respectively.
Thus, as observed by Kritchevsky (1976), whilst the change 
in type and quantity of dietary fat has been implicated in the 
epidemic increase in cardiovascular disease, our diet has 
changed overall. He summarizes the data of Friend (1967),
Rizek et al., (197*0 and Gortner (1975)» which demonstrate trends 
in nutrient intake in the United States between 1909 and 197*** 
From this he concludes thati
(a) Although protein availability has not changed, the 
ratio of animal to vegetable protein has doubled.
(b) Carbohydrate availability has fallen by 21#.
(c) Dietary fibre intake has fallen by 30#.
(d) Fat availability has increased by 20#, although the 
polyunsaturated: saturated fatty acid ratio has risen from 
0.21 to 0.43.
(e) Cholesterol intakes have risen only slightly from 
509 to 5**0mg per day.
These trends have also been observed in the U.K.and other 
Western countries and correlate with an increased death rate 
(Masironi, 1970).
Relationship Between Dietary Protein Intake and Hyperlipidaemia
Yudkin (1957) and Yerushalmy and Hilleboe (1957) demon­
strated a strong positive correlation between the intake of 
animal protein and the incidence of heart disease. Vegetarians
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are known to have lower plasma lipid levels than the average 
population, although this could also result from difference 
in fibre, vitamin or mineral intake (Sacks et al., 1975).
Young women consuming a diet containing 50g of vegetable 
protein were shown to have lower serum cholesterol concentrations 
than those eating an equivalant amount of animal protein 
(Walker et al.., i960). Similarly, Hodges et al., (1967) 
substituted soya protein for mixed protein in the diet of human 
volunteers,with a consonant decrease in mean serum cholesterol 
level from 300mg to 200mg/100ml. More recently the substitution 
of soya for animal protein in the diets of normolipaemic 
(Carroll et al., 1978) and hyperlipidaemic (Sirtori et al.,
1977) individuals, has been shown to lower serum cholesterol.
Many early feeding studies in animals, particularly the
rabbit, provided evidence for a hypercholesterolaemic effect of 
casein and beef protein (reviewed by Kritchevsky, 1976 and Carroll,
1978). Other workers (Lofland et al., 1961;' Clarkson et al.,
1962; Middleton et al., 1967) varied the quantity of both 
cholesterol and protein in diets.fed to pigeons or squirrel 
monkeys and found that the high protein diets were most 
atherogenic^ Howard et al. (1965) observed that the hypercholes- 
terolaemia and atherosclerosis induced in rabbits by feeding
a cholesterol-free, high fat,purified diet could be reduced 
by substituting soya flour or soya bean meal for casein. These 
results have been confirmed by other workers (Carroll and 
Hamilton, 1975? Hermus, 1975? Hamilton and Carroll, 1976).
In general, proteins derived from animal sources gave a 
hypercholesterolaemic response, although pork and albumin were
- 14-
exceptions to this (Carroll and Hamilton, 1975). It has also 
been shown in rabbits that the serum cholesterol concentration 
may be influenced by the amino acid content of the diet (Huff 
et al., 1977)•
Relationship Between Dietary Carbohydrate Intake and Hyperlipid- 
aemia
As a result of finding correlations between coronary heart 
disease mortality and sucrose intake, Yudkin has proposed that 
sucrose consumption is of prime importance in the aetiology 
of coronary heart disease (Yudkin, 1957; Yudkin, 1963; Yudkin 
and Roddy, 1964; Yudkin, 1966). He has postulated that sucrose 
may act by influencing serum lipid levels, platelet adhesiveness 
or hormonal balance (Yudkin, 1972). In general, sucrose intake 
does not appear to affect serum cholesterol levels, although 
it does elevate serum triglycerides (Anderson et al., 1963; 
Denbesten et al., 1973)* Yudkin's hypothesis has been criticised 
(Grande, 1967; St Hamler et al., 1972)and there is apparently 
considerable interaction between the influences of sucrose and 
saturated fat (Macdonald, 1967; Macdonald, 1972). There is a 
definite variation in response to sucrose feeding in experimental 
animals and man. Yudkin has thus suggested that it may only 
be atherogenic in some individuals (Worcester et al.. 1975).
Relationship Between Dietary Fibre Intake and Hyperlipidaemia
Recently attention has been focussed on the role of complex 
carbohydrates and non-nutritive fibre in coronary heart disease.
-15-
Many experiments, carried out in rabbits fed semipurified diets, 
showed some interaction between the fibre and protein components of 
these diets with respect to hypercholesterolaemia (Kritchevsky 
et al., 1977b). It has been proposed (Trowell, 1972; Burkitt 
et al., 197*0 that a deficiency of dietary fibre may be a 
causative factor in coronary heart disease.
Human studies designed to test this hypothesis give 
conflicting results. Some workers have observed an hypocholes- 
terolaemic effect on feeding rolled oats (deGroot et al., 1963), 
bengal gram (Mathur et al., 1968) or lignin (Thiffault et al.,
1975)» whilst others using wheat bran, have been unsuccessful 
(reviewed by Truswell and Kay, 1976), Jenkins et al.(1975) 
showed that dietary pectin and guar gum significantly reduced 
serum cholesterol concentrations in healthy volunteers whilst 
wheat fibre was without effect. The hypocholesterolaemic action 
of pectin has also been demonstrated by Judd et al. (1977). Thus, 
in humans the response would seem to depend on the nature of the 
dietary fibre.
Similar conclusions can be drawn from experimental studies 
in animals. In the rat, both pectin and lignin were hypocholeste­
rolaemic (Judd et al., 1975, Chang and Johnson, 1976), whereas 
wheat fibrer had a minimal effect (Kay and Truswell, 197*+) • In 
the rabbit, wheat straw and alfalfa were more hypocholesterolaemic 
than pure cellulose (Story et al.,1976). These experiments will 
be discussed in greater detail in Chapter 2.
II Cholesterol Metabolism and its Control
The pathways of cholesterol metabolism which influence
- 16-
tissue and plasma cholesterol concentration are summarized in 
Fig 1.1.
Methods used to investigate these pathways have been whole 
body sterol balance studies and analyses of plasma cholesterol 
kinetics (Sabine, 1977)* Data derived from these studies has 
facilitated the understanding of the three major aspects of 
cholesterol metabolism i.e. absorption, synthesis and catabolism 
and their interrelationships.
Cholesterol Absorption
Dietary cholesterol mixes in the small intestinal lumen 
with cholesterol derived from the bile and desquamated mucosal 
cells and with sterol newly synthesised in the intestine itself 
(Dietchsky and Wilson, 1970b), although a more recent study 
in rabbits (Rudel et al.,1972) showed that within the mucosal 
cell, absorbed and newly synthesised cholesterol remained 
separated. Cholesterol is incompletely absorbed and transported 
in the splenib circulation to the liver via the thoracic duct 
as very low density lipoprotein and chylomicrons (Borgstrom, 
1969; Quintao et al., 1971; Kudchodkar et al., 1973).
Absorbed cholesterol is used in the synthesis of plasma 
lipoproteins (8-12mmol/day) and bile acids (lmmol/day) or is 
re-excreted in the bile (2.5mmol/day) (Angelin, 1977)* The 
percentage of cholesterol absorbed is dependent on various 
factors: species, age and sex (Lutton and Chevallier, 1972), 
the nature of dietary fatty acids and rate of bile flow 
(Dietchsky and Wilson, 1970b). The size of the bile acid pool 
also influences cholesterol absorption. Decreased bile acid
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reabsorption, induced by cholestyramine treatment or bile duct 
ligation, inhibits cholesterol absorption, whilst expansion 
of the bile acid pool by the administration of taurocholate 
enhances it (Siperstein et al., 1952; Lutton et al., 1973)*
Some investigators (Kaplan et al.., 1963; Wilson and Lindsay, 
1965) consider that in man there is a maximum rate of absorption 
of approximately 500mg per 24 hours. Conversely, Borgstrom 
(1969) considers the rate to be unlimited, although the percentage 
absorbed is reduced at higher intakes. This was confirmed by 
Grundy and Ahrens (1969)* In some individuals, the effects of 
increased absorption are compensated for by two mechanisms: 
enhanced excretion of faecal neutral sterols and suppression 
of endogenous cholesterol synthesis (Quintao et al., 1971)*
In contrast to other species, such as the rat, dog or squirrel 
monkey, there is no increase in cholesterol degradation to bile 
acids in man.
Cholesterol Synthesis
Most tissues are capable of cholesterogenesis, although 
the liver and intestine predominate (Dietchsky and Wilson,
1970a) and together with skin are considered to contribute in 
excess of 90?6 of endogenous cholesterol (Lewis, 1976). Cholesterol 
is synthesised from acetate via a series of steps, of which 
the formation of mevalonate fromjS-hydroxy yg-methylglutaric 
CoA (HMGCoA), catalysed by the microsomal enzyme HMGCoA reductase, 
is rate-limiting (Siperstein and Fagan, 1966). This enzyme is 
subject to a negative feedback control; thus hepatic synthesis 
is inhibited by cholesterol itself* In rat liver, exogenous
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cholesterol (derived from chylomicrons) is more effective than 
endogenous cholesterol in this respect (Weis and Dietchsky,
1969)* Intestinal cholesterogenesis is apparently largely 
regulated by bile acids (Dietchsky, 1968), although McIntyre 
and Isselbacher (1973) have shown that intestinal cholesterol 
may also play some part. In some tissues, cholesterol synthesis 
may be depressed due to feedback inhibition by low density 
lipoproteins, mediated by receptors on the cell surface 
(Balasubramaniam et al., 1976). It has been proposed that a 
major function of these receptors is to permit the transport 
of low density lipoprotein into the cell, where they suppress 
the activity of HMGCoA reductase and thereby inhibit cholesterol 
synthesis (Brown et al., 1975)*
Cholesterol Excretion
Under steady-state conditions, the cholesterol eliminated 
in the faeces and urine should equal that derived from synthesis 
and absorption. A small quantity of cholesterol is excreted 
through the skin (Bhattacharyya et al., 1972). In man, the 
principal route of excretion is via the faeces, which contain 
unabsorbed cholesterol from the diet, biliary excretion and 
desquamated epithelial cells (Dietchsky and Wilson, 1970c;
Lewis, 1976). In the rat, faecal excretion of cholesterol itself 
is relatively low compared with that of bile acids (Lutton,1976). 
In the large bowel, cholesterol undergoes bacterial metabolism, 
largely through ring saturation, to yield coprostanol and 
cholestanol (Snog-Kjaer at al., 1956; Rosenfeld et al., 1967)*
7
The second major route of cholesterol excretion is via its
- 20-
catabolism to bile acids. Bloch et al. (19^3) reported the 
conversion of isotopically labelled cholesterol to bile acids.
More than 80$ of cholesterol is excreted in this form in the 
rat (Bergstrom, 1952; Siperstein et aX., 1952) and in man 
(Siperstein and Morray, 1955); however, Lewis and Myant (1967) 
state that bile acids account for only 28-59$ of the net sterol 
loss in man.
The transformation of cholesterol to bile acids occurs 
via a series of oxidative steps, involving the introduction of 
hydroxyl groups into the steroid nucleus and shortening of the 
side chain (Dietchsky and Wilson, 1970c). This is summarized 
in Fig 1.2. The initial reaction is the introduction of a/ 
hydroxyl group in an ck-configuration at the 7~position of 
cholesterol, to form cholest-5-ene-3yfi,7fa*.-diol. In subsequent 
steps, the 3/?-hydroxy group is inverted to the 3c*.- position 
via a 3-keto intermediate, the A d o u b l e  bond is saturated and 
the orientation of the A and B rings is shifted from a trans- 
to a cis- relation i.e. from a 5oL-H to a 5/2—H sterol.
In the pathway leading to cholic acid, 12d-hydroxylation 
also occurs. Subsequent steps involve the loss of the three 
terminal carbon atoms from the side chain and oxidation of the 
C2^ carbon to a carboxylic acid group. This process is achieved 
by6)-oxidation to the corresponding 26-oic acid, followed by 
y^-oxidation and cleavage of the three-carbon unit in the form 
of propionyl-CoA (Suld et al., 1962). In this manner, 5yS-choles- 
tone-3«<, 7<*» 12oL-triol and 5/?-cholestone-3ol, 7K.-diol are converted 
to cholyl-CoA and chenodeoxycholyl-CoA respectively. These 
compounds may then be conjugated through a peptide linkage to
-2 1 -
Fig. 1.2 Biosynthetic Pathways of Primary Bile Acids
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either glycine or taurine and secreted into the bile as tauro- 
cholic, glycocholic, taurochenodeoxycholic or glycochenodeoxycholic 
acids, which are known as primary bile acids.
Within the intestine, further chemical transformations 
may be effected by bacteria. Deconjugation to the free bile 
acids and 7ct-dehydroxylation to form deoxycholic from cholic 
acid or lithocholic from chenodeoxycholic acid may occur (Norman 
and Sjovall, 1958)* These are known as secondary bile acids.
Bile acids are efficiently reabsorbed by active transport 
from the distal ileum, although;lithocholic acid is mostly lost 
in the faeces. Unconjugated bile acids which are reabsorbed 
are conjugated with taurine or glycine prior to re-excretion in 
the bile,which thus contains a mixture of conjugated primary 
and secondary bile acids. There is considerable species 
variation in the pattern of bile acids present in bile (Haslewood,
1967)» but in man,cholic, chenodeoxycholic and deoxycholic acids 
predominate in the proportions 1.1*1.0:0.9 (Einarsson et al., 
197^). The bile salt pool, which is largely in the biliary 
tract, liver, small intestine and portal circulation, also varies 
in size (Sabine, 1977) but in man is of the order of- 3g (Lewis,
1976). It is known to recycle several times each day (Hofman, 
1967; Shefer et al., 1969). but it is apparent that different 
bile acids may have different rates of enterohepatic circulation 
(Sabine, 1977)• Approximately 10% of the pool is lost each 
day.
In man and other species bile acid synthesis is under 
complex control. Ihe major rate-limiting event is the initial 
step in the biosynthetic pathway i.e. 7x-hydroxylation and is
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apparently under negative feedback control from the intestinal 
bile acid pool (Shefer et al., 1970). Evidence supporting this 
emanates from studies in cholestyramine-treated or bile-fistula 
rats, where the activity of cholesterol 7o<--hydroxylase was 
induced (Shefer et al., 1968; Johansson, 1970), whilst that 
of other enzymes in the pathway was unaffected. However,
Johansson (1970) has suggested that the 12dO-hydroxylase enzyme 
may have a secondary regulatory function. Further studies (Shefer 
et al.,1970; Mosbach et al., 1971) have shown that the incorpo-
14
ration of C from cholesterol into bile acids was inhibited 
in the presence of the circulating bile acid pool, but that
14
incorporation of C from cholest-5-ene 7c^-diol (the product 
of TsC-hydroxylation) was unaltered in the presence or absence 
of the bile acid pool. The characteristics of the 7<*.-hy dr oxylase 
enzyme system and the factors influencing its activity will be 
discussed in the next section.
It has thus been assumed that alterations in total body 
cholesterol will be reflected by corresponding changes in the 
concentration of plasma cholesterol. Consequently an obvious 
area of research has been the relationship between bile acid 
turnover and hypercholesterolaemia. As a result of the known 
association between diet and hyperlipidaemia, relationships 
between diet and bile acid metabolism have been sought, these 
will be considered in greater detail in the relevant experimental 
chapters.
Ill Role of Cholesterol 7^-Hydroxylase and Its Relationship to
Foreign Compound Metabolism
Cholesterol 7^-hydroxylase (EC 1.14) belongs to the class
of enzymes known as mixed function oxidases. This term was 
introduced by Mason (1957) and is specific for enzyme-catalysed 
hydroxylations in which one atom of a molecule of oxygen is 
introduced into the substrate, the other being reduced to water 
by a reduced coenzyme. Two electrons are consumed for each 
molecule of oxygen. The reaction may be represented thus:
RH +  NADPH +  H+  +  0 2  ----- -3> ROH +  NADP+ +  HpO
where RH is the substrate.
These enzymes, which are located in the hepatic endoplasmic 
reticulum are membrane-bound and are responsible for the 
metabolism of a wide range of exogenous substrates such as 
drugs, carcinogens and other foreign compounds, together with 
endogenous substrates such as steroids and fatty acids (Conney, 
1967; Kuntzman, 1969; Gillette et al., 1972). Originally, 
this microsomal enzyme system was thought to consist of at least 
two functional protein components: a haemoprotein called cyto­
chrome P-450 and a flavoprotein known as NADPH-cytochrome c 
reductase or NADPH-cytochrome P-450 reductase.
Cytochrome P-450 acts as the substrate- and oxygen-binding 
site of the system, whilst the reductase acts as an electron 
carrier, transferring electrons from NADPH to cytochrome P-450.
Lu and Coon (1968) solubilised the system using detergent, and 
as a result identified 3 components:- cytochrome P-450, NADPH- 
cytochrome c reductase and a lipid, shown to be phosphatidyl­
choline. More recently, both protein components have been 
purified (Imai and Sato, 1974; Levin et al., 1974; Van der Hoeven 
and Coon, 1974; Ryan et al., 1975)* Using these preparations,
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an absolute dependence on the 3 components for the metabolism 
of foreign compounds has been demonstrated (Levin et al,, 1974;
Lu and Levin, 1974; Van der Ho even and Coon, 1974).
A proposed scheme for the series of reactions occurring 
during hydroxylation is shown in Fig 1.3* The sequence of 
events has been extensively investigated by studying changes 
in both optical and EPR spectra of the cytochrome during the 
reaction (reviewed by Estabrook et al., 1975)* The mechanisms 
of subsequent reactions concerned with the transfer of the 
second electron and the introduction of the activated oxygen 
atom into the substrate are still unclear. The nature of the 
acceptor for the second electron remains undetermined, although 
Hildebrandt and Estabrook (1971) have postulated that cytochrome 
b^ may be important in this reaction. However, if this were 
so, it is difficult to understand why this cytochrome is not 
an essential component of the solubilised hydroxylating system.
Cytochrome P-450 and Its Specificity
Cytochrome P-450 is considered to be the most essential 
component of the enzyme system, as a consequence of its oxygen 
-activating role. 'The designation "P-450" to the cytochrome 
is derived from the observation that when complexed with carbon 
monoxide, which it binds avidly (Oraura and Sato, 1962) it shows 
a maximal absorption in the Soret region at 450nm.
An induction of mixed function oxidase activity, concomitant 
with an induction of cytochrome P-450, has been observed following 
administration of, or accidental exposure to, various chemical 
agents (Conney, 1967; Reramer, 1972). The classical inducers
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Fig . 1.3 A Schematic Diagram of Cytochrome P-^50 Mediated 
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of cytochrome P-450-catalysed reactions are phenobarbitone and 
20-methylcholanthrene, the cytochromes induced by these agents 
being known as P-^50 and P-448 respectively (Comai and Gaylor, 
1973)* Phenobarbitone induces the metabolism of a wide range 
of substrates, whereas methylcholanthrene is more specific in 
its induction (Conney, 1967)*
Studies carried out over the last decade suggest that 
cytochrome P-^50 is heterogeneous and that both between 
different animals and within each species there exist multiple 
forms of the cytochrome, specific for various substrates (Lu 
et al., 1972; Comai and Gaylor, 1973; Ryan et al., 1975; Thomas 
et al., 1976). Variation in the proportions of P-^50 types in 
a particular microsomal preparation, could explain the species, 
strain, sex and age differences observed in microsomal metabolism 
(Lu, 1977)* Likewise, it might be anticipated that just as 
pretreatment with a particular drug may affect the relative 
proportions of P-^50 present, variations in the nutritional 
composition of the diet may also have some effect.
Characteristics of Cholesterol 7oC~Hydroxylase
Cholesterol 7«C-hydroxylase has been shown to require 
NADPH and molecular oxygen (Shefer et al., 1968; Mitton et al., 
1971; Mitropoulos and Balasubramaniam, 1972). The reaction 
can be inhibited by carbon monoxide (Boyd et al., 1969; Wada 
et al., 1969) and the inhibition can be reversed by monochromatic 
light at ^50nm (Boyd et al., 1971; Boyd et al. ,1973) * Bjorkhem 
et.al. (197^),using partially purified preparations of cytochrome 
P-^50, were able to restore the cholesterol 7d~-hydroxylase
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activity of inactive subfractions of liver microsomes. These 
findings suggest that cytochrome P-450 acts as the terminal 
oxidase in the Tbt-hydroxylase system.
Investigation of the factors controlling the activity of 
this enzyme have yielded equivocal results. As stated earlier, 
the rate of hydroxylation of foreign compounds by hepatic 
microsomes is largely determined by cytochrome P-450 concentration. 
For example, the rate of oxidative demethylation of ethylraorphine 
parallels changes in P-450 concentration induced by various 
experimental modifications (Balasubramaniara and Mitropoulos,
1975); similar findings were reported for aminopyrine (Emster 
and Orrhenius, 1965)- However, changes in the activity of 
cholesterol 7cA»-hydroxylase do not consistently correlate with 
concentrations of either the cytochrome or its reductase. Thus, 
whereas 7c<--hydroxylase activity is induced in cholestyramine- 
treated or bile-fistula rats, cytochrome P-450 and ethylmorphine 
activities are unaffected (Balasubramaniam and Mitropoulos,
1975)* Pretreatment of rats with phenobarbitone, whilst markedly 
inducing cytochrome P-450 concentration and ethylmorphine 
demethylation', has variable effects on cholesterol 7<*-hydroxylase. 
In general, its activity is unaltered, but certainly in the rat 
there is'a notable strain variation (Einarsson and Johansson,
1968; Shefer et al., 1972; Balasubramaniam and Mitropoulos,
1975)* Recently, Mellon and his colleagues (1978) have presented 
data which confirms this earlier work and also shows a lack of 
correlation of ?oC-hydroxylase activity with that of cytochrome
c reductase or bc.
. j :
These findings have led to speculation as to the mechanism
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of induction of cholesterol ?&.-hydroxylase, bearing in mind 
this apparent dissociation from the components of the enzyme 
system. The existence of multiple forms of cytochrome P-450 
may offer some explanation for these observations. It may 
be possible that there is a form of the cytochrome specific 
for the /K-hydroxylation of cholesterol (Wada et aJ.., 1969;
Atkin et al., 1972). If this specific form comprised only a 
small part of the bulk of cytochrome P-450, no observable 
change in total microsomal P-450 would be expected. Alternatively, 
Brown and Boyd (1974) have postulated that the in vivo regulatory 
mechanisms of cytochrome P-450 and cholesterol ’fct-hydroxylase 
are different. They propose the existence of an additional 
component to the enzyme system, such as a carrier protein 
specific for cholesterol, the concentration of which would 
control the amount of cholesterol accessible to the oxygen- 
activating site on the cytochrome.
In order to clarify these mechanisms, solubilisation of 
the microsomal P-450 required for 7>C-hydroxylation, as carried 
out for the drug hydroxylation reactions (Lu and Coon, 1968) , 
has been attempted (Bjorkhera et al., 1974; Hattersley and 
Boyd, 1975)* However, as there is considerable loss of activity 
of the enzyme during contact with the concentrated detergents 
used in the purification procedure, this approach has been 
unsuccessful.
A further area of uncertainty, of prime importance in
establishing a suitable assay system, is that of the origin
of intracellular cholesterol acting as preferential substrate
fl4 1for the enzyme in vivo. On incubating L C J cholesterol with
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hepatic microsomes, under conditions suitable for 7*-hydroxy- 
lation, the specific activity of the 7^-hydroxycholesterol 
generated is lower than that of the added cholesterol. This 
indicates that a proportion of endogenous cholesterol equilibrates 
with the added substrate and is thus accessible to the enzyme 
(Mitropoulos and Balasubramaniam, 1972; Balasubramaniam et al., 
1973). These workers have proposed the term "substrate pool” 
for this fraction of microsomal cholesterol and have attempted 
to estimate its size, assuming immediate equilibration of the 
pool with added radioactive cholesterol. However, the form in 
which the cholesterol is added to the incubation system has been 
shown to influence the accessibility of the substrate to the 
enzyme (Balasubramaniam et al.,1973» Bjorkhem and Danielsson, 
1975)* The concept of "substrate pool" has consequently been 
criticised (Bjorkhem and Danielsson, 1975)* Concern as to the 
interpretation of experiments in which cholesterol 7*C-hydroxy- 
lation was determined by the addition of exogenous cholesterol, 
led to the development of an assay for 7«^-hydroxylation of 
endogenous cholesterol using a mass fragmentographic technique 
(Bjorkhem and Danielsson, 1974). However, comparison of both 
assays in this and subsequent studies (Bjorkhem and Danielsson, 
1975; Bjorkhem and Kallner, 1976; Bjorkhem et al., 1978) have 
shown them to give similar results.
The origin of the microsomal cholesterol per se used 
preferentially by the enzyme has been questioned. By the 
isolation of the liver microsomal fraction from rats administered 
intravenous O  c ]  cholesterol immediately prior to killing, it 
was shown that the specific activity of the products formed
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in vitro was lower than that of the total microsomal cholesterol 
(Balasubramaniam et al., 1973)* They concluded that plasma 
cholesterol does not rapidly equilibrate with the pool from 
which 7<*»-hydroxycholesterol is synthesised and consequently 
that this pool is derived from cholesterol synthesis de novo 
in the liver. Evidence supporting this has been provided 
by Bjorkhem and Danielsson (1975)» who showed that the specific 
activity of 7c^-hydroxycholesterol formed from E5-^H D mevalonic 
acid incubated with rat liver microsomes in vitro was greater 
than that of the total microsomal cholesterol.
Factors Affecting Cholesterol 7<*-Hydroxylase Activity
In addition to the regulatory action of the enterohepatic 
circulation of bile acids on cholesterol 7oL-hydroxylase, factors 
known to influence this enzyme can be divided into hormonal 
and dietary.
The thyroid hormones are known to modify bile acid metabolism. 
Triiodothyronine has been shown to increase the rate of synthesis 
of total bile acids (Strand, 1963)* In agreement with this,
Wada et al. (1969) and Balasubramaniam et al. (1975) have shown 
a marked induction of cholesterol 7^-hydroxylase activity after 
administration of thyroxine; thyroidectomy decreases the activity 
(Balasubramaniam et al., 1975 ; Mayer, 1975)* However, the 
work of Story et al. (1974) does not confirm this. It has been 
suggested that thyroid status may also influence other enzymes 
in the synthetic pathway (Mitropoulos et al., 1968; Bjorkhem 
et al., 1973).
Cholesterol /^.-hydroxylase activity shows a pronounced
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diurnal variation, with a maximum during the dark period (Gielen 
et al., 1969; Danielsson, 1972; Mayer, 1976). Thus it has been 
suggested that experiments investigating the effect of environ­
mental changes on the enzyme should take this into account 
(Mayer, 1976). However, Bjorkhem et al. (1978) showed that 
the effects of modified fat diets on 7<^-hydroxylation were the 
same, irrespective of the lighting conditions. The exact 
mechanism of the diurnal variation is uncertain. From studies 
in which the rhythm is maintained under conditions of both 
fasting and feeding (reviewed by Myant and Mitropoulos, 1977), 
it is apparent that there is an inherent periodicity in cholesterol 
7?L-hy dr oxylase activity which may be secondarily influenced by 
external factors such as diet or alteration in light cycles.
This contention is supported by the findings of Van Cantfori 
(1973; 1974), who showed that in rats kept in continued darkness 
and in genetically blind mice, the diurnal rhythm is maintained. 
Plasma corticosterone concentration, which itself displays a 
pronounced diurnal response,is known to affect cholesterol 
7cC-hydroxylase activity. Gielen and coworkers (1975) reported 
abolition of the diurnal rhythm after hypophysectomy or 
adrenalectomy. This was confirmed by Balasubramaniam et al. 
(1975)* Administration of glucocorticoids to rats increased 
the activity of cholesterol 7<^-hydroxylase, an effect which 
could be counteracted by the injection of Actinomycin D (Gielen 
et al., 1976). These studies implicate a regulatory function 
for corticosterone in 7t*-hydroxylase activity which may be 
at the level of RNA synthesis. Additional evidence was provided 
by Van Cantfort (1973) who showed that the circadian rhythm in
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enzyme activity was not established until the 20th day after 
birth, which corresponds exactly with the appearance of a 
diurnal rhythm in adrenocorticotrophin secretion and plasma 
corticosterone concentration (Myant and Mitropoulos, 1977)*
With respect to the influence of diet on cholesterol 
7cC-hydroxylase, investigations to date have been limited, 
largely focussing on the effect of cholesterol feeding on its 
activity. This will be discussed in Chapter 2. However, it 
is likely that the nutritional status of the animal would 
influence this enzyme as the activities of the microsomal mixed 
function oxidase enzymes and their components are markedly 
influenced by alterations in diet.
Influence of Nutrition on Mixed Function Oxidase Activity
The influence of nutritional status on the metabolism of 
foreign compounds by the microsomal mixed function oxidase 
enzymes is a subject which has been frequently reviewed 
(Campbell and Hayes, 1974? Campbell and Hayes,1976; Becking,
1976? Wade and Norred,1976; Zannoni and Sato, 1976? Campbell, 
1977; Conney et al., 1977; Kato, 1977)• Variations in the 
quantity or quality of the major nutrients protein, carbohydrate 
or fat and of minerals or vitamins may influence foreign compound 
metabolism. The effects of dietary lipid, vitamins and minerals 
will be considered in Chapters 2, 3 and 4, but the role of 
carbohydrate, protein and the total energy content of the diet 
will briefly be discussed here.
Manipulation of dietary carbohydrate results in alterations 
in mixed function oxidase activity, although it is thought
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that the influence of carbohydrate is not specific to the enzyme 
system itself hut acts by modifying intermediary metabolism 
(Campbell and Hayes, 197*0* Hats fed sucrose or a mixture of 
glucose and fructose were shown to display decreased biphenyl 
4-hydroxylase activities associated with decreased levels of 
cytochrome P-450 (Dickerson et al., 1971). Similarly, Boyd 
et al. (1970) reported an increased toxicity of benzylpenicillin 
as a result of its decreased metabolism in rats fed high sucrose 
diets. Likewise, increased consumption of various monosaccharides 
prolonged the barbiturate-induced sleeping time of mice (Strother 
et al., 1971)*
The effects of protein deficiency on mixed function oxidase 
activity have been thoroughly investigated; a reduction in 
either its quantity or quality results in diminished metabolism. 
Drill (1952) first reported the increased toxicity of drugs
*
under conditions of protein deficiency. The in vitro oxidative 
microsomal metabolism of various substrates such as phenobarbi­
tone, strychnine, aminopyrine, zoxazolamine, aniline and 
ethylmorphine is reduced by protein deficiency (Kato et al.,
1968; Mgbodile and Campbell, 1972), as is their capacity for 
induction(Mgbodile et al., 1973; Campbell, 1977). It is also 
evident that reduced quality of the protein influences metabolism. 
Rats fed different types of protein exhibited varying suscepti­
bility to the lethal effects of heptachlor (Webb and Miranda, 
1973)* In agreement with this, in vivo and in vitro drug 
metabolism, cytochrome P-450 and microsomal protein concentrations 
were low in rats fed gluten compared to those fed casein as the 
protein source (Miranda and Webb, 1973)*
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The consequencesof alteration in dietary carbohydrate and 
protein have also been studied in man (Kappas et al., 1976;
Conney et al., 1977)• These workers determined the antipyrine 
and theophylline half-lives in volunteers fed a "normal" home 
diet, a high protein/low carbohydrate diet and a high carbohy­
drate/low protein diet. Whereas the high protein diet resulted 
in a pronounced diminution in plasma half-life of both drugs, 
the high carbohydrate regime tended to increase them, thus 
giving support to the animal experiments.
Finally, it should be noted that foreign compound metabolism 
is measurably, although variably, influenced by starvation.
Dixon et al. (I960) reported a decrease in both in vivo and 
in vitro hepatic drug metabolism in starved mice. Conversely,
Kato et al. (1962) demonstrated a slight increase in meprobamate 
metabolism in fasted female rats. Later, Kato and Gillette
(1965) concluded that there was a marked sex difference in ' 
response to starvation^ex-dependent enzymes such as hexobarbitone 
and pentobarbitone hydroxylase and aminopyrine N-demethylase 
were impaired, whilst p-nitroanisole O-demethylation and 
zoxazolamine hydroxylation, which are less sex-dependent, were 
little affected. This sex difference was also observed by 
Gram et al. (1970); males tended to be more responsive to fasting.
Aim of Present Study
In view of the established association between dietary 
composition, hyperlipidaemia and bile acid metabolism, the 
present study was designed to investigate this association, 
emphasising the rate-limiting enzyme in bile acid biosynthesis,
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cholesterol 7<^-hydroxylase. In this way, it was hoped to elucidate 
the role of diet in the pathogenesis of hypercholesterolaemia 
and atherosclerosis. As the enzyme is known to belong to the 
mixed function oxidase system, which is also responsible for 
foreign compound metabolism, studies on drug metabolism were 
carried out in parallel.
Chapter 2
The Interaction Between Dietary Lipid and the Hepatic 
Metabolism of Cholesterol and Foreign Compounds in the
Rabbit
-38-
Introduction
A relationship between the lipid content of the diet and 
atherosclerosis in man, was noted as early as the 1st world war, 
when Aschoff in Germany observed a decline in frequency of severe 
atherosclerotic lesions at autopsy, which he attributed to a 
decrease in total fat intake in the population (Grande, 197**) • 
Similarly, Malmros (1950) noted a reduction in mortality from 
atherosclerosis during the 2nd world war, a period when rationing 
enforced decreased intakes of dietary fat. Groen et al. (1952) 
observed that, in man, diets rich in animal fats increased serum 
concentrations of cholesterol compared with vegetarian diets. 
Numerous experiments have confirmed these findings; this earlier 
literature has been reviewed by Jollife (1961) and Page et al. 
(1957).
Much data is derived from epidemiological studies (reviewed 
by Stamler, 1967), notably those of Keys and his colleagues. In 
an early study (Bronte-Stewart et al., 1955)» showed that a 
Capetown population consuming foods rich in fat had higher serum 
cholesterol levels than a Bantu tribe consuming less fat. . A 
subsequent more extensive study, in which 18 population groups 
in seven countries were compared, provided a strong positive 
linear correlation (r = O.89) between intake of saturated fat 
and serum cholesterol concentration (Keys et al., 1970). The 
International Atherosclerosis Project (Scrimshaw and Guzman, 1968) 
showed that the rank order of serum cholesterol concentrations 
was similar to that of the percentage energy derived from total fat.
Evidence in favour of a hypercholesterolaemic role for 
saturated fat has also been provided by the study of geographical 
differences in dietary fat intake and by the observation of
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migrant populations. The serum cholesterol levels of primitive 
populations are substantially lower than those of Western 
industrialised societies. In these groups, a significant 
relationship between dietary fat, serum lipid levels and coronary 
heart disease is apparent (Mendez et al. 1962; Truswell 1968 ; 
Sinnett and Whyte, 1973)* In individuals migrating from primitive 
areas associated with a low incidence of coronary heart disease 
to urbanized areas with a higher incidence, there is a consistent 
relationship between alteration in dietary fat consumption and 
serum lipid levels. Keys et al. (1958) noted an apparent gradient 
for saturated fat, blood lipids and coronary event rate, increa­
sing from indigenous Japanese men to migrant Japanese in Hawaii 
and Los Angeles to Caucasians. Those observations have been 
confirmed in similar populations (Kato et al., 1973 ; Worth et al., 
1975; Robertson et al., 1977)*
Serum lipids are influenced by total fat intake, by dietary 
cholesterol and by the nature of dietary fatty acids. Attention 
has largely been focussed on the degree of unsaturation of these 
fatty acids, as will be considered in further detail below, but 
it should also be noted that their chain length (Hashim et al., 0-960); 
Grande et al., 1970) and their stereoisomeric nature (Vergroesen, 
1972) are important.
Beveridge et al., (1955)» using liquid formula diets in 
human volunteers, demonstrated considerable reductions in serum 
cholesterol concentration by feeding a corn oil/margarine mixture 
which supplied either 28$ or 59$ of the total energy. Supplemen­
tation of the diet with equivalent amounts of butter resulted 
in significant serum cholesterol elevation. It is thus generally
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accepted that saturated and polyunsaturated fats have opposite 
effects on serum cholesterol levels and several equations have 
been derived to predict this response when altering the propor­
tions of these two types of fat in the diet. Keys et al. (1957; 
1965) employed the equation: cholesterol = 2.7^AS - 1.31AP
and Hegsted et al. (1965)* cholesterol = 2.16AS - I.65AP +
6.66C - 0*53* In these equations, S and P represent changes 
in the percentage energy derived from saturated and polyunsat 
fatty acids respectively; C is the dietary cholesterol in mg$. 
From these equations, it can be concluded that on a weight 
basis, saturated fats have a hypercholesterolaemic effect which 
is twice as great as the influence of polyunsaturated fats in 
the opposite direction.
Experimental and epidemiological data in support of the 
hypocholesterolaemic action of polyunsaturated fat is continually 
being published. Thus, Sacks et al. (1975) reported that 
vegetarians displayed lower serum cholesterol concentrations 
than a control group. The consumption of polyunsaturated meats 
by a volunteer group of young adults was also shown to be 
associated with a reduction in serum lipids (Hodges et al.,
1975)• However, these workers qualify their results by noting 
that substitution of these polyunsaturated products is only 
effective in "responsive persons", i.e. those with initially 
higher serum lipid levels. Similar results were reported by 
Stein et al. (1975)» Brown et al. (1976) and Salel et al. 
(1977). Further recent evidence emanates from the study of 
Hill and Wynder (1976), who achieved a reduction in serum 
cholesterol levels in young, healthy volunteers by increasing
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the polyunsaturated to saturated fat ratio of the diet from 
0.3 to 1.2.
The considered importance of dietary cholesterol per se 
as an aetiological agent in hyperlipidaemia has tended to wax and 
wane,thus the original contention (Engelherg and Newman, 1943) 
that cholesterol intake was a major determinant of serum levels, 
was modified when the more obvious effects of total dietary 
fat were recognised, together with the inter-individual variation 
in response to cholesterol intake (Keys et al., 1956). 
Nevertheless, Mattson et al. (1972) reported that in subjects 
ingesting a diet containing 317mg of cholesterol per 1000 Kcal, 
serum cholesterol concentrations increased by 25$ over those 
measured on a cholesterol-free diet. However there would appear 
to be a threshold level of intake (500-600rag per day) beyond 
which additional dietary cholesterol is without effect 
(Beveridge et al., i960; Connor et al.. 1961). This has recently 
been confirmed by Slater et al., (1976), who showed that feeding 
of extra eggs (2 per day to young men, 1 per day to older men), 
in addition to a normal diet, resulted in no significant increase 
in serum cholesterol.
Experimental studies in animals also tend to support the 
relationship between dietary lipid intake and serum concentra­
tions. Much of the work has been performed in rabbits, following 
the initial studies of Anitschkow and Chalatow (1913). who produced 
lesions resembling those seen in human atherosclerosis by adminis­
tering diets high in cholesterol. Although these diet-induced 
lesions have been reproduced by other workers, the use of such an 
experimental model has been extensively criticised as not being
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analogous to the human condition and representing a storage 
phenomenon rather than the true degenerative change of atheros­
clerosis (Roberts and Straus, 1965; Wissler and Vesselinovitch,. 
1968).
However, by feeding semi-synthetic diets, high in saturated 
fat but without additional cholesterol, to the rabbit, it is 
possible to induce hypercholesterolaemia and atherosis (Lambert 
et al., 1958; Wigand, 1959)* Using this model, the substitution 
of linoleic-rich polyunsaturated oils in the diet can be shown 
to reduce serum cholesterol concentrations and protect against 
atherosclerosis (Malmros and Wigand, 1959; Moore and Williams, 
1964). The severity of these lesions has been shown to be 
inversely proportional to the iodine value of the ingested fat 
(Kritchevsky, 1970).
Mechanism of Action of Rat-Modified Diets
The mode of action of these diets, particularly regarding 
the hypocholesterolaemic effect of polyunsaturated fats, remains 
controversial. Possible mechanisms have been reviewed by Grundy 
and Ahrens (1976) • These fats could act via a) a reduction in 
cholesterol absorption, b) a decrease in endogenous cholesterol 
synthesis,' c) an increase in faecal excretion of cholesterol 
as neutral sterols or bile acids, or by a combination of these. 
Spritz and Mishkel (1969) have suggested that the effect of 
polyunsaturated fat might be to modify lipoprotein structure 
and there is some evidence to support this concept. Detailed 
consideration of this postulated mechanism is however considered 
to be beyond the scope of this thesis and has been recently
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review ed by Jackson et aJ.. (1978).
Dietary Lipid and Cholesterol Absorption
Data derived from experiments on cholesterol absorption 
is equivocal. In the rat (Byers and Friedman, 1958) and in
man (Pinter et al., 196*0 polyunsaturated fat has been shown
to increase cholesterol absorption. Conversely, Wood et al.
(1966) reported a decreased absorption of this sterol in men 
fed polyunsaturated fats. Other workers have not shown any
change in the rat (McGovern and Quackenbush, 1973)» in normal
human subjects (Nestel et al., 197*0 or in patients suffering 
from hyperlipidaemia (Grundy, 1975)*
Dietary Lipid and Cholesterol Synthesis
Investigations into cholesterol synthesis in man and 
experimental animals fed the two types of fat have been equally 
controversial, with reports of an increase (Wood and Migicovsky, 
1958), a decrease (Wiech et al., 1967) and no change (Ahrens, 
1957; Grundy and Ahrens, 1970; Nestel e_t al., 197*+)*
Dietary Lipid and Cholesterol Excretion
Human Studies
In man, faecal neutral sterol excretion has been measured 
under conditions of an increased intake of polyunsaturated fat. 
An increased excretion was reported by several workers (Wood 
et al., .1967; Moore et al., 1968); others have not observed this 
increase, despite a reduction in serum cholesterol concentration
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(Eneroth et al., 1964; Avignon and Steinberg, 1965; Grundy 
and Ahrens, 1970).
Many investigations have included measurements of bile 
acid excretion and perhaps the most widely studied hypothesis 
is that polyunsaturated fats may enhance the conversion of 
cholesterol to bile acids. Abnormalities in bile acid excretion 
have been observed in patients suffering from primary disorders 
of lipid metabolism. Using isotopic techniques, Miettinen et "al.
(1967) observed low faecal bile acid excretion in patients 
with familial hypercholesterolaemia. However, the relationship 
is complex as demonstrated by the work of Hellstrom and Lindstedt
(1966) and Kottke (1969)1 who found that whilst bile acid 
synthesis was subnormal in patients suffering from primary 
hypercholesterolaemia, it was abnormally high in those with 
combined hypercholesterolaemia and hypertriglyceridaemia. 
Similarly, Einarsson and Hellstrom (1972) reported differences 
in bile acid turnover in patients with different types of 
hyperlipoproteinaemia; lower turnovers were observed in Type II 
(hypercholesterolaemia) compared with Type IV (hypertriglycerid­
aemia) subjects. Similar differences were observed by Sodhi 
and Kudchodkar (1973)» who also noted that faecal excretion of 
bile acids was lower in Type II than Type IV subjects.
Several investigators have suggested that the inclusion 
of mainly unsaturated fats in the diet results in an increased 
excretion of bile acids (Gordon et al., 1957; Haust and Beveridge, 
1958; Goldsmith et al., i960; Antonis and Bersohn, 1962).
However, others have reported diminished (Ali et al., 1966) or 
unchanged excretion (Avignon and Steinberg, 1965)• Nevertheless,
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some of these experiments were carried out on small groups 
with varying degrees of initial cholesterolaemia, which as 
mentioned above may itself influence bile acid metabolism.
Moore et al. (1968) studied normal subjects given a polyunsatu­
rated fat diet (*10$ safflower oil as compared to kOfo butterfat) 
and found an increase in both faecal bile acid and neutral 
sterol excretion. However, differences in cholesterol content 
of the two diets limits the interpretation of this study.
Connor et al. (1969) performed similar experiments, using 
cholesterol-free diets and also observed a significant increase 
in bile acid excretion in response to polyunsaturated fat feeding. 
More recently, Nestel et al. (1973; 197*0 have shown that whilst 
faecal steroid excretion, including bile acid excretion, increases 
initially after feeding polyunsaturated fats, once a new steady- 
state condition is reached, steroid excretion is similar to 
that observed with saturated fat in the diet.
In a study involving the effects of polyunsaturated fat 
diets on bile acid excetion in hyperlipidaemic subjects (Grundy,
1975)» results showed considerable variation, depending on the 
type of lipidaemia, in accordance with the findings of Einarsson 
and Hellstrom (1972) and Sodhi and Kudchodkar (1973)*
Animal Studies
Investigations of the interaction between dietary lipid 
and bile acid metabolism in animals have generally be designed 
to examine the effects of cholesterol feeding. In general, 
it can be concluded that in animals such as the rat, who show 
little hypercholesterolaemia in response to cholesterol feeding,
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there is a pronounced increase in bile acid excretion (Wilson, 
1962; Wilson, 1964; Uchida et al., 1977)• Conversely, in 
species displaying hypercholesterolaemia, bile acid excretion 
is virtually unchanged (Hellstrom 1965; Beher et al., 1970).
The effects of administration of diets rich in com oil to 
rats has also been examined (Beher et al., 1970; Kim et al.,
1976), no change in bile acid turnover was reported.
In view of the role of the enzyme cholesterol ^-hydroxylase 
in the control of bile acid synthesis, it would seem logical 
to examine the effect of variation in the dietary lipid 
component at this site. The influence of cholesterol feeding 
on the activity of this enzyme has been studied. An increase 
in activity was observed by some workers (Boyd et al., 1969; 
Mitropoulos et al., 1973; Raicht et al., 1975)» whereas others 
have failed to detect any significant change (Bjorkhem and 
Danielsson, 1975)* To date, the influence of the degree of 
saturation of the fat on the activity of this enzyme has not 
been examined. Such an effect might be anticipated in view 
of the known relationship between essential fatty acids and 
mixed function oxidase metabolism.
Effects of Dietary Lipid on Mixed Function Oxidase Metabolism
The mixed function oxidase enzymes are associated with 
the lipoprotein membranes of the hepatic endoplasmic reticulum; 
30-55# of the dry weight of these membranes is lipid, comprised 
largely of phospholipids (Siekevitz 1963; Glaumann and Dallner,
1968), which are of prime importance to the integrity of the 
enzyme system. Chaplin and Mannering (1970) observed a decrease
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in ethylmorphine and hexobarbital metabolism together with a 
depression of Type I binding following treatment of microsomes 
with phospholipase C. Likewise, extraction of microsomal 
phospholipid with iso-octane also resulted in a depression of 
type I binding (Leibman and Estabrook, 1971)» indicating that 
this form of binding is dependent on phospholipid. An absolute 
requirement for phosphatidylcholine in a reconstituted enzyme 
system was demonstrated by Coon and his associates (Lu and 
Coon, 1968; Strobel et al., 1970). In addition to this specific 
function, lipids are also essential for the maintenance of the 
integrity of the membrane itself, as indicated by the observation 
that the phenobarbitone-induced increase in microsomal phospho­
lipid, triglyceride and cholesterol is of a similar order to 
that of the protein component (Glaumann and Dallner, 1968).
The effects of dietary lipid on mixed function oxidase 
metabolism have been recently reviewed (Wade and Norred, 1976; 
Kato, 1977)* The majority of investigations have examined the 
changes associated with manipulation of polyunsaturated fatty 
acids, particularly the essential fatty acid content of the diet. 
Experiments in which saturated fat was fed to rats have yielded 
equivocal results* Caster et al. (1970b) fed saturated fats 
at the level of 15-35$ of total energy and observed an increase 
in aniline hydroxylation but no change in hexobarbital metabolism. 
Conversely, Hietanen et al. (1975) reported a decrease in aryl 
hydrocarbon hydroxylase activity but little effect on the 
O-demethylation of p-nitroanisole in rats fed 34# cacoa butter.
In accordance with this, Agradi et ad.. (1975) demonstrated a 
decrease in benzoCalpyrene hydroxylase and cytochrome P-450
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concentration in male rats fed a diet containing 10$ saturated 
fat but observed no change in aniline metabolism.
In general, supplementation of fat-free diets with polyunsa­
turated fatty acids results in an increase in mixed function 
oxidase activity. Caster et al. (1968) observed a loss of drug 
metabolising ability in linoleate-deficient rats, which could 
be reversed by the addition of 3 linoleic acid to the diet. 
Similarly, rats fed diets deficient in unsaturated fatty acids 
show a diminished cytochrome P-450 content, (Marshall and 
McLean, 1971; Kaschnitz, 1970; Norred and V/ade, 1972). The 
activity of NADPH-cytochrome c reductase is largely unaffected 
by essential fatty acid deficiency (Wade et al., 1972; Norred 
and Wade, 1976)•
The effects of essential fatty acid deficiency on the 
kinetics of some mixed function oxidase reactions were examined 
by Norred and Wade (1972)* The apparent Vmax*s for metabolism 
of aniline, hexobarbital and ethylmorphine were increased by 
supplementation of a fat-free diet with com oil. However, 
the apparent Km's for the reactions were unaffected, with the 
exception of aniline and hexobarbital^which, although not 
influenced by 3% com oil were elevated by a diet containing 
10$ com' oil. This has led Wade and Norred (1976) to conclude 
that increases in mixed function oxidase metabolism induced 
by dietary lipid are largely a function of increased enzyme 
concentration rather than any qualitative alteration in the 
enzyme system.
Data derived from in vivo experiments, notably those 
measuring hexobarbital sleeping times, are conflicting. Most
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workers (Caster et ad.. , 1970a; Kaschnitz, 1970; Century, 1973) 
have found this parameter to he slightly increased or unchanged. 
However, more recent experiments (Wade and Norred, 1976) showed 
a reduction in sleeping time in both rats and mice fed diets 
supplemented with com oil.
The effect of dietary lipid on induction of mixed function 
oxidase enzymes has also been investigated. Microsomal prepara­
tions derived from rats maintained on diets deficient in essential 
fatty acids were shown to have a reduced capacity for induction 
by phenobarbital (Century and Horwitt, 1968; Marshall and McLean, 
1971)* In order to permit maximal induction of cytochrome P-450 
synthesis in response to phenobarbitone administration, Marshall 
and McLean (1969; 1971) showed that the addition of herring oil, 
linoleic acid, 0.1$ oxidised cholesterol or sitosterol was 
necessary. Supplementation with coconut or olive oil was without 
effect. They thus postulated a "permissive effect" for linoleic 
acid which they consider might be a function of the degree of 
the unsaturation of the fat or of its susceptibility to peroxi­
dation.
From this review of the literature, it can be concluded 
that adequate amounts of polyunsaturated fats are required to 
maintain microsomal metabolism. Deprivation may result in 
quantitative and some qualitative changes in the components of 
the enzyme system.
Selection of an Animal Model for Dietary Experiments
A major problem in the investigation of the interaction 
between dietary and serum lipid levels and atherosclerosis is
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the selection of a suitable animal model. The subject has been 
frequently reviewed (Roberts and Straus, 1965; Kritchevsky, 1974; 
Clarkson et al., 1976). As mentioned earlier, the New Zealand 
white rabbit has been used extensively in these studies, as 
it is susceptible to the dietary induction of hyperlipidaemia 
and atheroma.
Other species such as the rat and dog are generally more 
resistant to the development of atheromatous lesions (Roberts 
and Straus, 1965; Kritchevsky, 1974). Thus although it is 
possible to engender atherosclerosis in these species, mechanical, 
chemical or immunological injury to the arterial tissue is 
usually needed as an adjunct to the atherogenic diet (Gutstein 
et al., 1963; Bajwa et al., 1971; Testa et al., 1975)• The 
validity of results emanating from these experiments is doubtful . 
as the conditions are aphysiological.The diet-induced changes 
in the rabbit would suggest this species as a better model 
although it is vegetarian and the constitution and distribution 
of the induced atheromatous plaques are dissimilar to those 
seen in man.
In recent years, the trend in atherosclerosis research 
has been towards the use of non-human primates such as the 
monkey or baboon. These animals have the advantage of being 
omniverous and to exhibit a progression and distribution of 
lesions similar to man. However, there is a considerable 
inter-species variation in response to diet and some workers 
have found it necessary to use additional methods to induce 
atheroma (Corey et al., 1974).
Scott et ad.. (1972) outlined the properties which an ideal
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animal should possess. They suggested that it should be possible 
to rapidly induce atheroma in the animal, without recourse to 
expensive or extremely unphysiological means; the animal should 
be of sufficient size to provide tissue for multiple studies; 
it should be easily available, inexpensive and easy to house 
and feed; the induced lesions should resemble those seen in 
man. Thus, whilst overall the monkey would seema suitable 
model, the expense and housing difficulties encountered with 
this species are considerable and in other respects, the rabbit 
satisfies many of the above-stated criteria.
Aim of Present Experiment
Despite the acknowledged influence of dietary lipid on 
bile acid metabolism, there is little available information 
regarding its effect on cholesterol 7ol-hydroxylase activity.
It could be postulated that alterations in the concentration 
or conformation of this enzyme might affect the fate of choles­
terol and consequently its availability for tissue deposition.
As a. corollary to this, factors such as diet, which are known 
to modify cholesterol and lipid metabolism, might be expected 
to influence the nature of the enzyme. Thus, considering the 
association between lipid and mixed function oxidase metabolism 
generally, an experiment was designed using the New Zealand 
white rabbit as the experimental model. The effect of feeding 
semi-synthetic diets containing either saturated or polyunsatu­
rated fats on certain parameters of cholesterol and bile acid 
metabolism were examined. Additionally, in an attempt to 
elucidate the heterogeneity of cytochrome P-450 with respect
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to its involvement in the cholesterol 7dL-hydroxylase system, 
levels of cytochromes and some typical mixed function oxidase 
enzymes were measured.
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Materials
Specific chemicals were supplied as follows:
Enzymes and Cofactors
Nicotinamide adenine dinucleotide (NAD), nicotinamide 
adenine dinucleotide phosphate (NADP), its reduced form NADPH, 
glucose-6-phosphate (disodium salt), glucose-6-phosphate 
dehydrogenase (Type XII) were purchased from Sigma Chemical 
Company, London. ^3-hydroxysteroid dehydrogenase (0.5 units/mg, 
from Pseudomonas testeroni) was obtained from P-L Biochemicals 
Inc. (International Enzymes Ltd., Windsor, Berks.).
Radiochemicals
Radiochemical Centre, Amersham, Bucks.
Bile Acids
Sodium glycocholate was purchased from Maybridge Research 
Chemicals, fintagel, N. Cornwall.
Substrates
Biphenyl was obtained from B.D.H. Ltd., Poole, Dorset and 
was recrystallised from absolute ethanol. Ethylmorphine 
hydrochloride was purchased from May and Baker Ltd., Dagenham, 
Essex and cytochrome c (Type VI) from Sigma.
Other Chemicals
2- and 4-hydroxybiphenyls, formaldehyde and bovine serum
(50mCi/mmol) was supplied by the
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alburain were obtained from B.D.H. Ltd. XAD-7 resin (Rohm and 
Haas Ltd., Croydon, Surrey) was kindly donated by Dr. S. Barnes 
(Medical Unit, The Royal Free Hospital, London).
Most other chemicals were supplied by. B.D.H.Ltd.,Fisons (Fisons 
Scientific Apparatus, Loughborough, Leics.), or as specified 
in the text. <
Gases were supplied by B.C.C. Ltd., Crawley, Sussex and 
solvents were obtained from Fisons. Water was glass-distilled 
and stored in polypropylene containers.
Methods 
I Serum Analyses
(a) Serum Total Cholesterol
Serum total cholesterol concentrations were measured using 
a reagent kit (Biochemica Test Combination No. 15969, Boehringer 
Mannheim GmbH, Mannheim, Germany), based on the method of 
Watson (i960). This is an adaptation of the Li eb ermann - Bur chard 
colour reaction, involving the reaction of cholesterol in acetic 
anhydride with concentrated sulphuric acid and in the presence 
of dimethyl benzene sulphonic acid to form a coloured complex, 
the absorbance of which is measured at 573 run using a Cecil 
model CE 272 U.V. spectrophotometer (Cecil Instruments Ltd., 
Cambridge).
(b) Serum Triglycerides
Serum triglyceride concentrations were measured using 
reagent kit (Biochemica Test Combination No. 15395, Boehringer
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Mannheim GmbH). This uses the method of Wahlefeld (1974), 
involving the following series Of reactions:-
Triglyceride Glycerol + Fatty acid.
Glycerol + ATP -Qry^iFokS'as'e^ Glyoerol-l-phosphate + ADP.
ADP + PEP Phosphokinase) ^ v a t e  + ATP.
Pyruvate + NADH + H+ — i,DH"~* Lactate + NAD.
The NAD generated is measured at 340 nm using the S.P. 1800 
spectrophotometer.
(c) Serum Total Bile Acids
A modification (Barnes and Chitranukroh, 1977) of the 
assay system of Murphy et al. (1970) was utilised. Bile 
acids are isolated from serum by a liquid-solid extraction 
and measured by an enzymic-fluorimetric method. The enzyme 
used is 3-hydroxy steroid dehydrogenase, derived from Pseudomonas 
testeroni, which was originally used for the quantitative 
assay of. androgenous steroids. It is also applicable to bile 
acids hydroxylated in the 3-position. The reaction may be 
presented as:
Steroid alcohol + NAD* Steroid ketone + NADH + H+
The reaction is encouraged to proceed to the right by the
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addition of a ketone-trapping agent semicarbazide hydrochloride 
and the NAD is determined fluorimetrically.
Extraction Procedure
The resin, XAD-7 is a non-ionic acrylic polymer in the 
form of 350-500yU m beads.
It was soaked overnight in 5 volumes of distilled water 
to remove the sodium chloride and sodium carbonate added as 
a preservative. The fine particles were removed by repeated 
swirling and decanting, so that the remaining beads sedimented 
in 20-30 seconds. The resin was then extracted by stirring 
r for 2-3 hours, firstly with methanol, followed by chloroform: 
methanol (1:1 v/v) and finally with methanol. Thorough washing 
with water was then required until the chloroform odour 
disappeared. This resin was stored under water until required.
After use the resin was soaked in aqueous methanol 
(1:1 v/v) and regenerated by repeating the solvent extraction 
procedure.
XAD-7 resin (lg) was placed in a glass 10 ml sovirel tube 
fitted with a screw cap (V.A. Howe and Co, Ltd., London, SW6).
A 1ml aliquot of each test serum was added to separate tubes, 
followed by 0.1M sodium hydroxide, to give a final volume of 
9 ml. An extraction blank was set up using lg of XAD-7 and 
9ml of sodium hydroxide only.
The tubes were mixed using a Rollermix (Luckham Ltd., 
Burgess Hill,Sussex) at room temparature (20°C) for 60 minutes. 
After mixing, the supernatant was removed by aspiration on a 
water pump. In order to maintain a pH of 10 at all stages
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throughout the washing procedure, a 2ml volume of dilute sodium 
hydroxide (0.004M) was added, each tube was mixed briefly and 
the supernatant discarded. A 6ml volume of methanol was added 
to the resin and the contents of the tubes were mixed for a 
further 20 minutes on the Rollermix. The methanolic supernatant 
was transferred to a 25ml "pear-shaped" flask, the resin . 
extracted into a second 6ml of methanol and the supernatants 
combined. The methanol was removed in vacuo using a rotary 
evaporator at 50°C.
Enzymic Assay
The following incubation system was set ups
NAD
Blank
Reagent Extract Extract Serum Serum Standard 
Blank Blank‘d Blank^ Blank Test
*
Reagent A(ml ) 2.0 - 2.0 - 2.0 ' — -
Reagent B(ml ) - 2.0 - 2.0 - 2.0 2.0
50# aqueous 0.05 
methanol(ml)
0.05 — "■ — . — — ■
Serum Extract(ml) - - - -
ino•o 0.05 ' -
Blank Extract(ml) - - 0.05 0.05 - - -
Standard (ml) - - - - - 0.05
* Reagent A /100ml
94.5ml sodium pyrophosphate buffer 0.1M pH 10.2 
5.0ml methanol (A.R.)
4mg semicarbazide hydrochloride 
6mg & NAD
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** Reagent B /100ml
As reagent A plus 0.5mg (0.25iu) ^#-hydroxysteroid dehy­
drogenase.
These reagent mixtures were prepared immediately prior to use. 
Standards were prepared by diluting a stock solution of sodium 
glycocholate in 50$ aqueous methanol (lmg/ml) to cover a range 
of concentration from 10.25 to 205^ 1 mol/litre (5-100^(g/ml).
Tubes were set up in duplicate as above and mixed on a 
"Whirlimixer” Incubation was carried out at 37°C, in an atmosphere 
of air, in a shaking incubator (Mickle Laboratory Engineering 
Co., Gomshall, Surrey) with a shaking rate of about 80 oscilla­
tions per minute for 45 minutes.
The reaction was terminated by plunging the tubes into 
an ice-water slurry (0°C). The tubes were subsequently maintained 
at this temperature whilst the fluorescence intensity was 
measured. The fluorescence of the solutions was read using a 
Perkin Elmer Spectrofluorimeter Model MPF3* with a xenon lamp,
2 monochromators and quartz cuvettes of 1cm light path, excitation 
wavelength 365nm, emission wavelength 457nm.
II Liver Analyses
(a) Preparation of Liver Fractions
Rabbits were killed as described in section V between 08.00 
and 09.00 hours, the livers rapidly excised and the gallbladders 
detached. The livers were immediately placed in ice-cold buffer 
(modified Bucher medium: 10.8g KH^PO^ ; 3*9g KOH ; l.Og MgC^
6H2O ; 0.372g ED'i’A per litre). Any adhering fat or connective 
tissue was removed from the liver which was blotted dry and
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weighed. After 'scissor-mincing', a rough homogenate was 
prepared in 1 volume of ice-cold buffer using a Silverson 
mixer-emulsifier (Silverson Machines Ltd., Waterside, Chesham, 
Bucks.). An aliquot of this was taken and a further homogenate 
prepared in 2 volumes of ice-cold buffer using k return strokes 
of a Size C Potter-Elvejhem type, teflon-glass homogeniser 
(A.H. Thomas and Co., Philadelphia, U.S.A.) power driven at 
2,950 r.p.m. The homogeniser was rinsed with a further volume 
of ice-cold buffer and the resultant 20$ homogenate centrifuged 
in polypropylene tubes at 20,000 g av. for 15 minutes at 2°C 
(M.S.E."Highspeed 18% 8.x 50ral angle rotor at 12,900 r.p.m.). 
The supernatant, subsequently referred to as the microsomal 
supernatant and comprising the microsomal and soluble cell 
fractions was used for the determination of several enzyme 
activities.
Further centrifugation at 105,000 g av. for 60 minutes at 
2°C (M.S.E. "Superspeed 50", 8, x 25ml angle rotor at 40',000 
r.p.m.) yielded a clear supernatant which was discarded and 
a microsomal pellet which, after rinsing to remove residual 
supernatant, was resuspended with 2 return strokes in a size B 
homogeniser in buffer to give a 25$ suspension.
All procedures were performed as rapidly as possible and 
at a temperature of 0-^°C. All fractions were maintained 
at 0°C prior to use.
(b) Measurement of Microsomal Protein
The method of Lowry et al. (1951) was used; 0.2ml aliquots 
of microsomal suspension were diluted to 10ml with 0.5M NaOH,
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from which further 0.5ml aliquots were taken and mixed with 
5ml of freshly prepared Lowry reagent (Z°/o Na2C0^, 1% CuSO^, Z°/o 
Na K tartrate, 100 : 1 : 1 by volume). After at least 10 minutes,
0.5ml of Folin-Ciocalteau Phenol reagent (diluted 1:1 with 
water) was added and immediately vortex mixed. After allowing 
30 minutes for development, the blue colour was measured at 
720nm in the Cecil spectrophotometer. All determinations were 
carried out in duplicate and blanks (0.5M NaOH) and standards 
(25-100 g bovine serum albumin in 0.5M NaOH) were treated 
identically.
(c) Measurement of Total Lipid
Extraction
Lipid was extracted by a modification of the method of 
Bligh and Dyer (1959)•
Duplicate 2ml aliquots of the "rough homogenate" were 
homogenised with 38.0ml chloroform: methanol (2:1, v/v). The 
resultant homogenate was filtered through glass wool. A 3*2ml 
volume of methanol followed by 5*3ml of water was added to 
10ml of the clear filtrate in a universal container and mixed 
by inversion. The mixture was then centrifuged in a bench 
centrifuge at approximately 2,000 r.p.m. for 5 minutes. The 
upper aqueous layer was removed by aspiration at the water pump.
Estimation of Total Lipid
A 5^1 aliquot of the chloroform layer was taken into a 
weighed 25ml conical flask. The extract was evaporated in a
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stream of nitrogen and the flask desiccated overnight over 
silica gel,under vacuum. The flask was then reweighed to give 
the weight of lipid by difference.
(d) Measurement of Total Liver Cholesterol
The lipid residue was taken up in 3ml of absolute ethanol. 
Duplicate lOC^ t.1 aliquots were transferred to test tubes and 
evaporated to dryness in a water bath at 50°0, in a stream of 
nitrogen. The cholesterol content of the extract was determined 
using the same method as for serum.
(e) Viiro Enzyme Assays;. General Considerations
1. All incubation systems were prepared in duplicate on ice.
2. Incubations were carried out in an atmosphere of air in a 
shaking incubator, with a shaking rate of about 80 oscilla­
tions per minute.
3. An M.S.E. "Mistral 6L" centrifuge with a 6 x 1L swing-out 
rotor was used for all centrifugations.
4. For assays based on colo rimetric measurement of the 
reaction product there was a linear relationship between 
optical density and amount of product formed over a concen­
tration range greater than the extremes of variability 
encountered.
(f) Ethylmorphine N-Demethylase
N-demethylation is a typical reaction of the microsomal 
mixed function oxidase system. The formaldehyde produced 
is measured by the method of Nash (1953). The incubation
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system, (Holtzman et aa.,1968), was set up as follows:-
Test Blank Standard
Buffer(ml) 0.7 0.7 0.6
Semicarbazide solution(ml) 0.2 0.2 0.2
Cofactor solution ml 0.2 0.2 0.2
Substrate(ml) 0.2 0.2 0.2
Microsomal supematant(ml) 0.5 0.5 0.5
Standard (ml) - -
- * 0.1
* denotes added after the incubation.
Incubation volume - 1.8ml.
Buffer * Tris-HCI, 0.3M pH 7.4
Semicarbazide solution : 2?4(w/v) aqueous solution, adjusted to
pH 7.0 with NaOH.
Cofactor solution t Each 0.2ml of buffer contained NADP ^.mol,
glucose-6-phosphate 20/i(mol and magnesium
as M gC^» lO^mol.).
Substrate t Ethylmorphine hydrochloride, 75niM aqueous solution.
Standard i Aqueous formaldehyde f u^nol/ml, standardised using
-1 —1an extinction coefficient of 8mM cm for the 
HCHO-Nash reagent complex.
Incubation was for 10 minutes at 37°C, the reaction was terminated 
by the addition of lml 15$(w/v) zinc sulphate, after placing 
the tubes on ice. After addition of substrate and standard to 
the appropriate tubes, 1ml of saturated barium hydroxide was 
added to each tube and the contents mixed. All tubes were then 
centrifuged at 2,000 r.p.m. for 15 minutes at 4°C. A 2ml aliquot
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of clear supernatant was transferred into clean tubes to which 
a 2ral volume of freshly prepared Nash reagent (0.4?&(v/v) 
acetylacetone in 4M ammonium acetate ) was added. After heating 
at 37°C for 40 minutes with shaking, the resultant yellow colour 
was measured at 412nm using the Cecil spectrophotometer.
(g) Biphenyl 4- and 2-Hydroxylase.
Biphenyl undergoes hydroxylation at a number of positions, 
the major metabolite being 4-hydroxybiphenyl. Small quantities 
of 2-hydroxybiphenyl are generated and both isomers can be 
measured simultaneously, since at pH 5«5» they exhibit different 
fluorescence spectra. The following incubation system (Creaven 
et al., 1965) was used*-
Test Blank 20H Standard 40H Standard
Cofactor solution in 
Buffer(ml) 1.0 1.0 1.0 1.0
1.15?& KCl(ml) 0.5 0.5 - - ;
Substrate(ml) 0.5
*
0.5
*
0.5
*
0.5
Microsomal supernatant(ml) 0.5 0.5 0.5 0.5
2-hydroxybiphenyl
standard(ml) — ...
■*
0.5 —
4-hydroxybiphenyl 
standard(ml) _ _ —
ft
0.5
* denotes added after incubation. 
Incubation volume = 2.5ml.
Buffer * Tris-HCI, 0.05M pH 8.1
Cofactor solution * each 1.0ml contained NADP yunol, glucose-6-
phosphate l^ uraol, MgCl^ lOjmol.
Substrate s Biphenyl 12mM in 1.15ft KC1 containing 2.5?»(w/v)
Tween 80 (polyoxyethylene sorbitan monoleate). 
Standards x 2-hydroxybiphenyl 12^g/ml in lOWv/v) aqueous ethanol 
4-hydroxybiphenyl Jojxg/ml in 10ft(v/v) aqueous ethanol 
All tubes were incubated at 37°C for 15 minutes. The reaction 
was terminated by the addition of 0.5ml of 4M HC1 after placing 
the tubes on ice, substrate and standard being added to the 
appropriate tubes. After the addition of 7ml of n-heptane, all 
tubes were extracted for 15 minutes on a rotary shaker. Any 
emulsion formed was broken by centrifugation at 2,000 r.p.m. 
for 15 minutes. A 2ml aliquot of each heptane layer was 
transferred to clean tubes, 5ml of 0.1M NaOH added and the tubes 
extracted for a further 15 minutes on the rotary shaker. After 
centrifugation at2,000 r.p.m. for 15 minutes, the heptane layer 
was aspirated off at the water pump. Hydroxybiphenyls in the 
NaOH phase were stable in the dark at 4°C for at least 24 hours.
A 2ml aliquot of the NaOH phase was pipetted into a fluo- 
rimeter cuvette and the pH brought to 5.5 by the addition of 
0.5ml of 0.25M succinic acid. 2- and 4-hydroxybiphenyls were 
determined using the Perkin Elmer spectrofluorimeter at 290nm 
(excitation) and 4l0nm (emission) and 276nm (excitation) and 
332nm (emission) respectively.
Under the conditions employed, 4-hydroxybiphenyl fluoresces 
slightly at the wavelength maxima of 2-hydroxybiphenyl. It 
is thus necessary to read the 4-hydroxybiphenyl standard and 
all test samples and blanks at both wavelength maxima and apply
a correction factor for subtraction from the 2-hydroxy readings 
of all test samples and blanks as follows*
4-OH biphenyl reading; x concn. 4-OH biphenyl standard 
4-OH biphenyl standard reading
(Amax 4-OH biphenyl)
v 4-OH biphenyl^ standard reading 
concn. 4—OH biphenyl standard
(Amax 2-OH biphenyl)
(h) NADPH-Cytochrome c Reductase
The absorption of reduced cytochrome c was followed at 
550nm, (Gigon et al., 1969)•
Two lcm glass cuvettes were set up as follows:-
Tris-HCI 0.02M in 1.15J6 KC1, pH 7«4(ml) 0.5
Potassium cyanide 3mM(ml) 1.0
Cytochrome c 0.15mi»l (ml) 1.0
Microsomal suspension, 25ft in Tris/KCl as above(ml) 0.1
The cuvettes were placed in the forward cell compartment 
of the SP 1800 spectrophotometer. After zeroing the recorder, 
0.2ml Tris/KCl was added to the reference cuvette. After 
allowing 2 minutes for equilibration to ambient temperature,
0.2ml of NADPH solution (1.5mM) was added to the test cuvette. 
The increase in absorption at 550nm was followed and from the 
initial, linear phase of the reaction, -cytochrome c reductase 
activity was calculated using an extinction coefficient for 
reduced cytochrome c of 27.7mM”^cm"(Mahler and Cordes, 1966).
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(i) Cytochrome b5
A modification of the method of Omura and Sato (1964) 
was used. A 1ml aliquot of microsomal suspension (as in (h) 
above) and 2ml of-Tris/KCl were pipetted into each of two 1cm glass 
cuvettes. A small amount (approximately l-2mg) of sodium 
dithionite was added to the test cuvette and the reduced minus 
oxidised difference spectrum recorded between 390 and 500nm 
using the SP 1800 spectrophotometer. Cytochrome b5 content 
was calculated using an extinction coefficient of 171mM"1cra“1 
for the extinction difference between 409 and 426nm.
(j) Cytochrome P-450s Carbon Monoxide Ligand
In its reduced form, the cytochrome P-450-C0 complex 
absorbs strongly at 450nm. Measurement of this spectral maximum 
enables quantification of the cytochrome (Omura and Sato, 1964).
Test and reference cuvettes were set up as in (i) above 
and both reduced with a small amount of sodium dithionite. CO 
was bubbled through the contents of the test cuvette for 30 
seconds and the difference spectrum between 390 and 500nm 
recorded as previously. Cytochrome P-430 content was calculated 
using the extinction coefficient 91mM“^cm“^ for the extinction 
difference between 450 and 490nm.
(k) Measurement of Cholesterol 7dL-hydroxylase activity
The method employed was based on that of Berseus et al.(1969) .
Incubation
The incubation system was as followsj
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Test Control
Microsomal supernatant (ml) 1.0 -
Boiled Microsomal supernatant (ml) - 1.0
Cofactor solution (ml) 0.2 0.2
£"3-
Substrate (ml) 0.5 0.5
Acetone (ml) 0.02 0.02
* Cofactor solution /ml modified Bucher medium
25/imol NADP
** C W ^ C 3 Cholesterol lynCi/ml absolute ethanol.
The incubation was carried out in 25ml conical flasks. A 0.5ml 
volume cholesterol was added to each flask and the
ethanol evaporated to dryness in a water bath at 50°C in a 
stream of nitrogen. The residue was taken up in the acetone 
and test and control incubates set up as above. Flasks were 
incubated at 37°C, with shaking, for 60 minutes.
Extraction Procedure
The reaction was terminated by the addition of 5ml of 
methanol, the mixture transferred to a 15ml glass tube with a 
screw cap and the flask washed out with a further 5ml of methanol. 
Neutral lipid was subsequently extracted according to the method 
of Hattersley (1975) (Pig.2.1). Extraction recovery was of the 
order of 80-90^, being checked by sampling at each stage of 
the extraction procedure.
The combined lipid extract was transferred to a 25ml 
“pear-shaped 1 flask and evaporated to dryness in vacuo using a
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Incubation Medium
Supernatant <-
Add 2 x 5ml methanol, extract 
10 minutes, centrifuge 2000 
r.p.m., 10 minutes.
Pellet
Mix 10 minutes cen­
trifuge 5 minutes, 
2000 r.p.m., discard 
upper layer.
-Supernatant <r
V
Chloroform Extract
Add 10ml chloroform, 
extract 10 minutes, 
centrifuge 2000 r.p.m., 
10 minutes.
V
Pellet
Add 5ml ^0, mix 5 
minutes, centrifuge 
2000 r.p.m., 10 mi­
nutes. Discard upper 
layer.
Lioid Extract
•Supernatant 4-
Add 5ml hot ethyl 
acetate, extract 10 
minutes, centrifuge 
2000 r.p.m., 10 minutes.
Pellet discarded
Fig. 2.1 Extraction Procedure for Cholesterol ^-hydroxylase 
Assay
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rotary evaporator at 30-^0°C.
Thin-Layer Chromatography of Extract
Analysis of the radioactive products formed was carried 
out by thin-layer chromatography (TLC) using Silica gel G 
(Scheicher and Schttll, W. Germany) on plates measuring 20cm x 
20cm, with a gel layer 0.25mm thick. The solvent system employed 
was toluenes ethyl acetate (7*13 v/v). Ascending chromatography 
in saturated air was used, allowing approximately 50 minutes 
for development at room temperature (20°C) or until the solvent 
had reached a distance of 17-18cm from the edge of the plate 
(15-16cm from the origin). Duplicate plates were set up as 
follows.
The residues obtained from the extraction of test and 
control incubates were redissolved in ZSOj/Cl of choroform and 
a 25^ ,1 aliquot of each applied as narrow bands to the origin 
of both plates. To the second plate only, was applied a similar 
band of 7<*-hydroxy cholesterol (Cholest-5-ene-3^,7«t‘diol), so 
that the two bands (standard + extract) overlapped slightly, 
thus allowing more certain identification of the product.
After chromatography, the second plate was visualised by 
spraying with a 20% (w/v) solution of dodecomolybdophosphoric 
acid in absolute ethanol, followed by gentle heating. The 
small quantities of metabolites generated, made identification 
of the bands by a thin-layer radioactive scanner impossible. 
Similarly, autoradiography was not possible as time was limiting. 
Thus, each chromatoplate was divided into 0.5cm x 2.0cm zones 
from 0.5cm below the origin to the solvent front. Each zone
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was scraped into a polypropylene "mini-vial", (G.D. Searle Ltd., 
High Wycombe, Bucks.), to be counted individually, thus enabling 
a histogram to be constructed, showing the distribution of 
radioactivity on the plate.
Radioactivity - Counting Procedures
The following counting conditions were used:
Either a) 0.05ml of sample (aqueous or non-aqueous)was trans­
ferred to 'mini-vials' and diluted with 0.4ml of distilled 
water. A 4ml volume of Toluene: Synperonic (B.D.H.) scintillant 
was added (2:1,v/v Toluene: Synperonic, 5*5g/litre P.P.O) 
and mixed on a "Whirlimixer" to give a clear gel. 
or b) segments of gel scraped into 'mini-vials' from the plates 
were shaken vigorously with 5ml of'Cab-0-3il' scintillant 
(5*5g P.P.O, 4.5g Cab-0-3il, (Packard), in 1 litre of toluene).
Each vial was "counted" using an LKB Wallac 1210 Ultrobeta 
liquid sutillation counter, for a period of 10 minutes. The 
scintillation counter was programmed to correct automatically 
for quenching by the external standard channels ratio method.
In the case of the aqueous and non-aqueous samples, efficiencies 
of counting were of the order of 85^97%.
Ill Histology
After removal, of adventitious fatty tissue, the hearts 
and aortas were fixed in formalin (10# (v/v) formaldehyde in 
Q.05M sodium phosphate buffer). Each aorta was subsequently 
stained with Sudan Black B (1.5/& (w/v) in 70# (v/v) ethanol).
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IV Statistics
Where multiple determinations were made, results were 
expressed as the arithmetic mean + the standard error of the 
mean. To establish significant differences between the means 
(minimum of 3 individual values), the student's t-test was used.
V Animals
Male New Zealand white rabbits, 8 weeks old (900-l400g), 
supplied by Ranch Rabbits (Crawley Down, Sussex) were used.
The animals were randomly assigned to the two experimental 
groups, six to each group. They were housed individually in 
aluminium cages (46cm x 49cm x 6lcm), on aluminium grids over 
sawdust which was changed twice a week.
Animals were allowed access to diet and tap water ad 
libitum at all times. The temperature and relative humidity 
of the animal house were regulated to 22°C and 50$ respectively. 
The lighting was time-switched on at 06.30 hours and off at 
18.30 hours. Measurements of body weight and food intake were 
made at regular intervals, no allowance was made for spillage 
of diet, as this was minimal and relatively constant among 
animals. Initially, animals were maintained on stock diet 
(RGP pellets, Labsure Animal Diets, supplied by J. Lillico 
and Sons, Reigate, Surrey). The experimental diets were 
gradually introduced to the animals over a pre-experimental 
period of 6 weeks by grinding the commercial diet and the 
successive addition of 25$» 50$ and 75$ of the test diets, 
followed by repelleting. Each dilution of diet was fed for 2weeks.
The rabbits,which were divided into Group A (20$ butterfat)
\
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and Group B (20fo com oil), were fed for a total of *fl weeks,
i.e. an experimental period of 3^ weeks.
Dietary Treatment
The diets used were semi-synthetic basal diets, supplemented 
with either c om oil or butterfat, similar to those employed 
by Moore and Williams, (196*0 . The formulation of these diets 
is summarized in Tables 2.1 to 2.3*
For Group A, Zk parts of butter, equivalent to 20.6 parts 
dry weight, were added to 80 parts of the basal.diet and for 
Group B, 20 parts of com oil were added. Diets were mixed 
at weekly intervals, using a Hobart food mixer (Model A 200), 
mixing the dry ingredients for 15 minutes at the slowest speed, 
adding the oil or melted butter whilst mixing and finally mixing 
for 5 minutes at medium speed. For addition to diets, butter 
was melted in a water bath at 60°C. The experimental diets 
were subsequently mixed with tap water (approximately 500nil/kg 
diet) and passed through the mincing attachment of the Hobart 
mixer. The resultant pellets were dried Overnight at •.
To prevent oxidation of the diet as far as possible, small 
batches were prepared and stored at 4°C.
Experimental Procedure
At intervals throughout the experiment, blood was withdrawn 
from the animals by marginal ear vein puncture. Samples were 
collected in non-heparinised glass bottles, allowed to stand 
for at least 60 minutes and centrifuged using a bench centrifuge 
for 10 minutes to separate the serum. Aliquots of serum were
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Table 2.1 Composition and Gross Energy Value of Diets 
Fed to Rabbits
Percentage Composition (by weight):______Group A Group B
Fat 24.0A 20.0aa
+ V/heat Starch 16.2 16.3
t Sucrose 9*9 10.0
A Casein 24.8 25.0
*#Cellulose 18.9 19.0
+ Methyl cellulose 1.0 1.0
+ Potassium acetate 2.5 2.5
+ Magnesium oxide 0.5 0.5
+ Sodium chloride 0.7 0.7
* Choline chloride 0.5 0.5
Mineral Mixture 4.0 4.0
Vitamin Mixture 0.5 0.5
- Gross energy value (Kcal/lOOg Diet) 532 532
(MJ/lOOg Diet) 2.23 2.23
Percentage total energy supplied as fat 35 35
Percentage total energy supplied as starch 13 13
Percentage total energy supplied as protein 28 28
* + +f Sigma B.D.H. +Tate and Lyle, Croydon, Surrey.
A Casein Industries, London, SVf'8 (Lactic acid casein)
A Equivalent to 20.6$ dry matter, 'Lurpak*,
AA *Saladin', Van der Burgh and Jurghens Ltd., London.
# Originally wheat straw, J. Lillico and Sons, Reigate, 
Surrey, replaced by purified cellulose at week 13 of 
the experiment.
* As calculated by Moore and Williams (1964)
-7*+-
Table 2.2 Composition of Vitamin Mixture (per Kg mix)
*
+
*
«
*
*
Biotin lOOmg Nicotinic acid l6g
Folic Acid lOOmg + Meso-inositol 30g
p-aminobenzoic acid 70g * •Ascorbic acid 10g
Calcium pantothenate 10g
*
Cyanocobalaraine 8mg
Thiamine hydrochloride log Menadione sodium bisulph. l*5g
Riboflavin log * .ek-tocopheryl acetate lOg
Pyridoxine hydrochloride log
*
Cholecalciferol 5mg
Retiny1 acetate 
The base of this mixture was glucose.
666mg
Table 2.3 Composition of Mineral Mixture (per 10.Kg mix)
X
Calcium lactate monohydrate 
+ Ferric citrate trihydrate
Di-potassium monohydrogen orthophosphate
+ . .Tncalcium orthophosphate
•g-3-
Monosodium dihydrogen orthophosphate dihydrate
j .  .
Magnesium sulphate 
Sodium chloride 
+ Manganese sulphate tetrahydrate 
+ Cupric sulphate pentahydrate 
+ Potassium iodide
Zinc carbonate 
Supplied by Sigma
3202g
355g
2862g 
l620g
1177g 
793g 
519g
60g
15g
1.5g
1.5g
Supplied by Fisons Supplied by B.D.H
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stored at 4°C for 1-5 days for analysis of lipids and at -20°C 
for 1-6 months for the determination of bile acids.
At the end of the experiment, the tv/o groups, together 
with 5 control animals of the same age and maintained on 
laboratory chow, were killed by exsanguination via cardiac 
puncture followed by cervical dislocation. The animals were 
allowed free access to food up to the time of death. Serum was 
prepared as above and the livers and gall bladders removed 
together with the hearts and aortas extending to the point of 
division into the two common iliac arteries. Tissues were 
treated as described in sections II and III.
-76-
Results
a) Animal Weights and Food Intakes
During the course of the experiment, one animal from each 
group had to be killed. One was suffering from severe diarrhoea, 
which had started in the pre-experimental period and was not 
apparently related to the dietary treatment, whilst the other 
had severe otitis media. A second animal from Group A developed 
a large ventral hernia and was subsequently excluded from the 
experiment. Any experimental data obtained from these rabbits 
up to their time of death was eliminated from the mean values 
presented.
The original diet formulation contained 20$ ground wheat 
straw as the source of fibre. However, due to the lack of any 
facilities for grinding the straw, it was decided to change 
the source of fibre to purified cellulose; this change was 
made at week 13 of the experiment.
From the growth curves (Fig. 2.2) it would appear that 
weight gain was adequate and similar in both groups during 
the first 12-13 weeks of the experiment. Both curves plateaued 
at this point, an event which corresponded with a decrease in 
food intake (Table 2.4) and could have been the result of the 
change in source of fibre. Between weeks 14 and 15 the growth 
curves of Group A and B crossed so that by week 22, the growth 
rate of the animals in Group A appeared to exceed those in 
Group B, although the difference was not statistically signi­
ficant. Again, the food intake pattern corresponded to the 
change in growth rate, increasing in both groups beyond week 22
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but more noticeably in Group B.
b) Serum Cholesterol Concentration
As shown in Fig. 2.3» during the experimental period there 
was a pronounced elevation of mean serum cholesterol concentration 
in Group A, as compared to Group B which remained relatively 
constant. This difference was apparent (p<0.1) after only k 
weeks on the full experimental diets.
The reason for the increased cholesterol concentrations 
at week 20 is uncertain, but as it is common to both groups it 
is more likely to be due to factors independent of diet. An 
error in methodology cannot be discounted as the measurements 
could not be repeated due to insufficient serum.
The mean serum cholesterol level of the control group C 
in the terminal experiment was significantly lower than that 
of either experimental group (Table 2.6).
c) Serum Total Bile Acid Concentration
There was no significant difference between groups in total 
serum bile acids measured throughout the course of the experiment, 
with the exception of week 16 when the mean concentration in 
Group A was more than double that of Group B (p<0.01) (Table 
2.5)• However there was an apparent increase in this parameter 
in both groups during the experiment, although this was not 
statistically significant.
In the terminal experiment, the mean total serum bile 
acid concentration of Group C appeared.to be lower than that 
of the experimental groups but again the difference was not
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Pig. 2.3 Mean Serum Cholesterol Concentration of Rabbits Immediately Prior 
to the Pre-experimental Period and at Intervals During the Expe­
riment
20.0
SERUM
CHOLESTEROL 12.0
mmol/litre
8.0
"^"l2 20
WEEKS
© — — o Group A 
a = p^0.05 
b = p^O .01
a Group B
Table 2.5 Mean Serum Total Bile Acid Levels (mmol/l) of 
Rabbits at Intervals During the Experiment
WEEK GROUP
+A*
**
B
0 1.96 + 0.23 1.55 + 0.29
12 1.67 + 0.25 1.45 + 0.33
16 1.22 + 0.07 0.59 + 0.10
20 1.83 + 0.35 1.11 + 0.27
24 1.20 + 0.42 0.99 + 0.23
28 2.90 + 0.29 3.4 6 + "0.76
36 2.24 + 0.33 3-07 +
-3-00•o
42 2.43 + 0.42 2.42 + Q.k6
Values expressed as mean + standard error of mean
* 20% butterfat, (n=4)
20% com oil, (n=5)
+ No significant difference between groups with the exception 
of week l6(p<0.01.)
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significant (Table 2.6).
d) Serum Triglyceride Concentration
This parameter was measured only in the terminal experiment 
when the triglyceride concentration in Group A was significantly 
elevated above Group B and C. No difference was observed 
between Groups B and C (Table 2.6).
e) Results of Terminal Experiment
These results are summarized in Table 2.6.
On dissecting the animals, it was observed that those in 
Group A had greater deposits of intra-abdominal, peri-renal 
and peri-cardiac fat. The livers of these rabbits were much 
paler and significantly larger than those in Group B, but were 
comparable in size to those in Group C. When the weight of 
this organ was expressed relative to body weight, the difference 
between A and C became highly significant whereas that between 
the two experimental groups was less pronounced, though still 
significant.
The liver microsomal protein content did not vary signifi­
cantly between groups but total liver lipid was substantially 
greater in the butter-fed animals than in either of the other 
groups. Similarly»there was a pronounced accumulation of 
cholesterol in the livers of these animals when compared to 
B and C.
Cholesterol 7eC-hydroxylase activity
Table 2.7 shows the metabolism of Cu-^cJ cholesterol to
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7«t-hydroxycholesterol. Whilst the activities of this enzyme 
were significantly higher in the chow-fed controls compared 
with both experimental groups, differences between groups A 
and B were less obvious. There was however an indication of 
a slight reduction in activity in B as compared to A which 
became more pronounced when results were expressed on a total 
liver basis. However, the significance of data expressed in 
this way to metabolism in vivo is uncertain.
Mixed Function Oxidase Activities
Tables 2.8 and 2.9 show the concentrations of cytochromes 
P-^50 and b^ together with the activities of NADPH-cytochrome 
c reductase and certain mixed function oxidase enzymes expressed 
per g liver or as specific activities. Both experimental 
groups displayed an apparent increased cytochrome concentration 
accompanied by a decrease in enzyme activities as compared to 
the control animals. However these changes were not statistically 
significant, or only marginally so, which is probably a reflection 
of the small sample numbers.
A similar, but less pronounced difference was observed 
between the two experimental groups. The cytochrome levels 
and enzyme activities in the com-oil fed animal being respecti­
vely higher and lower than in those fed butter. This was 
particularly evident with respect to cytochrome P-^50 levels 
and biphenyl 2-hydroxylase activity.
Histological Examination of Aortic Tissue
Gross staining of the hearts and aortas of animals from
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each group revealed a greater degree of lipid degeneration of 
the intimal surface of those from Group A as judged by the 
extent and density of Sudan Black Staining. However it was 
not possible to detect differences in aortas derived from 
animals in groups B and C. Owing to the nature of the prepara­
tions, particularly with regard to the degree of background 
staining, more sophisticated analysis of the severity of the 
atheromatous lesions was not possible.
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Discussion
In this experiment, a group of animals designated as. 
controls, which were age-matched to the experimental animals 
and had been fed on laboratory chow, were killed at the same 
time as the experimental groups. The inclusion of such a 
group is arguable and the interpretation of observed differences 
is difficult as these animals were not maintained under 
identical experimental conditions and the diet formulations 
are very different. However the design of a "control" semi- 
synthetic diet is also problematical as it would necessitate 
the use of a diet excessively high in carbohydrate, which would 
further complicate interpretation of data. Thus, strictly 
speaking, comparisons should only be made between the experimental 
groups themselves, but the chow-fed group was included as it 
was considered of interest to establish the effect of the 
semi-synthetic diet per se on the parameters measured. This 
was of particular importance with respect to the mixed function 
oxidase metabolism data as much of the work reported in the 
literature has been carried out in experimental animals other 
than the rabbit.
The experimental animals appeared healthy but did not 
attain their full growth potential when compared with the control 
animals. Food intakes were 50-60$ of those reported by Moore 
and ■Williams (196^) but were comparable to the findings of 
Funch et al. (I960). All three experiments employed identical 
semi-synthetic diets with the exception of the source of dietary 
fibre (see below). This phenomenon of a reduced weight gain 
and food intake in animals fed semi-synthetic diets has recently
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been reported by Hamilton and Carroll (1976). It is possible 
that the high fat content of the experimental diets rendered 
them unpalatable. Arrington et al. (197^0 reported reductions 
in the voluntary feed intakes of rabbits on increasing the fat 
content of the diet from 2% to 1 However in these animals 
there was also an improved feed conversion and they conclude 
that the rabbits adequately tolerated the increase. Inclusion 
of a group of pair-fed control rabbits fed laboratory chow, 
would facilitate interpretation of the significance of the body 
weight data.
Feeding of the high butter fat diet resulted in an appre­
ciable elevation in serum cholesterol. Once again, this finding 
was more similar to that of Funch et al. (i960) than to Moore 
and Williams (196*0 , who observed a less pronounced hypercholes- 
terolaemia. The difference in dietary fibre would appear to 
account for these disparities. In the present experiment, 
although wheat straw was used initially, as in the experiments 
of Moore and Williams, purified cellulose was subsequently 
used, in common with the experiments of Funch and his colleagues. 
Moore (1967) showed, that purified cellulose was less palatable 
and enhanced the hypercholesterolaemic effect of dietary lipid. 
Serum triglyceride concentration was also significantly increased 
in Group A compared to B as was total liver lipid and cholesterol. 
These findings are in accordance with those of previous workers 
using high fat diets without added cholesterol (Wigand, 1959;
Funch et al., i9 6 0 ;--Moore and Williams, 196*0 and confirm 
the establishment of the hypercholesterolaemic model.
There was no change in total serum bile acids between
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Groups A and B during the course of the experiment, but there 
appeared to be an increase in both groups with time.
This might reflect a gradual response to the administration- 
of high fat diets, although the effect of age on bile acid 
metabolism cannot be excluded.
There is little information in the literature pertaining 
to the effect of variation in dietary lipid on levels of serum 
bile acids. This may in part reflect difficulties . encountered 
in establishing a method of adequate sensitivity for measuring 
the low. levels in serum. However, measurement of this parameter 
should provide information regarding the dynamics of the 
enterohepatic circulation of bile acids (LaRusso et a1., 197^)•
As considered earlier, most experiments have examined the 
effects of lipid on the excretion and turnover of bile acids. Thus 
Beher et aJL. (1970) showed that administration of com oil to 
rats had no effect on cholic acid turnover. Similarly, Kim 
et al. (1976) followed the oxidation of G26-1\j] cholesterol 
as an index of rate of bile acid formation and found no difference 
between rats fed low fat, 15$ com oil or 15$ butter diets.
They did note however that com oil increased the excretion 
of faecal labelled lipid,giving support to the earlier work of 
Gerson et al. (1961) and Wilson (1961). The lack of response 
in bile acid metabolism to saturated fat feeding in the present 
experiment is in accordance with the conclusions of Uchida 
et al. (1977)• These workers were generally concerned with 
the effects of cholesterol feeding but they conclude that 
species such as the rabbit, which are prone to an hypercholes­
terolaemic response, display little change in bile acid metabolism.
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Failure to observe an effect of polyunsaturated fat may indicate 
that the hypocholesterolaemic effect of these fats results 
from some other mechanism, as will be considered later.
At the end of the experiment, serum total bile acid levels 
in each experimental group were compared to those in the chow- 
fed animals. They were found to be slightly elevated in the 
latter group, but this was not statistically significant despite 
the concomitant significant increase in cholesterol 7*-hydroxylase 
activity. It would thus seem that feeding an unrefined chow 
diet as compared to a semi-synthetic diet results in an increase 
in bile acid synthesis, which in this experiment was associated 
with decreased serum and liver cholesterol levels. Other workers 
(Johansson, 1970; Kritchevsky et al., 1977a) have reported this 
effect on 7ol-hydroxylation. Further support is given by the 
work of Fisher et al. (1976) who measured bile acid pool size 
in rats. In those fed semi-synthetic diets, it was reduced 
to 60fo compared with animals fed commercial control diets; no 
qualitative differences in bile composition were observed.
Although not measured in the present experiments faecal bile 
acid excretion has been repeatedly shown to be higher in animals 
fed commercial chow diets (Portman and Murphy, 1958; Grundy 
et al ., 1965; Gustafsson and Norman, 1969; Kritchevsky et al.., 
1973a; Balmer and Zilversmit, 197^)• Similarly, Kim et al.
(1976) demonstrated an increased oxidation of [ 26- ^ c ]  cholesterol 
in rats on commercial feed compared to semi-synthetic diets.
The observed hypocholesterolaemic effect of commercial 
chow diets has been attributed to various components. Originally, 
Malmros and Wigand (1959) suggested that trace amounts of lipid
-93-
associated with the commercial feed might be important. Evidence 
contrary to this was produced by Kritchevsky and Tepper (1968), 
who showed that fat-extracted chow did not induce hypercholes- 
terolaemia or atherosclerosis in rabbits. Similarly, addition 
of the extracted fat to a semi-synthetic diet did not prevent 
its hypercholesterolaemic action. The importance of the nature 
of the protein component has also been considered (Howard et al., 
1965; Hamilton and Carroll, 1976). However, Kritchevsky et al. 
(1977b) have concluded that the effects of protein can be 
eliminated by alteration of the fibre component of a semi­
synthetic diet.
The hypocholesterolaemic influence of the fibre content 
of commercial diets was examined earlier by Moore (1967) and 
Kritchevsky et al. (1973a). The ability of various types 
of fibre to bind bile acids has been demonstrated (Eastwood 
and Hamilton, 1968; Balmer and Zilversmit, 197^; Birkner and 
Kern, 197^; Kritchevsky and Story, 197*0* From this it has 
been inferred that consumption of commercial chow diets may 
be associated with an enhanced bile acid excretion* Portman 
and Murphy (1958) reported that increasing the fibre content 
of purified diets from 5$ to 20$ resulted in a greater cholic 
acid production. Gustafsson and Norman (1969) found this to 
be unaffected by the addition of pure cellulose, demonstrating 
the importance of the type of dietary fibre. The difference 
between crude and purified fibre was confirmed by the experiments 
of Morgan et al. (197*0 > who investigated the effect of these 
two fibres on cholesterol 7tL-hydroxylase activity. Crude fibre 
only was found to stimulate the activity of this enzyme.
- 94-
Finally it has been suggested that rather than the fibre per se, 
trace contaminants of the unrefined fibre, such as sterols, 
which have been shown to be hypercholesterolaemic in both 
experimental animals and man (Swell et al., 1954; Best et al.,
1955; Sachs and Weston, 1956; Kudchodkar et al., 1976), might 
be responsible. It would be of interest to investigate the 
effect of administration of such sterols on the activity of 
cholesterol 7«C-hydroxyiase activity and hypercholesterolaemia 
in the type of model used in this experiment.
Thus, the mechanism of hypercholesterolaemia of commercial 
chow has been confirmed by this experiment. However that of 
the polyunsaturated fatty acids is still uncertain. Although 
the difference was small, the activity of cholesterol 7rt*-hydroxy- 
lase in the com oil-fed animals was unexpectedly lower than 
in those fed butterfat. This is contrary to the finding of 
Mayer and Mayer (1975) who reported an enhancement of 7dl-hydroxy- 
lation after feeding a polyunsaturated fat diet. However 
comparison with this experiment is difficult, as these workers 
used rats and only fed the diet for 14 days. Kritchevsky 
et al. (1977a) also found that feeding a diet rich in unsaturated 
fats led to a decrease in 7oC-hydroxylation of cholesterol. As 
observed by Bjorkhem et al. (1978), these conflicting findings 
might be due to compositional differences in the fats, 
particularly with respect to their peroxide content. These 
workers found that whilst the small amounts of peroxides 
naturally present in the unsaturated triglycerides (triolein 
and trilinolein) had little effect on cholesterol 7*-hydroxylase, 
a diet consisting of peroxidised linoleic acid reduced its
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activity. The peroxide content of the com oil used in this 
experiment was not measured, although it would be expected 
to be low, owing to the presence of natural antioxidants such 
as ct-tocopherol. However mixing of the oil with the other 
constituents of the diet may have resulted in its interaction 
with certain pro-oxidants, thus increasing the overall peroxide 
value of the diet. Although oxidation of the saturated fat 
diet may also have occurred, its peroxide content would be 
unlikely to have increased, thus the possibility that the 
observed reduction in 7oL-hydroxylation was due to peroxides 
cannot be excluded. Bjorkhem et al. (1978) also compared the 
effect of diets containing triglycerides of different fatty 
acid composition on 7oC-hydroxylation. They again found that 
in rats fed trilinolein or triolein this was decreased compared 
with those fed tripalmitin or trierucin. However, they conclude 
that the level of cholesterol 7dL-hydroxylase activity was 
better related to the degree of absorption of the fat than to 
its unsaturation. They suggest that, as the reduced absorption 
of some fatty acids is coupled with a reduced absorption of 
bile acids, unabsorbed fatty acids could lead to increased 
7<*.-hydroxylation due to diminished feedback inhibition.
Data emanating from this experiment would indicate that 
the hypocholesterolaemic action of polyunsaturated fats is not 
mediated, by an effect on cholesterol 7*-hydroxylase, despite 
the observations by some workers of an increased bile acid 
excretion (see above). Ahrens and his colleagues maintain 
that the hypocholesterolaemic action is more likely to be due 
to a redistribution of tissue cholesterol (Spritz et al.* 1965;
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Grundy and Ahrens, 1970). If this were so, one might expect 
to see an increase in hepatic cholesterol concentration, a 
finding not apparent in the present investigation.
It may be that we have taken too simplistic an approach 
in assuming that any factor modifying serum cholesterol concen­
trations will act via cholesterol absorption, synthesis or 
excretion. This view was recently expressed by Sodhi and his 
colleagues (197?)• They consider that cholesterol transport 
in plasma is dependent on the availability of lipoproteins and 
that the rate of entry or exit of the sterol to or from the 
lipoprotein may be more critical in determination of serum 
cholesterol concentration. Thus, it is possible that the 
influence of polyunsaturated fats on this parameter is mediated 
via lipoproteins. Evidence in support of this contention 
derives from studies on the effects of these fats on lipoprotein 
turnover, which suggest that they inhibit hepatic secretion 
of low density lipoprotein (Yeshurun et al., 1976). As 
discussed in Chapter 1, high density lipoprotein levels in 
serum would appear to have a strong negative correlation with 
incidence of coronary heart disease but to date few studies 
have investigated the effect of diet on this fraction of serum 
cholesterol. A possible area of further investigation could 
be the effect of polyunsaturated fat intake on high density 
lipoprotein cholesterol.
Interpretation of the observed changes in mixed function 
oxidase metabolism associated with the dietary treatments can 
only be tentative due to the lack of statistical significance. 
Comparison with studies in the literature is diffilcult, as most
-97-
investigators have used the rat as an experimental model and 
have examined metabolism on fat-free basal diets compared with 
those supplemented with saturated or unsaturated fats, (Caster 
et al.,1968), at levels lower than those used in the present study. 
In general, these experiments have shown lower levels of cyto­
chromes and enzyme activities in rats fed saturated fat, findings 
which are at variance with the present experiment. Marshall 
and McLean (1971) observed that polyunsaturated fats enhanced 
the inductive effect of phenobarbitone on microsomal metabolism, 
it would therefore be of interest to repeat the present experiment 
in animals pretreated with an inducer such as phenobarbitone.
Several explanations may be offered for the observed increase 
in cytochrome concentrations accompanied by decreased mixed 
function oxidase and 7eC-hydroxylase activities. Firstly, the 
fat feeding may have a specific inhibitory effect on a particular 
form of P-^50 whilst actually inducing the bulk of the cytochrome. 
In order to verify this, it would be necessary to examine a 
much wider range of substrates under similar experimental 
conditions. Secondly, one might envisage a qualitative alteration 
in the cytochrome, which could alter the binding characteristics 
of the substrates. It would be of interest to examine the 
kinetics of this system under these conditions, particularly 
as there is some evidence of anvinfluence of dietary fat on the 
Km's of these enzymes (V/ade and Norred, 1976). It could be . 
postulated that as fatty acids themselves act as substrates 
for cytochrome P-^50» they might bind to the molecule, thus 
preventing metabolism of other exogenous substrates; this would 
explain the paradoxical findings of an increase in cytochrome
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P-^50 and a decrease in enzyme activity.
Metabolism of fatty acids via cytochrome P-^50 occurs by 
the process ofw -oxidation (Robbins 1961; Preiss and Bloch,
196^; W a d a et al., 1968; Bjorkhem and Danielsson, 1970). It 
is known that short, medium and some long chain saturated fatty 
acids may be oxidised via this pathway, but the participation 
of unsaturated long chain fatty acids is apparently undocumented. 
The proportion of fatty acid oxidation normally occurring by 
this route is small and its physiological significances uncertain. 
Conditions of starvation and diabetes have been shown to enhance 
6>-oxidation (Wada et al., 1971; Bjorkhem, 1973)* Thus, Wada 
and his colleagues (1971) speculated that under those conditions, 
when fatty acids were utilised in preference to glucose and 
formation of ketone bodies was increased,Q -oxidation might be 
induced. This would result in the production of succinyl-CoA 
from dicarboxylic acids, which could subsequently be used for 
oxidation of acetyl-CoA and gluconeogenesisin the livers of 
starved or diabetic animals (Wada and Usami, 1977) •
It could be hypothesised that under conditions of high fat 
intake as in the present experiment, where ketone levels might 
be expected to be increased, a greater proportion of fatty 
acids might be oxidised by this pathway. Thus, although normal 
or increased amounts of cytochrome P-^50 were available for 
metabolism, competition for binding sites by the fatty acids 
might inhibit metabolism of other substrates. To test this 
hypothesis, it would be of interest to measure the oxidation of 
[■^cllabelled laurate or stearate in animals fed high fat or 
control diets.
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A further alternative is that feeding of high levels of 
fats, whilst increasing amounts of the cytochrome, may unfavourably 
alter the composition of the microsomal membranes in such a 
manner that metabolism is reduced. This is consonant with the 
view of Stier (1976), who considers the cytochrome P-^50 system 
to be dynamic. He suggests that the system may be coupled or 
decoupled by changes in the lipid environment of the membrane 
which could be induced by environmental factors such as nutrition 
or xenobiotics.
In summary, feeding a high level of polyunsaturated fats 
was shown to prevent the hypercholesterolaemia and aortic lipid 
accumulation seen in the saturated fat-fed rabbits but an 
increased bile acid synthesis, as demonstrated by an increase 
in cholesterol 7^-hydroxylase activity was not observed. Thus, 
in the rabbit, under these particular experimental conditions, 
the hypercholesterolaemic action of polyunsaturated fats is 
not due to an effect on bile acid biosynthesis.
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Chapter 3
The Effects of Ascorbic Acid Depletion and Supplementation 
on Cholesterol and Foreign Compound Metabolism in the
Guinea Pig
-101-
Introduction
Several vitamins have been observed to influence the 
concentration of plasma lipids. Supplementation with vitamin 
D in man has been shown to elevate serum cholesterol (Dalderup 
et al., 1965)• Similarly, vitamin D-induced infantile hypercal- 
caemia is characterised by a marked hypercholesterolaemia 
(Forfar and Thompsett, 1959), and Linden (197^) has suggested 
that regular consumption of fish liver may predispose to an 
increased level of plasma cholesterol and risk of coronary 
heart disease. A deficiency of vitamin E has been reported to 
cause hypercholesterolaemia, possibly via a stimulation of 
cholesterogenesis (Eskelson et al., 1973)* Some of the B 
vitamins have also been implicated. In pharmacological doses, 
nicotinic acid acts as an effective hypocholesterolaemic agent 
(Carlson et al., 1968). Similarly there are some reports of 
hypercholesterolaemia associated with deficiencies of biotin 
and pyridoxine (Scott, 1958, Pool et al., 1971; Spitzer et al., 
1966). Probably the most widely studied vitamin with respect 
to lipid metabolism and coronary heart disease is ascorbic acid.
Myaniskova (19^7) first observed a reduction in serum 
cholesterol concentration in hypercholesterolaemic patients, 
following the administration of ascorbic acid. In a study 
designed to determine human requirements for this vitamin, Krebs 
(1953) reported the occurrence of severe cardiac events in 2 
out of 10 young adults on a scorbutogenic diet.. These events 
occurred in the absence of signs of acute scurvy. Willis and 
his colleagues determined arterial ascorbate concentrations in 
three groups of patients at autopsy: (a) sudden traumatic deaths;
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(b) those dying after supplementation with ascorbic acid prior 
to death; (c) routine hospital autopsies. They recorded 
minimal or undetectable levels of ascorbate in the latter group, 
none of whom had shown signs of clinical scurvy (Willis and 
Fishman, 1955)• This localised depletion of ascorbate was 
apparent in areas of mechanical stress, areas known to be 
primarily susceptible to atheroma (Velican and Velican, 1976). 
These early studies suggested a fundamental similarity in 
mechanisms of vascular damage in both scurvy and atherosclerosis.
The influence of ascorbic acid in the pathogenesis of 
atherosclerosis is at least two-fold. Firstly, it is known 
that ascorbic acid is essential to the integrity of collagen 
biosynthesis in the vascular wall (Gore et al., 1965) and to 
glycosaminoglycan composition of the aorta (Nambisam and Kurup,
1975)• Thus the development of structural abnormalities in 
the arterial wall is likely,(Willis, 1957; Gore et al., 1965)• 
Secondly, this vitamin plays an important role in cholesterol 
metabolism, a relationship which has been the subject of 
innumerable investigations (reviewed by Krumdieck and Butterworth, 
197^; Turley et al., 1976).
Animal Studies
The type of animal model used in many of these studies 
has resulted in conflicting data which is difficult to interpret. 
Animals such as the rat, hen and rabbit have been used (Kirk,
1973; Nockels, 1973)* These species however are able to 
synthesise ascorbic acid. Thus, assuming their tissues were 
saturated with the vitamin, any parameters studied under
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conditions of experimental hypercholesterolaemia should be 
independent of its influence. In man,there is an absolute 
dietary requirement for ascorbic acid, due to the absence of 
the enzyme L-gulonolactone oxidase in the biosynthetic pathway 
(Burns et al., 1956; Bums, 1957; Nishikimi and Udenfriend,
1976). The non-human primate, the guinea pig and several species 
of bird have a similar metabolic defect and are thus more 
suitable experimental models. Numerous studies have used the 
acutely scorbutic guinea pig, although the inanition induced 
by this condition tends to mask the more subtle metabolic effects 
encountered in chronic ascorbate deficiency. This may account 
for the conflicting results emanating from these studies (Bolker 
et ad.., 1956; Lahiri and Bannerjee, 1956; Bannerjee and Singh, 
1958; Ginter et al., 1965).
It has been suggested that the study of cholesterol 
metabolism under conditions of chronic ascorbate deficiency is 
more relevant to man, as acute or clinical scurvy is rare in 
human populations. Latent or subclinical deficiencies,arising 
from a chronic dietary inadequacy of the vitamin.are however 
quite prevalent, notably in certain population groups such as 
the elderly (Booth and Todd, 1972) and those with a seasonal 
variationln ascorbic acid intake (Ginter et al., 1970). As 
a consequence, Ginter and his colleagues have developed an 
improved experimental model (Ginter et al., 1968), in which 
a condition of chronic deficiency or hypovitaminosis is induced 
in the guinea pig by the daily administration of 0.5nig of 
ascorbic acid, which is adequate to maintain food intake, some 
growth and to prevent the overt symptons of scurvy. This model
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is considered to simulate the latent deficiency state observed 
in man (Ginter, 1975a; Hughes, 1976).
Ginter demonstrated an hepatic accumulation of cholesterol 
in these animals (Ginter and Nemec, 1969; Ginter et al., 1969), 
an effect augmented by dietary supplementation with cholesterol 
which also led to aortic deposition of lipid (Ginter, 1975b).
As the corollary to this, cholesterol feeding increased the 
ascorbic acid requirement of the guinea pig (Ginter and Zloch, 
1972) and eventually resulted in a depletion of tissue ascorbic 
acid (Ginter, 1976).
Human Studies
In man,investigations of this relationship have yielded 
equivocal results. Clinical trials executed in Eastern European 
countries, where the vitamin was fed at levels approximately 
tenfold of those required to prevent scurvy, demonstrated a 
reduction of serum cholesterol in hypercholesterolaemic patients 
(Turley et al., 1976). In general, supplementation of normoli- 
paemic individuals with ascorbic acid did not alter serum 
cholesterol levels (Anderson et al., 1958; Sokoloff et al.,
1966; Crawford et al., 1975)» although Fix et al. (19.7*0 3n<3i 
Kothari and Jain (1977) did observe a slight diminution. 
Furthermore, other workers were not even able to achieve any 
reduction in cholesterolaemia in hypercholesterolaemic subjects 
(Samuel and Shalchi, 1964; Peterson et al., 1975)• Contrary 
to all these findings, Spittle (1971), using "megadoses” of 
ascorbic acid, succeeded in decreasing the serum cholesterol 
concentration in young,normocholesterolaemic subjects, but
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reported its elevation in atherosclerotic patients. She 
attributed this latter finding to a mobilisation of arterial 
cholesterol, although this view was challenged by Morin (1972).
All these studies can be criticised as they rarely provide 
information regarding the ascorbic acid status of the subjects 
concerned. Differing degrees of tissue saturation could 
contribute to the lack of conformity of the data. In support 
of this, Ginter et al. (1977) have postulated that ascorbic 
acid is probably only important as a hypocholesterolaemic 
agent in the presence of a chronic latent deficiency.
Elwood et al. (1970a)attempted unsuccesfully to correlate 
plasma ascorbic acid and cholesterol concentration in normo- 
cholesterolaemic individuals. Nevertheless, Gatenby-Davies 
and Newton (1974), in a study undertaken in pastoral African 
tribesmen, did demonstrate a positive correlation between these 
two parameters, although the statistical treatment of their 
results has been criticised (Turley et,al., 1976). Ginter 
and his coworkers (1970) noted a definite seasonal occurence 
of hypercholesterolaemia which corresponded to times when 
food sources of ascorbate were limited in availability; this 
was in accordance with the work of Fyfe et al. (1968).
Mode of Action of Ascorbic Acid
The mechanism of the interaction between ascorbic acid 
and cholesterol metabolism has also been extensively investigated. 
An increase in absorption of cholesterol does not appear to 
account for the hypercholesterolaemia. Ginter and his colleagues 
(1969), using the chronically deficient guinea pig, followed
-106-
the distribution of an Intragastric dose of U-^cJ cholesterol. 
Compared to controls, activities in the blood and livers of 
these animals were low, whilst those of the gastrointestinal 
tract and stools were high. Rather than enhancing the process, 
ascorbate deficiency appeared to slightly inhibit cholesterol 
absorption, a finding consonant with that of Bronte-Stewart 
et al. (1963) in acutely scorbutic humans.
The role played by ascorbic acid in cholesterol biosynthesis 
is uncertain. In acutely scorbutic guinea pigs, increased 
biosynthesis has been observed (Becker et al., 1953), although 
Bolker et al. (1956) failed to confirm this. Similarly in 
chronically deficient guinea pigs and baboons, hepatic cholestero-
r  1 4  1genesis, as measured b y L 1- CJ acetate incorporation, was 
unchanged (Ginter and Nemec, 1969; Weight et al., 1974). More 
recently however, Kallner (1977) reported a preliminary finding 
of a reduction in hepatic hydroxymethylglutaryl CoA reductase 
activity in chronically deficient guinea pigs. They also found 
a reduction in cholesterol catabolism in the same animals and 
suggest that the observed hepatic cholesterol accumulation is 
a function of an ascorbate-induced defect in both pathways.
Studies investigating the role of ascorbic acid in bile 
acid biosynthesis have been more definitive, indicating a 
decreased biosynthesis in both acutely (Guchait et ah ,  1963) 
and chronically (Ginter et al., 1971) deficient guinea pigs.
When U - 1^ ]  cholesterol was administered to these latter 
animals, there was a diminished excretion of label in the bile 
fraction of liver, gall bladder bile and faeces. Similarly, 
after administration of C 26-lZfC - cholesterol there was a lower
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1^recovery of could be reversed by repletion with
ascorbic acid (Ginter et aJL., 1972). Using this technique,
Ginter (1973) estimated bile acid biosynthesis and showed that 
on a body weight basis, significantly less bile acids were 
synthesised by deficient animals (8.3mg/day) as compared to 
controls (11.8mg/day). The rate of synthesis was positively 
correlated with liver ascorbate concentration and as expected, 
negatively correlated with plasma and liver cholesterol 
concentration. In support of this, Hornig and Weiser (1976) 
have demonstrated a negative correlation between liver ascorbic 
acid and liver total bile acid content.
A further aspect of cholesterol metabolism has been explored 
by Iwamoto et al. (1978). They demonstrated an inhibition of 
bile acid absorption by ascorbic acid. The results of this 
study and those discussed above do not mutually exclude each 
other, as a reduction in bile acid absorption would enhance 
synthesis by releasing the feedback mechanism, although this 
might also be expected to enhance the biosynthesis of cholesterol 
per se.
The site and nature of the interaction between ascorbate 
and bile acid biosynthesis remains to be firmly established. 
Initial investigations concentrated on the mitochondrial side 
chain cleavage reaction. Guchait et al. (1963) demonstrated 
an enhanced synthesis of bile acids in vitro by guinea pig 
mitochondria isolated from livers of deficient animals and 
incubated with ascorbic acid; Kritchevsky et al. (1973b)using 
normal mitochondria, could not repeat this. Guchait's 
experiment has been criticised (Turley et al., 1976) in that
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it may not have measured the normal biosynthetic pathway via 
7«^-hydroxycholesterol, but the alternative proposed by Mitropoulos 
and Myant (1967), where side chain cleavage is the initial 
reaction.
Ginter (1975b) has hypothesised that the rate-limiting 
enzyme of bile acid biosynthesis, cholesterol 7^-hydroxylase 
might be the site of action of ascorbic acid. In comparing 
the oxidation of [■26> c3 cholesterol and 7<<-hydroxy cholesterol he 
observed that whereas the oxidation of cholesterol was significantly 
lower in the chronically deficient guinea pigs, that of the 
hydroxylated metabolite was unaffected. This indicated that 
the site of ascorbic acid intervention was at or before the 
rate-limiting enzyme. More recently, Bjorkhem and Kallner 
(1976) showed that 7dL-hydroxylation in microsomes from chronically 
deficient animals was lower than that in supplemented animals 
but no stimulation by ascorbate added in vitro was found. This 
is contrary to the findings of Kritchevsky et al. (1973b) who 
reported a marginal in vitro stimulation.
Ascorbic Acid and Mixed Function Oxidase Metabolism
Ascorbic acid is known to play an important role in mixed 
function;Oxidase metabolism. Both in vivo and in vitro 
investigations have shown that acute ascorbate deficiency 
results in the impaired metabolism of a variety of xenobiotics 
and steroids (reviewed by Zannoni and Lynch, 1973; Zannoni and 
Sato, 1976). Reactions such as 0- and N- demethylation and 
hydroxylation were decreased (50-70^), as were the individual 
electron transport components cytochrome P-^50 (kQ$) and
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NADPH-cytochrome c reductase (85$), after 21 days of deficiency. 
Repletion of the deficient animals with ascorbate for 6 to 10 
days resulted in a restoration of enzyme activities (Zannoni 
et al., 1972). Studies with foetal guinea pig livers have 
shown a correlation between drug metabolism activities, the 
quantity of electron transport components and liver ascorbate 
concentration (Zannoni and Sato, 1975)• In fact, weanling 
animals seem to be particularly sensitive to this effect of 
ascorbate deficiency (Sato and Zannoni, 197*0*
The mechanism of the depression in mixed function oxidase 
metabolism is uncertain. Ascorbate deficiency has been shown 
to have a qualitative as well as a quantitative effect on 
cytochrome P-^50. Type I and type II substrate binding spectra 
in microsomes isolated from deficient animals were shown to 
be atypical (Zannoni et al., 1972; Gundermann et al., 1973)*
The Km values for aniline, aminopyrine and p-nitroanisole were 
also higher (Zannoni et al., 1972). It has also been suggested 
that ascorbate deficiency might influence the phosphatidylcholine 
content of the enzyme system (Zannoni, 1977)*
The capacity for induction of these enzymes is not impaired 
in ascorbate-deficient animals (Wade £t al., 1972; Zannoni 
et al., 1972). Luft et al. (1972) showed that administration 
of S-aminolevulinic acid, a precursor of haem synthesis, led 
to increased cytochrome levels in deficient guinea pigs# indicating 
the participation of ascorbic acid in haem biosynthesis.
In view of these findings, it would seem feasible that 
the site of action of ascorbic acid in bile acid biosynthesis could, 
be cholesterol 7dL-hydroxylase. Further indirect evidence in
-110-
this respect was contributed by Ginter (1975b), who showed a 
parallel increase in levels of cytochrome P-**50 and the oxidation
acid to deficient guinea pigs.
Megadoses of Ascorbic Acid
The magnitude of the daily dose of ascorbic acid required 
to maintain normal cholesterol metabolism is still uncertain. 
Over the last decade, the concept of "megavitamin therapy" has 
emerged. The term "megatherapy" is itself rather ill-defined, 
but would imply ingestion of the vitamin in excess of the daily 
recommended intake (for ascorbate in man 30mg U.K. ^ 5mg U.S.A.). 
Various authors however have different concepts of these levels. 
The original thesis for ascorbic acid "megatherapy" was proposed 
by Stone (1965) and elaborated by Pauling (1968), who 
concluded that the recommended intakes for this vitamin were 
set far too low. From studies in animals synthesising ascorbic 
acid, Stone proposed that intakes should be 50 to 500 times 
those recommended. However others such as Ginter (1975b) have 
employed levels of lg per day as "megadoses".
Baker et al. (1971b) reported that only a small proportion 
of an administered labelled "megadose" was incorporated into 
body pools. Similarly, the administration of either 80mg or 
lg of ascorbate per day to women resulted in similar leucocyte 
ascorbate levels (Baird et al., 1976). Thus a "megadose" is 
apparently not required for tissue saturation, in accordance 
with the conclusions of earlier workers(Chatterjee, 1967;
Vitler, 1967)» who suggested that a daily intake of 100-2G0mg
following the administration of ascorbic
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was adequate.
To date, it has been widely assumed that owing to its 
water soluble nature, ascorbic acid is excreted in the urine 
at high levels of intake and is thus harmless. However, . 
information pertaining to its toxicity at high dose levels is 
accumulating. One associated problem is that on cessation of 
"megatherapy", certain individuals may manifest symptoms of 
overt scurvy (Rhead and Schrauzer, 1971). Indeed, the same 
workers reported that blood levels of the vitamin,in a subject 
given l-3g daily for up to 5^ months fell below control levels 
after discontinuation of therapy (Schrauzer.and Rhead, 1973)* 
However studies in guinea pigs are at variance with these 
findings (Horaig et al., 1973; Nandi et al., 1973)•
A further complication of "megadoses" of ascorbic acid 
was discussed by Brown (1973)* He demonstrated a disturbance 
of bone metabolism in chicks, following the administration of 
high doses{Supporting data in man however is lacking. "Megadoses” 
of the vitamin have also led to an increased urinary excretion 
of oxalic acid and in some individuals to the formation of 
urinary calculi (Briggs, 1976). Similarly uric acid stones were 
reported in man after the chronic daily administration of 8g 
of ascorbate (Stein et al., 1976). In addition, an haemolytic 
effect of ascorbic acid (5g/day) has been observed in healthy 
volunteers (Mengel and Green, 1976).
A further complication of ascorbic acid "megatherapy" hasbeen 
proposed by Basu (1977)• To some extent, ascorbic acid is 
metabolised to the sulphate in man (Baker et al., 1971a). Thus, 
by depleting sulphur amino acids, high levels of ascorbic acid may
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potentially interfere with the metabolism of some foreign 
compounds and amino acids.
There is as yet little evidence available regarding the 
effect of "megadoses" of ascorbic acid on the mixed function 
oxidase enzyme system. However, it is recognised that high 
concentrations of ascorbate in vitro are capable of generating 
free radicals and stimulating lipid peroxidation (Ottolenghi, 
1959; Thiele and Huff, i960). One might therefore hypothesise 
that high concentrations of ascorbate in vivo could lead to 
an increase in peroxide-induced membrane damage and subsequent 
disruption of the microsomal enzyme system, thus altering the 
metabolism of both foreign and endogenous substances. Similar 
changes might occur in the absence of the vitamin, as paradoxi­
cally, ascorbate at lower concentrations protects against 
oxidation (Bielski et'al., 1975)• It could be envisaged that 
the vitamin might be required within a certain limited range 
of concentration to maintain normal membrane structure and 
function. Divergence from this concentration in either direction 
could result in aberrations within the membrane,ultimately 
interfering with the metabolism of foreign compounds and endoge­
nous substances such as cholesterol.
In order to investigate this hypothesis, experiments were 
designed to examine the effects of various levels of deficiency 
and excess of the vitamin. Data regarding the modulatory 
effect of ascorbic acid on cholesterol 7ok-hydroxylase activity 
is limited, the experimental design of the studies from which 
it is derived being open to criticism, particularly with respect 
to dietary control. It thus seemed desirable to conduct a more
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definitive study, in which serum and hepatic concentrations 
of ascorbate, cholesterol and bile acids, together with indices 
of hepatic xenobiotic and bile acid metabolism were measured 
in the same animals.
Materials
These were as described in Chapter 2, with the addition 
of the following:
L-ascorbic acid for dietary administration was supplied 
by Fisons and for analytical purposes by B.D.H.
Activated charcoal (Norit) acid-washed and 0-phthalaldehyde 
were supplied by Sigma.
Malonaldehyde bis (-dimethyl acetal) (1,1,3,3-tetramethoxy- 
propane),for use as a standard,was obtained .from Aldrich Chemical 
Co. Ltd., Gillingham, Dorset.
Standard bile acids were obtained from Steraloids Ltd., 
Croydon, Surrey.
sodium glycocholate 16 mCi/mmol was supplied by 
the Radiochemical Centre, Amersham.
NADP was obtained from P-L Biochemicals Inc.
Methods
These were also as described in Chapter 2, with the 
exception of the following:
I Blood Analysis
.s'
(a) Serum Total Cholesterol Concentration
Owing to the expense of the method used in Chapter 2, the 
0-phthalaldehyde method (Rudel and Morris, 1973) was employed.
This method involves a preliminary saponification of the 
serum, followed by extraction of the non-saponifiable lipid 
with hexane and reaction of the dried extract with O-phthalal-
-115-
dehyde to form a cholesterol-specific coloured product which 
absorbs at 550nm.
A 0.1ml aliquot of serum, 0.3ml of 33$(w/v) KOH and 3ml 
of 95^(v/v) ethanol were placed in a 15ml glass sovirel tube.
After thorough mixing, the tube was placed in a heating block 
at 60°G for 15 minutes. A blank, consisting of 0.1ml of absolute 
ethanol and 0.1ml of cholesterol standard (lmg/ml absolute 
ethanol) were saponified in parallel (see page ). After 
cooling the tubes, a 10ml volume of hexane was added forcefully 
to each; followed by 3ml of distilled water. The tubes were 
shaken for 1 minute on a rotary shaker to ensure complete 
mixing. 1ml aliquots of each hexane layer were pipetted in 
duplicate into 10ml test tubes and the solvent evaporated 
under nitrogen.
A 2ml volume of 0-phthalaldehyde reagent (50rag O-phthalal- 
dehyde/lOOml glacial acetic acid) was added to each tube, 
followed by thorough mixing to dissolve the residue. Approximately 
10 minutes after this addition, 1ml of concentrated sulphuric 
acid was slowly added, immediately followed by vigorous mixing.
The extinction of the solutions at 550nm was measured 10 to 
30 minutes after addition of the acid, using the Cecil 
spectrophotometer.
(b) Serum Triglyceride Concentration
This was measured using a fully enzymatic, automated 
method No. 126012 (Boehringer Mannheim GmbH) . This method is 
the same as that described in Chapter 2 (Wahllfeld, 197^) •
(c) Plasma Total Ascorbic Acid Concentration
Plasma ascorbic acid was measured according to the method
of Denson and Bowers (1961). Total ascorbic acid i.e. ascorbic
acid, dehydroascorbic acid and diketogulonic acid is determined
by coupling with 2, Jj—dinitrophenylhydrazine, following oxidation
of the ascorbic acid. The resultant orange-coloured addition
compound is dissolved in sulphuric acid and absorbs at 520nm.
Plasma was prepared by collecting blood into polystyrene
tubes containing EDTA (Teklab,Sacreston, Durham), mixing
thoroughly and centrifuging for 10 minutes on a bench centrifuge.
Duplicate 0.5nil aliquots of plasma were transferred to
small polystyrene tubes (LP3) containing 2ml of 5$ (w/v)
trichloroacetic acid. The tubes were thoroughly mixed and
spun for 10 minutes on a bench centrifuge. The supernatants
were transferred to clean LP3 tubes and subsequently stored
overnight at 0-^°C or for up to 1 week at -20°C, prior to
determination of the ascorbic acid.
A 1.5^1 aliquot of supernatant was pipetted into a test
tube containing 0.5nil of working 2, 4-dinitrophenylhydrazine
reagent (2, ^-dinitrophenylhydrazine stock solution, 2.2$ (w/v)
in ION sulphuric acid, 5% (w/v) thiourea, 0.6$ (w/v) copper
sulphate,' 100:5* 5 by volume). Samples and blanks (1.5ml 5$
trichloroacetic acid) were set up in duplicate. Replicate
ascorbic acid standards (bjig/ml 5fo trichloroacetic acid) were
prepared; duplicate aliquots of both of these were run in
*
parallel with the samples and blanks. After thorough
# ..
The relationship between cholesterol and ascorbate concentration
and extinction could be shown to be linear over a range of concen­
trations greater than the extremes of variability encountered.
mixing, all tubes were stoppered and incubated in a water 
bath at 37°C for 4 hours. After cooling in an ice-bath, a 
2.5ml volume of ice-cold 65fo (v/v) sulphuric acid was slowly- 
added to each tube with shaking. The solutions were thoroughly 
mixed and allowed to equilibrate to room temperature (at least 
30 minutes). The extinctions of all solutions were determined 
at 520nm using the Cecil spectrophotometer.
II Liver Analysis
(a) Preparation of Liver Fractions
This was as described in Chapter 2, with the exception 
of certain details.
The homogenisation medium '.was 0.02M Tris/l.15/6 KC1, pH 7 .^ . 
Homogenisation was carried out using a Potter homogeniser in 
k volumes of buffer, to give a 20°/o homogenate as described 
previously.
The microsomal pellet was obtained by centrifugation at 
170,000 g av. for 35 minutes at 2°C (Beckman Model L5-65 
ultracentrifuge, 8 x 25ml angle rotor, 50,000 r.p.m.).
(b) Measurement of Total Lioid Content
The method used in Chapter 2, was modified for use on 
the 20^ homogenate.
A 5ml aliquot of homogenate was mixed with 20ml of 
chloroform: methanol (1:1, v/v) and extracted for 10 minutes 
on the rotary shaker. After filtering through glass wool,
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a 10ml volume of clear filtrate was added to 3.75ml of methanol 
followed by 6.25ml of water in a universal container and mixed 
by inversion. After centrifuging for 5 minutes at 2,000 r.p.m., 
the upper aqueous layer was removed by aspiration. Total 
lipid was estimated as described previously.
(c) Measurement of Total Liver Cholesterol
2ml of the chloroform layer from 11(b) was evaporated to 
dryness in a "pear-shaped,f flask in vacuo at ^0°C, on a rotary 
evaporator. The residue was taken up in 200yul of absolute 
ethanol and lOO^ul aliquots saponified and treated as described 
for serum cholesterol.
(d) Liver Ascorbic Acid Concentration
5ml aliquots of liver homogenate were precipitated with 
k volumes of 5$ (w/v) trichloroacetic acid, mixed and spun 
for 10 minutes in a bench centrifuge. 10ml volumes of super­
natant were transferred to glass screw-capped vials and routinely 
stored at -20°C for up to 1 week. Acid-washed Norit (0.33g) 
was added to the supernatant and the mixture shaken and filtered 
(Whatman No 1, size 11). Ascorbic acid concentration was 
determined in duplicate 1.5ml aliquots using the procedure 
described for plasma.
(e) Measurement of Cholesterol 7ol-hydroxylase Activity
As a result of work carried out in this department in 
optimisation of the conditions for this assay, the incubation 
system was modified as follows:
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Test Control
Microsomal supernatant(ml) 3.0 -
Boiled microsomal supernatant (m3) - 3-0
^-mercaptoethylamine l40mM(ml) 0.05 0.05
Substrate (ml) 2.0 2.0
Cofactor solution(mlf* 1.0 1.0
* I , 14 1
Substrate: 0.5^ .0i L^- CJ cholesterol stabilised in Tween
80 (7«2mg) and dissolved in 2.0ml of 0 .1M potassium phosphate
buffer, pH 7«^*
Cofactor solution: NADP, 5^ -niol and glucose-6-phosphate, 
50^ lmolf dissolved in 1.0ml of distilled water.
The first 3 constituents were pre-incubated at room
temperature in 25ml conical flasks for 10 minutes before the
reaction was initiated by the addition of the cofactor solution. 
The flasks were subsequently incubated at 37°C for 60 minutes 
with shaking.
The extraction procedure and thin-layer chromatography of 
the extracts were as described previously. However single 
chromatoplates were run and the radioactive bands localised 
by autoradiography for ^-6 .weeks, rather than by the colo .rime- 
trie procedure. Counting conditionswere as described previously
■(f) Measurement of p-Nitroanisole O-Demethylase Activity
An assay system based on that of Netter and Seidel (196^)
was used, in which the formation of p-aminophenol is followed 
at 4l7nm.
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Two 1cm glass cuvettes were set up as follows:
Tris-HCl 0.05M, pH 7.85(ml) 1.^
Microsomal supernatant(ml) 0.5
* Substrate(ml) 0.005
MgCl2 O.lM(ml) 0.1
* .Substrate: p-nitroanisole 500mM in dimethyl formamide, added
after temperature equilibration.
The NADPH generating system was prepared in 0.05M Tris-HCl
buffer, each 0.5ml contained NADP, 3mM and glucose-6-phosphate,
30mM (as microsomal supernatant was used, no glucose-6-phosphate
dehydrogenase was added).
The cuvettes were placed in the forward cell compartment
of the SP 1800 spectrophotometer, at 37°C. for 5 minutes to
allow temperature equilibration. After zeroing the recorder,
0.5ml of buffer was added to the reference cuvette, and the
reaction started by the addition of 0.5ml of NADPH generating
system to the test cuvette. The increase in absorption at
^17nm v/as followed and from the linear phase of the reaction,
p-nitroanisole 0-demethylase activity was calculated using
—1 —1an extinction coefficient of 6.8 mlvl” Cm“ .
(g) Measurement of Microsomal Lipid Peroxidation
Lipid peroxidation was measured using a modification of 
the method used by Slater and Sawyer (1971)* This is based 
on the in vitro measurement of malonaldehyde, the product of
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peroxidation of polyunsaturated fatty acids, after its reaction 
with thiobarbituric acid. The following incubation system was used:
Test Control
Buffer*(ml) 1.8 2.0
Microsomal suspension(ml) 0.25 0.25 ‘
0.02M Tris/l.15$ KC1 pH 7-^(ml) 0.25 0.25
Cofactor solution (ml) 0.20 -
Incubation volume 2.5ml 
* Buffer = 65mM KCl/57mM Tris pH 8.3
Each 0.2ml of buffer contained NADP 2^ «nol, glucose-6-phosphate 
15jmol and glucose-6-phosphate dehydrogenase 1 unit.
Duplicate tubes were incubated for 20 minutes at 37°C with 
shaking. The reaction was terminated by the addition of 5ml 
of 10$ (w/v) trichloroacetic acid and the tubes centrifuged 
for 10 minutes in a bench centriguge.
A 2ml aliquot of supernatant was mixed with 2ml of 0.67$ 
(w/v) thiobarbituric acid in a clean test tube and incubated 
for 10 minutes in a water bath at 100°C. Duplicate tubes were 
set up,together with blanks (10$ trichloroacetic acid) and a 
range of standards (tetramethoxypropane, 0.25-2.5yu.g/ml 10$ 
trichloroacetic acid). The resultant pink colours were 
measured at 535nm, using the Cecil spectrophotometer.
(h) Clucose-6-Phosphatase Histochemistry
Glucose-6-phosphatase activity can be examined histochemi-
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cally in cryostat sections of liver and may provide qualitative 
data on the intracellular alteration in enzyme distribution 
and activity.
Small pieces of liver (approximately 4mm cube) were cut 
from the centre of the left lobe and frozen on to microtome 
chucks standing in a shallow dish containing an ethanol/solid 
carbon dioxide freezing mixture. These tissue blocks could 
be stored at -20°C for at least 48 hours, without detectable 
loss of enzyme activity. lO^isections were cut using a cryostat 
fitted with a rotary, rocking microtome (Bright Instruments, 
Huntingdon), at -20°C and directly transferred to glass 
microscope slides.
Enzyme activity was measured by the method of Wachstein 
and Meisel (1956)» in which inorganic phosphate released from
the substrate is "captured" by lead ions in the medium and
precipitated as lead phosphate. This is converted to the 
readily visible black lead sulphide by treatment with ammonium 
sulphide.
Sections of liver were incubated at 37°C for 30 minutes 
in 50ml of solution containing Tris-maleate buffer pH 6.7»
40mil; lead nitrate 4.5mM; glucose-6-phosphate 1.5mM. After 
incubation, slides were twice washed in distilled water and 
treated as follows:
1) Dilute ammonium sulphide solution(2-4 drops stock B.D.H. 
solution in approximately 50ml of distilled water), for 
2 minutes.
2) Distilled water for 2 minutes.
3) 6$ (v/v) formaldehyde solution for 2 minutes.
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4) Distilled water for 2 minutes.
Sections were mounted in glycerol jelly and examined in a 
light microscope. Sites of glucose-6-phosphatase activity 
were stained dark brown.
Ill Biliary Analysis
(a) Biliary Cholesterol Concentration
The cholesterol concentration of gall bladder bile was 
measured by a modification of the method for serum. 200^1 of 
bile was saponified and extracted into 10ml of hexane, 3ml of 
the hexane layer was evaporated to dryness in a stream of 
nitrogen and‘the cholesterol content determined by the 0-phthalal- 
dehyde method.
(b) Biliary Bile Acid Concentration
For determination of total bile acid concentration, bile 
samples were diluted with 50$ aqueous methanol, pH 10.0 (1 in 
250) and 50^ tl aliquots taken for assay using the enzyme-fluori- 
metric method described for serum in Chapter 2.
For a qualitative and quantitative assessment of the 
individual bile acids present, a method was developed which 
used a thin-layer chromatographic separation,followed by elution 
of appropriate bands from the plate and subsequent quantification 
using the same techique as above.
A 20^ ul aliquot of bile was applied as a narrow 1 cm band 
to the origin of a thin-layer plate (Silica gel G). Two solvent 
systems were used. A. propionic acids isoamyl acetates water:
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n-propanol (3:4sl:2, v/v)j J1 2,2,4-trimethylpentane: di-isopropyl 
ethers acetic acids isopropanol (2:1:1:1, v/v) (Beke iet al., 
1976). Ascending chromatography in saturated air was used.
The plate was run in solvent system A for approximately 60 
minutes at room temperature (20°C), or until the solvent front 
had reached a distance of approximately 10 cm from the origin.
The plate was removed from the tank and thoroughly dried in a
cold air stream. A second development in solvent system A
was followed by development in solvent system B for approximately
90 minutes at room temperature, or until the solvent front
had reached 16-17 cm from the origin. The first 2 developments
permit separation of the conjugated bile acids, whilst the
third separates the free bile acids.
Plates were run in duplicate and after chromatography one 
was visualised by spraying with a solution of phosphomolybdic 
acid (20$ w/v in absolute alcohol), followed by gentle heating. 
Identification of the individual bile acids was achieved by 
comparison with a mixture of conjugated and free standard 
bile acids ran on the same plate.
In order to quantify the component bile acids, appropriate 
bands on the second plate were scraped into 10ml glass sovirel 
tubes and extracted with 5ml of methanol: glycine-NAOH 0.005M 
pH 9.7 (3sl» v/v) for 10 minutes on a rotary shaker. The 
extraction was repeated v/ith a further 5ml of buffered methanol, 
the combined extracts transferred to •'pear-shaped'* flasks and 
evaporated to dryness in vacuo using a rotary evaporator at 
30-40°C. Residues were taken up in 200^1 of 50$ aqueous 
methanol, pH 10.0 and 50/xl aliquots taken for assay. Total
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recovery of the procedure was measured by the addition of a
r  1
known quantity of LI- CJ sodium glycocholate to the bile, 
prior to chromatography and was of the order of 85-95$*
IV Aortic Histology
Hearts and aortas were fixed in buffered formalin (10$ v/v 
formaldehyde in 0.05M sodium phosphate buffer), dehydrated in 
alcohol, cleared in xylene and embedded in paraffin wax.
Sections of approximately 5yt thickness were cut on a base-sledge 
microtome (M.S.E. Ltd.) and stained with haematoxylin and 
eosin (Drury and Wallington, 1967)• Further pieces of tissue 
were embedded in gelatin and sections of 12-15yU. thickness cut 
on a freezing microtome (Leitz) and stained with Oil Red 0 
(Drury and Wallington, 1967).
V Dietary Analysis
Ascorbic acid content of the guinea pig diet was determined 
after extraction with metaphosphoric acid by titration with a 
standardized dye 2,6-dichlorophenolindophenol, which is 
quantitatively reduced by L-ascorbic acid in acid solution.
Duplicate 20g aliquots of diet were extracted by maceration 
in 350ml of 5$' (w/v) metaphosphoric acid for approximately 
1 minute in a liquidiser (Kenwood Instruments, Thom Appliances, 
Havant,Hants). The resultant homogenate was spun for 10 
minutes in a bench centrifuge. A 25ml. aliquot of supernatant 
was transferred to a 50ml conical flask and 1ml of 50$ (v/v) 
sulphuric acid followed by 2.9ml of formaldehyde were added. 
After thorough mixing, the solutions were allowed to stand for
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8 to 10 minutes. They were subsequently titrated against a 
solution of 0.02^ (w/v) dichlorophenolindophenol together 
with duplicate blanks of 5$ metaphosphoric acid and standard 
ascorbic acid solutions (200^tg/ml in 5$ metaphosphbric acid).
On addition of the dye it is decolo rized by ascorbic acid, 
the end point of the titration is taken when a pink colouration 
persists for at least 5-10 seconds.
Animals and Experimental Procedure
For all experiments, male guinea pigs of the Dunkin Hartley 
strain, 5-6 weeks old (300-^00g), supplied by the Animal Virus 
Research Institute, Pirbright, Surrey, were used. They were 
housed in alloy cages, measuring 53 cm x 11^ cm x 25 cm, over 
sawdust which was changed twice a week.
Animals were allowed access to diet and tap water ad libitum 
at all times. The temperature and relative humidity of the 
animal house was regulated to 22°C and 50>%respectively and 
lighting was time-switched on at 06*30 hours and off at 18.30 
hours. Measurements of weight and food intake were made at 
regular intervals, no allowance was made for spillage of diet 
as this was found to be minimal and relatively constant between 
groups. ;'The guinea pigs were maintained on stock diet (FD1 
pellets, Lab sure Animal Diets,, supplied by J. Lillico and Sons, 
Reigate, Surrey) for 3-7 days to allow acclimatisation to the 
animal house conditions.
Experiment 1 (Chronic Deficiency)
The guinea pigs were randomly assigned to three experimental 
groups with 18 to each group, 9 to each cage.
The groups,were A (ascorbate-deficient), B (control) and 
C (ascorbate-supplemented). All animals were fed on ascorbic 
acid-free pelleted guinea pig diet (Labsure Animal Diets, 
Christopher Hill Group Ltd., Poole, Dorset), shown by analysis 
to contain 2mg ascorbic acid/lOOg diet. Diets were supplemented 
by oral dosing with ascorbic acid dissolved in 20$ (w/v) sucrose 
solution as follows: Group A 0 .5^g/day; Group B 30mg/kg body
weight/day (20mg/ml)j Group C 300mg/kg body weight/day 
(200mg/ml). At the beginning of the experimental period,
Group A was totally depleted of ascorbic acid for 3 weeks, when 
signs of deficiency became apparent. During this period, 
these animals were dosed with sucrose solution alone. The 
animals were dosed orally for 5 out of 7 days, for the remaining 
2 days, ascorbic acid was dissolved in the drinking water as 
follows: Group A 50mg/litre; Group B 600mg/litre; Group C 
6g/litre, assuming an approximate fluid intake of 30nil per 
animal per day.
The original experimental design was such that 6 animals 
from each group should have been killed after 6 and 12 weeks 
of treatment. The animals in both experimental groups would 
then have been given control levels of ascorbic acid in an 
attempt to reverse any induced changes. However,this design 
was necessarily modified and the 6 week interval omitted 
due to the loss of 6 animals from Group A at an early stage.
These animals were suffering from eruptive lesions in the 
rear limbs, apparently arising from fractures sustained at 
an early post-natal stage and presumably exacerbated by the 
* **
Increased to 333mg/ml at week 13; Increased to 9g/l at week 13.
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deficiency of ascorbic acid.
A further difficulty was encountered in maintaining the 
Group A animals on Q.5mg ascorbate per day as suggested by 
Ginter (1968). It was impossible to maintain the body weight 
and food intake of these animals and overt signs of scurvy 
became apparent. To prevent these changes, a daily intake of 
1.5mg ascorbate was required.
Six animals from each group were thus killed after 12 weeks 
of treatment and as a consequence of the experimental findings, 
the daily dose of ascorbate in Group A animals was again reduced 
to 0.5mg per day and that in Group C increased to 500mg/kg 
body weight per day.
At both time intervals, animals were killed after an 18 
hour fast by exsanguination via cardiac puncture under mild 
ether anaesthesia, followed by cervical dislocation. Approximately 
2.5ml of blood was collected for preparation of plasma as 
described above. The remainder was collected in non-heparinised 
bottles for preparation of serum. The livers, hearts and 
aortas of each animal were removed and treated as described 
in Chapter 2. Bile was collected from each gallbladder and 
stored at -20°C prior to analysis.
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Results
Animal Weights and Food Intakes
Growth curves and food intake data are presented in Fig. 3*1 
and Table 3«1«
Following depletion of ascorbic acid, the mean growth rate 
of the animals in Group A began to decline. Administration of 
a daily dose of 0.5nig ascorbate per animal did not prevent this 
decline when commenced at week 3• A dose of between 1.0 and 
2.0mg per day was required to maintain food intake and growth 
and prevent obvious signs of deficiency in these animals.
Thus by week 7, all animals in Group A were established on a 
daily dose of 1.5mg ascorbic acid. Allthough the difference 
in mean body weight between Groups A and B became statistically 
highly significant by week 5 of the experiment and remained 
so throughout, the actual food intakes and rates of growth 
were similar until week 17. At this point Group A was again 
totally depleted of ascorbic acid and despite the introduction 
of a daily dose of 0.5mg at week 20, these animals did not 
increase their food intake and began to lose weight.
With respect to Group C, mean body weight, growth rate 
and food intake did not differ from the control group until 
week 11 When mean daily food intake suddenly diminished to 89$ 
of the control. It should be noted that the food intake of 
the control group also dropped at this time, but to a lesser 
extent. By week lh,food intake reached control levels but 
subsequently fell (79-88$ control) until the end of the
Fi
g.
 
3»
1 
Gr
ow
th
 
Cu
rv
es
 
of
 
Gu
in
ea
 
Pi
gs
 
Ma
in
ta
in
ed
 
on 
As
co
rb
ic
 
Ac
id
 
(A
A)
-D
ef
ic
ie
nt
 
a
 
a 
(A
) 
C
o
nt
ro
l
-130-
•H
3
•P
£
©s
•Hu©
AXw
|coV
CO
to•p
® i•H
R
B
04
a
©
*P
£
©£
©
H
A
AA
COI
•HO•aj
O•H
"SOOTO
<
00
PQ
0
0 4
<d bD e  
< e o  
o o  o©
Oo
o
-3-
o
CO
CO
VOo
( 2 )  J1H 9ISM  1 (1 0 9
W
E
E
K
S
Ta
bl
e 
3*
1 
Me
an
 
Da
il
y 
Fo
od
 
In
ta
ke
 
of 
Gu
in
ea
 
Pi
gs
 
Du
ri
ng
 
Ex
pe
ri
me
nt
 
1.
 
(g
ra
ms
/g
ui
ne
a 
pi
g/
da
y)
.
-131-
CA NO VA CM
C\2 CA VA VA -P
cd
CM NO rH rH >5
CM CA VA VA cd
• d
\
«H CO H 43- ■p
CM CA NO VA . d
bD
•H
O rH 1—1 CA 0
CM CA NO VA £
>5
CN CO H CM ' d
HI 4 3 NO VA 0
&
CO CA H O tiO
rH 'A NO VA X
\
bD
O CA O x—* £
rH VA NO VA TO O
X O
CD VA
NO 43- CO CA 0
rH 43- va VA £ •-
to
CA X
VA CM 0
rH 1 1 1 0
-P
03
43- O rH NO CM
rH VA VA VA >s rH
—H CCS ---S
ixj n to -P
M CA \ X cd
P i—1 1 1 1 w 0s 0 >s
VA £ cd
CM NO O'. • TO
O r—1 43" 43- CA O CA
CM -P
•«k , d
VI rH NO 43- O n CQ r d bD
& rH 43* 43- CA C •H
w 0 cd 0
W 0 £
O 0 0 CN- O £ CM
i—1 43- 4}" VA rH
CM " d
rH -P O
1A O NO cd P
ON 43- VA 43- -P
cd >5 bD
cd M
43- 43- O >5 nd
CO ' 4i- VA VA cd \ tiD
' d • p e
0
CA CM VA UD tiO 0
CN- 43” 43- 43- £ •H CA
va 0
• £
ON CM CM rH f t
NO 43- 43- 43- »—X >5 d
xi 0
f t 0 u
o o CM CM 3 & bD
NA CM 43- 43- O
U taO X5
w 0
A - H 0 - p
43" CM 4 3 43- • -p d
d . £ 0
0 0 £
NO NO £N- •H CA 0
CA CA CA CA O rH
•H ft
W ft ft
NO VA 0 0 0 d d
CM CA CA CA • d 0 m
1 u 1
0 bD 0
43- CA CA -p -p TO
rH CA CA CA cd rH cd
O \o 0
U U U 0
0 •P 0 £
0 d 0
* 03 O TO CA
Cl, * * cd O cd CM
S * * *
o < pq O *
03 *
C5 * * *
-132-
experiment. This drop in food intake led to a small reduction 
in growth rate, although the difference in mean body weights 
was not statistically significant.
Biochemical Changes Occurring in Animals on the Ascorbate- 
Deficient Diet (Group A)
These data are presented in Tables 3•2-3*7.
After administration of the deficient regime for 12 weeks, 
there was a significant reduction in both plasma and liver 
ascorbate concentrations. After 23 weeks, there was an even 
greater reduction in these parameters.
Serum total cholesterol concentrations did not differ 
from control at 12 weeks. Liver cholesterol content was 
slightly elevated, although the difference was not statistically 
significant. Serum triglyceride, liver total lipid and biliary 
cholesterol concentrations showed no variation from controls. 
After 23 weeks however, serum total cholesterol became signifi­
cantly elevated although the liver concentration was unchanged. 
Serum triglycerides were also raised but the difference was 
statistically non-significant. The other parameters of lipid 
metabolism were unaltered.
Both serum and biliary total bile acids were marginally 
reduced at 12 weeks; by 23 weeks the difference was no longer 
apparent. At 12 weeks the principal component bile acids 
were estimated both qualitatively and quantitatively but no 
changes were evident.
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Table 3*^ Effect of Ascorbic Acid Depletion and Supplemention
on the Principal Component Bile Acids in Gall Bladder
Bile Expressed as a Percentage of Total Bile Acids
Measured at 12 Y/eeks
Free Glyco- Tauro-
Chenodeoxycholate chenodeoxycholate chenodeoxycholate
A* 3-14 ± 0.54+ 57.0 + 9.2+ 21.5 + 3.1+
B** 2.01 + 1.34++ 57.2 + 7.6++ 14.9 + 1.8+
C*** 4.21 +0.65 66.4 + 5.3 9.52 + 1.66
Results expressed as mean + standard error of mean.
* . .Ascorbate-deficient
# *
Control
Ascorbate-supplemented 
Except where otherwise stated n=6 for all groups.
+ n=5
++ n=4
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Table 3*6 The Effect of Ascorbic Acid Depletion and Supplemen­
tation on Some Mixed Function Oxidase Enzymes and 
Related Parameters in the Guinea Pig (Experiment 1)
WEEKS
12 23
Liver weight (g)
*
A 26.1 + 2.2 33.5 + 2.9
B 31.3 + 1.4 40.8 + 2.2
C 29.7 + 2.1 36.0 + 3.6
Relative liver weight
*
A 3-99 4 0.19 4.34 4 0.23
(g/lOOg body weight) B 3.63 + 0.11 3.67 Hr 0.21
c 3.63 + 0.14 3.41 + 0.25
Microsomal protein A 14.4 + 1.6 17.7 + 1.7
(rag/g liver) B 14.3 + 0.3 17.6 1.6
C 15.1 + 0.9 15.1 + 1.2
p-nitroanisole O-deme-
*
. A 61.3 + 14.2++ 43.5 + 21.0
thylase (nmol produced/ B 64.4 +
++
12.8 30.0 + 3.6
g liver/hour)
■
C 55-6 + 21.1++ 34.1 + 2.6
Biphenyl 2-hydroxylase
*
A 173 + I6b 340 + 68
(nmol prodUced/g liver/
**
B 113 + 11 ao8 + 62
hour) C 148 + ioa 213 + 67
Biphenyl 4-hydroxylase
*
A 3-48 4 0.32 7.98 + 4.16
(jimol produced/g liver/ B 2.72 + 0.34 5.01 + 0.32
hour). C 2.82 + 0.24 4.47 + 0 .44
cont'd
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Table 3*6 The Effect of Ascorbic Acid Depletion and Supplemen­
tation on Some Mixed Function Oxidase Enzymes and 
Related Parameters in the Guinea Pig (Experiment 1)
cont'd
WEEKS
12 23
Cytochrome P-450
*
A 16.7 + 1.8 16.9 + 5-1
(nmol/g liver) B 16.9 Hr 1.3 18.2 + 2.2
C 14.7 + 1.7 15.4 + 1.2
Cytochrome b^
*
A 14.2 + 1.0 12.1 + 2.1
(nmol/g liver) B 13.1 + 0.7 12.9 + 1.5
.
a-s*
C 12.3 + 1.5 12 .1 + 0.9
NADPH-cytochrome c reduc­
*•
A 1.27 + 0.09a 1.64 + 0.24
tase (ixmol cytochrome c B 0.93 + ■0.07 0.75 + 0.10
/
reduced/g liver/minute) .
-a-a-a-
C 0.90 + 0.10 0.64 + 0.03
Results expressed as mean + standard error of mean.
Ascorbate-deficient Control *** ■Ascorl,ate-supplemented.
Except where .'otherwise stated for A,B,C at 12 weeks n=6
for A,B,C at 23 weeks n=3,6,6
respectively.
++ n=k
a = p<0.05 b = p^O.Ol
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Table 3*7 The Effect of Ascorbic Acid Depletion and Supplemen­
tation on the Activities of Some Mixed Function 
Oxidase Enzymes in Guinea Pig; Liver, Expressed per 
mg Microsomal Protein (Experiment 1)
WEEKS
12 23
p-nitroanisole 0-deme-
*
A 4.24 + 0.81++ 2.32 + 0.92
thylase (nmol produced/
**
B k.62 + 0.96++ 1.72 + 0.13
hour) , C '3-33 Hr 1.09++ 2.15 + 0.31
Biphenyl 2-hydroxylase
*
A 13-6 + 3.4 19-1 + 3-3b
(nmol produced/hour) B** 7.2 + 0.7 5.81 + 2.82
c 9.9 + 0.9a 15.6 + 6.1
Biphenyl 4-hydroxylase
*
A 269 + 61 419 + 181
(nmol produced/hour) B 191 + 24 293 + 2 4
C 188 + 14 314 + 58
Cytochrome P-450 (nmol)
*
A 1.24 JL1 0.22 0.92 + 0.19
**
B 1.18 + 0.09 1.02 + 0.06
C o • 00 + 0.09 1.06 + 0.15
Cytochrome b^ (nmol)
*
A 1.02 + 0.21 0.68 + 0.06
**
B 0.91 +
o
•
o
0.74 + 0.06
a-**
C 0.82 + 0.08 0.82 +  0.10
NADPH-cytochrome c reduc­
*
A 93.4 Hr 14.2 95-1 ±  19.5b
tase (nmol cytochrome c B 67.8 + 4.6 42.1 + 3.1
reduced/minute) c 59.5 + 5.8 44.1 + 4.1
Results expressed as mean + standard error of mean. 
For explanation of table see Table 3*6
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Liver weight and relative liver weight were unchanged 
after 12 weeks but after 23 weeks relative liver weight increased 
slightly, although this was not statistically significant. 
Microsomal protein content was unaffected by treatment at 
either time interval.
There appeared to be a gradation in activity of cholesterol 
7cL-hydroxylase between groups (C) B ) A) after 12 weeks,although 
again these differences were not statistically significant.
After 23 weeks this pattern was no longer apparent.
. The activity of p-nitroanisole O-demethylase did not differ 
from controls at either time interval. In contrast, the 
activity of biphenyl 2-hydroxylase at 12 weeks was significantly 
increased. The activity of this enzyme was also increased at 
23 weeks, although the difference was only statistically 
significant when expressed as specific activity. Biphenyl 
4-hydroxylase was unaffected at either time interval.
Concentrations of cytochromes P-450 and b^ measured at 
both time intervals showed no variation from control values. 
Conversely/ at 12 weeks, there was a significant increase in 
NADPH-cytochrome c reductase activity which became even more 
pronounced at 23 weeks.
Biochemical Changes Occurring in Animals Fed the Ascorbate- 
Supplemented Diet (Group C)
Data are presented in Tables 3*2-3«7«
-141-
The administration of a daily ascorbate dose of 300mg/kg 
body weight led to an elevation in both plasma and liver 
ascorbate concentration. Increasing the dose to 500mg/kg 
body weight did not result in any further increase in tissue 
ascorbate concentration, in fact for liver,the levels were 
slightly below the controls and less than when measured at .
12 weeks.
Serum cholesterol concentration did not vary from control 
at either time interval. Liver total cholesterol content was 
significantly less than control at 12 weeks, a difference 
which was not apparent at 23 weeks.
Values for the other parameters of lipid and bile acid 
metabolism showed no variation from controls.
There were no differences in absolute or relative liver 
weight or microsomal protein content at either time interval.
As mentioned above, cholesterol ^-hydroxylase activity 
displayed a slight but non-significant increase at 12 weeks 
but not at 23 weeks.
With the exception of biphenyl 2-hydroxylase activity, 
which showed a small but significant increase at 12 weeks 
only, no changes in the parameters of mixed function oxidase 
metabolism were observed.
The histological sections of the aortas from all 3 groups 
of guinea pigs were kindly examined by Dr. P. Grasso (Chief 
Pathologist, British Industrial Biological Research Association, 
Carshalton, Surrey). No evidence of lipid accumulation was 
apparent.
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Exoeriment 2 (Chronic Deficiency)
In this experiment, the guinea pigs were randomly assigned 
to four experimental groups with 14 in each deficient group 
(A and B) and 12 in each of C (control) and D (supplemented).
They were housed in groups of 12, 2 animals from each deficient 
group being housed separately. All animals were given the 
ascorbic acid-free pelleted diet and orally supplemented with 
ascorbic acid in sucrose solution as follows: Group A (ascorbic- 
deficient) lmg/kg body weight/day (0.3mg/ml); Group B (ascorbic- 
deficient) 3mg/kg body weight/day (0.9mg/ml); Group C (control) 
30mg/kg body weight/day (?mg/ml); Group D (ascorbate-supplemented) 
lOOOmg/kg body weight/day (3l0mg/ral). Both groups A and B 
were initially depleted of ascorbic acid as in Experiment 1, 
although in this case, the period of depletion was only 2 weeks, 
no signs of scurvy, with the exception of weight loss in some 
animals, being apparent prior to supplementation. As previously, 
the ascorbic acid was administered in the drinking water for 
2 days each week as follows: Group A 17mg/litre; Group B
50mg/litre; Group C 500mg/litre; Group D l6.7g/litre.
The experiment was designed to compare the effects of 
two low doses of ascorbic acid on cholesterol and mixed function 
oxidase metabolism, in view of the observed disparities between 
the results of Experiment 1, and those of Ginter (see introduction). 
All animals were dosed on a body weight basis; Group A being 
given a quantity of ascorbate equivalent to that used by Ginter 
(0.5mg/day), whilst Group B were given the equivalent of the 
deficient level used in Experiment 1(1.5mg/day) . The dose level 
in the supplemented group was increased -in view of the lack of
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effect of the dose used in Experiment 1. Animals from each 
group were killed after 6 and 12 weeks of treatment, tissues 
being treated as described for Experiment 1. However, in 
this experiment,hearts and aortas were not removed.
Results
Animal Weights and Food Intakes
Tha sa data cue presented in Fig.3*2 and Table 3*8*
After 3 weeks of the deficient regime A, the growth rate 
of the animals in this group began to decline, corresponding 
with a decreased food intake. Although some growth was 
maintained throughout the experiment, the rate was significantly 
less than that of the control animals.
The animals on the second deficient regime B maintained 
a normal growth rate until week 7-8 when it began to decline, 
again corresponding with a decreased food intake.
The growth rates and food intakes of the supplemented 
group did not differ from the controls.
Biochemical Changes Occurring in Animals Fed the Ascorbate- 
Deficient Diets (Groups A and B)
These data are presented in Tables 3*9-3*13*
There was a significant reduction in both plasma and liver, 
ascorbate concentration after 6 weeks of treatment. For plasma, 
this became even more pronounced after 12 weeks. There were no 
significant differences between the -two deficient groups.
At both time intervals} there was an indication of a trend
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towards increasing total serum cholesterol concentration relative 
to the decreased daily intake of ascorbic acid but this rela­
tionship was not statistically significant. Liver cholesterol 
appeared somewhat elevated at both 6 and 12 weeks in deficient 
Group A, but the difference was not significant. Serum 
triglycerides and liver total lipid were unaffected by treatment.
At 6 weeks, serum and biliary total bile acids were 
unchanged; however at 12 weeks in both groups A and B there 
was a slight reduction in these parameters, although the diffe­
rence was statistically non-significant.
Liver weight was slightly diminished in group A after 
both 6 and 12 weeks of treatment, the difference being statisti­
cally significant at 12 weeks, however the relative liver weight 
was unchanged. For group B,no change was seen in either 
parameter at 6 weeks but at 12 weeks there was some indication 
of a decrease in liver weight, which would accord with the 
body weight data. Microsomal protein content was unchanged 
at either time interval.
After 6 weeks of deficiency, the mean cholesterol ^-hydro­
xylase activity in Group A was significantly reduced but in 
Group B did not differ from the control group. After 12 weeks, 
there Was some indication of a decreased activity in both 
deficient groups, but the difference was not significant.
The activity of p-nitroanisole O-demethylase was unchanged 
in either deficient group at 6 weeks. By 12 weeks however, 
it was significantly reduced in Group A.
Biphenyl 2-hydroxylase activity was unaffected at 6 weeks; 
by 12 weeks, this enzyme was apparently slightly induced relative
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to the controls, but not significantly so. Biphenyl 4-hydroxylase 
activity however was induced in both deficient groups at 12 
weeks, although unaltered at 6 weeks.
Concentrations of cytochromes P-450 and b^ ‘did not differ 
significantly from control when measured at either time interval. 
At 6 weeks no variation in cytochrome c reductase activity was 
observed but by 12 weeks this activity was significantly 
elevated in both deficient groups,particularly in Group B.
Hepatic in vitro lipid peroxidation and glucose-6-phosphatase 
histochemistry were unaffected by either level of deficiency.
Biochemical Changes Occurring in Animals Fed the Ascorbic- 
Supplemented Diet (Group D)
Data are presented in Tables 3*9-3*13
Plasma ascorbate levels were increased at both time intervals 
following the administration of lg/kg ascorbic acid. Hepatic 
concentrations were increased above controls at 6 weeks but 
not at 12 weeks.
Serum and liver cholesterol concentrations, serum trigly­
ceride, liver total lipid content, serum and biliary total bile 
acids were apparently uninfluenced by treatment.
Similarly there were no differences in absolute or relative 
liver weight or microsomal protein content at either time 
interval.
Cholesterol 7<*--hydroxylase activity was unaffected by 
ascorbate supplementation. Similarly, the other parameters of 
mixed function oxidase metabolism were not influenced by this 
treatment, with the exception of cytochrome c reductase activity*
This was apparently induced after 12 weeks of treatment although 
unaltered after 6 weeks.
Hepatic in vitro lipid peroxidation and glucose-6-phosphatase 
histochemistry were unaffected by ascorbate supplementation.
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Experiment 3. (Acute Deficiency)
The guinea pigs were randomly assigned to two groups:
Group A (deficient) and Group B (control), with 5 in each group. 
They were housed as described previously and fed the ascorbate- 
free pelleted diet, supplemented orally as follows: Group A
20$ sucrose solution alone; Group B 30mg ascorbic acid/kg 
body weight/day in 20$ sucrose solution. For 2 days each week 
ascorbate was administered in the drinking water of the control 
animals at the level of 500mg/litre.
After 24 days on this regime, the animals were killed and 
the tissues treated as described in the previous experiment.
Results
Animal Weights and Food Intakes
The growth rate of the deficient animals began to decline 
after 1 week of depletion (Fig. 3*3) and by the third week, 
growth had virtually ceased,whilst food intake had fallen to 
approximately 70$ of control. 3 of the deficient animals were 
emaciated and were showing scorbutic signs,including hair loss.
Biochemical Changes
These data are presented in Tables 3-14-3.17*
The deficient regime resulted in a pronounced reduction 
in both plasma and liver concentrations of ascorbic acid.
Serum and liver total cholesterol concentrations were 
elevated by the acute deficiency, although the difference was 
only of marginal statistical significance. Serum triglyceride
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Table 3• 14 Effect of Acute Ascorbate Deficiency on Some Serum 
Parameters in the Guinea Pie; (Experiment 3)
*
A B
Ascorbic Acid (^ug/100ml) 24.5 + 8.7° 890 + 77
Total Cholesterol (mmol/litre) 2.08 + 0.21 1.66 + 0.08
Triglyceride (mmol/litre) 1.36 + 0.52 1.06 + 0.26
Total Bile Acids (^mol/litre) 1.67 + 0.65 3.63 + 0.97
Results expressed as mean + standard error of mean.
Ascorbate-deficierit (n=5)
Control (30mg/Kg body weight/day) (n=5) 
c = p<0.001
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Table 3.15 Effect of Acute Ascorbate Deficiency on Some Hepatic
and Related Parameters in the Guinea Fig (Experiment 3)
A B
Body V/eight (g) 3 64 ' + 3Aa 48 5 + 18
Liver Weight (g) 14.5 + 1.3a 19.0 + 1.2
Relative Liver Weight (g/lCOg 
body weight)
4.00 ± 0.90 3.90 + 0.17
Ascorbic Acid (mg/lOOg liver) 2.74 + 0. 54° 17.7 + 1.5
Total Cholesterol (mg/g liver) 2.03 '+ 0.22 I.55 + 0.06
Microsomal Protein (mg/g liver) 22.7 + 2.6 24.9 + 2.3
Biliary Total Bile Acids 
(mg/ml bile)
9.73 + 1.51 11.4 + 0 .4
Results expressed as mean + standard error of mean.
.g. .
Ascorbate-deficient (n=5)
Control (n=5) 
a = p<0.05 c =<p 0.001
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Table 3.16 Effect of Acute Ascorbate Deficiency on Hepatic
Cholesterol 7<<-hydyoxylase Activity (Experiment 3)
$ cholesterol metabo- 0.28 + 0.03 0.26 + 0.02
lised/hour
pmolC^-^cl cholesterol meta- 40.7 + ^-1 38*0 ± 2 *3
bolised/g liver/hour
pmol cholesterol meta- I.87 + 0.26 1*57 + 0.12
bolised/mg microsomal/protein/ 
hour ; .
Results expressed as mean + standard error of mean.
Ascorbate-deficient (n=5)
Control (n=5)
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Table 3»17 Effect of Acute Ascorbate Deficiency on Some Parame­
ters of Mixed Function Oxidase Metabolism Expressed 
•per g Liver (Experiment 3)
*
A
**
B
p-Nitroanisole O-demethylase 38.9 + 6.1 53-7 ± 5-9
(nmol produced/hour) '
Biphenyl 2-hydroxylase 15*9 ± 2.1 17.4+1.6
(nmol produced/hour)
Biphenyl 4-hydroxylase 3.67 ± 0.3^ 3.84 + 0.36
(umol produced/hour)
/
Cytochrome P-^50 (nmol) 13.4 + 4.6a 25.4 +1.5
Cytochrome b^ (nmol) 15.1 + 2.1 19.3 +0.8
NADPH cytochrome c reductase 1.51 + 0.12 1.69 + 0.80
(^ xmol cytochrome c reduced/minute )
Results expressed as mean + standard error of mean.
* .  /  .
Ascorbate-deficient (n=5)
Control (n=5) 
a = p<0.05
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concentration was also slightly increased and serum total bile 
acids decreased, although again not significantly. Biliary 
total bile acids were unaffected.
Liver weight was significantly reduced in accordance with 
the decreased body weight. Microsomal protein content was 
unaltered by treatment.
The activities of cholesterol 7c*w-hydroxylase, biphenyl 2- 
and biphenyl ^-hydroxylase were not reduced by ascorbate deficiency. 
However, p-nitroanisole O-demethylase activity and cytochrome 
b^ content were marginally reduced. Cytochrome P-^50 content 
was significantly decreased to approximately 50?o of control.
The activity of NADPH-cytochrome c reductase was unchanged.
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Discussion
A major problem encountered in the design of these experiments 
was the selection of suitable dose levels for ascorbic acid.
The daily requirement for this vitamin in the guinea pig remains 
uncertain. Williams and Deason (1967) showed that by the 
criterion of growth rate alone, the individual variation in 
requirement was considerable. In addition, there is still 
disagreement as to whether the requirement and recommended intake 
should be based on the level necessary to prevent scurvy plus 
a several-fold safety margin or on one which permits tissue 
saturation. An attempt to clarify the situation was made by 
Yew (1973)* She studied a wide range of ascorbic intakes in 
young male guinea pigs (350g), observing their effect on growth 
rate, wound healing and recovery from anaesthesia and surgical 
stress. There was a pronounced individual variation in require­
ment, but she concluded that whilst optimal growth was achieved 
on an daily intake in excess of 5mg/kg body weight, recovery 
from stress necessitated ten times this quantity. Age and 
metabolic status of the animal also modifies its ascorbic acid 
requirement (Andrews and Brook, 1966; Hughes and Jones, 1971;
Davies and Hughes, 1977)* The problem of marked individuality 
in requirement in both guinea pigs and man has been discussed 
by Yew (1975)•
Grinter employed a control dose of lOmg per day, irrespective 
of body weight (Ginter 1975b). In contrast, Bjorkhem and 
Kallner (1976) fed their control group pellets containing *
^50nig/kg ascorbic acid and allowed them free access to vegetables; 
no food intake data was presented, but it is probable that
these animals were receiving at least 25mg of ascorbate each 
day. In the present series, of experiments, the control group 
received a daily dose of 30mg/kg body weight, which is of the 
same order as chow-fed guinea pigs and similar to the dose used 
by Ginter (1975b).
The level of chronic deficiency was also difficult to 
establish! Whilst in the first experiment Ginter's regime was 
followed (Ginter et al, 1968; Ginter et aJ.., 1969; Ginter, 1975b), 
it was impossible to maintain the deficient animals on a daily 
dose of 0.5mg/day,without.the appearance of scorbutic signs.
Thus,for a 2-3 week period,larger quantities (l-3mg) were 
given, titrating the daily dose to the individual status of 
the animal. By week 6 of this experiment, all animals were 
maintained on a daily dose of 1.5mg and appearance and food 
intake were normal,in accord with Ginter's experiments. Similar . 
problems were apparently encountered by Sulkin and Sulkin (1975) 
and Bjorkhem and Kallner (1976) who, using 0.5mg ascorbate per 
day, found that although body weight was maintained, no growth 
occurred and the teeth and fur displayed signs of scurvy. These 
differencesmay again reflect the variability in ascorbic acid, 
requirement.
In-the second experiment, a shorter initial period of depletion 
was employed, supplementation commencing prior to any sign 
of weight loss. In this way it was possible to maintain a 
group of animals on a dose level closer to that of Ginter, 
although all groups of animals in this experiment were dosed 
on the basis of body weight.
With respect to the magnitude of the "megadose" in the
-16*+-
supplemented animals, doses of 500mg, lg and 4g have been used 
(Yew, 1973; Nandi et al., 1973; Sorenson et .al., 197*+; Veen-Baight 
et al., 1975)* Extrapolation of a human "megadose" to the 
guinea pig would only give a daily dose of l4-70mg/kg body 
weight, however the rationale behind such an extrapolation is 
questionable. Thus initially a dose ten times that of the 
controls was employed i.e 300mg/kg body weight.
After feeding the vitamin at this level for 11 weeks, there 
was no obvious effect on food intake or growth rate; the reduction 
in these parameters after this corresponded with a simultaneous 
but less drastic reduction in control food intake, thus the 
significance of this observation is debatable. Yew (1973),using 
a;500mg/kg dose,reported a slight reduction in growth rate as 
did Sorenson et al. (197*0, using a *+g/kg dose. In the second 
experiment,a daily dose of lg/kg for 12 weeks did not affect 
growth, in accordance with the findings of Nandi et al. (1973) 
and Veen-Baignt et ad.. (1975)•
In both experiments, the animals on the high ascorbate 
regimes displayed an increase in plasma and liver ascorbate 
concentration only when measured at the first time interval.
Keith and Pelletier (197*+) studied the effect of increasing 
ascorbic acid intake on its organ concentration. Data for 
liver was not presented, but information pertaining to other 
organs indicated that ascorbic acid concentration only increased 
until the animal's requirement was reached. Tissue retention 
of ascorbic acid diminishes as a result of a decrease in 
metabolic activity (Davies and Hughes, 1977). These authors 
only considered the effect of nutrient deprivation on tissue
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ascorbate retention but one could speculate that the high doses 
of ascorbate used might also induce some subtle alteration in 
metabolic capacity of the tissue. The observation that on the 
lower "megadose", this decrease was only apparent after 23 weeks, 
as opposed to 12 weeks on the higher dose, is concordant with 
this suggestion.
The effects of chronic ascorbic acid deficiency on the 
parameters of cholesterol metabolism measured in these experiments 
are somewhat at variance with other workers. In the first 
experiment, after 12 weeks of depletion,there was no change in 
serum total cholesterol concentration. This is in contrast to 
findings of Ginter (1975b) who reported that hypercholesterolaemia 
was evident after this time,although only presenting data from 
16-28 weeks. Furthermore, serum cholesterol values for his 
control animals were substantially higher than those encountered 
here. However, there was an indication of an increase in serum 
cholesterol when the animals in experiment 1 were further 
depleted and in the most deficient animals (Group A) in experiment 
2; liver cholesterol content was also elevated in these latter 
animals. In the acutely deficient animals (Experiment 3)» the 
increase in both serum and liver cholesterol content was more 
pronounced, although the statistical significance was negated 
by the large individual variation. However, in general the 
results would indicate an u n w ^  relationship between
OScorbotX intake and degree of cholesterolaemia. The experiments 
of Homig and Weiser (1976) lend some support to this contention. 
They used a daily dose of 1.5mg per day of ascorbic acid (as 
the sodium salt) and observed some increase in cholesterolaemia,
although the difference was small. It could therefore be 
postulated that there is a critical threshold intake of ascorbic 
acid, necessary to maintain a particular liver concentration, 
which in turn might be essential to regulate or maintain normal
From these experiments, it is apparent that hypercholesterol 
aemia is only manifest at very low levels of intake, since in 
animals supplemented with 3mg/kg body weight/day cholesterol 
levels were similar to controls. The above hypothesis is 
consonant with Ginter*s view: that the hypercholesterolaemic 
effect of ascorbate is dependent on its tissue concentration 
(Ginter et al., 1977)» and that of Homig and Weiser (1976), who 
suggest that cholesterol oxidation is only dependent on ascorbic 
acid status over a limited range of concentration. It is also 
possible that this "critical level" may vary between individual 
animals or between strains, thus contributing to the variability 
encountered in these and previous experiments.
Serum and biliary total bile acid concentrations showed 
little variation in either chronic experiment, except for a 
small reduction after 12 weeks depletion in both deficient 
groups in Experiment 2. In the acutely deficient animals, there 
was a reduction in serum bile acids and possibly in biliary 
bile acids although again the variation in individual values 
was great. From the data presented by Ginter (19751*) concerning
although perhaps consistent with the absence of any major 
effect on serum cholesterol levels. These findings are also at 
variance with those of Homig and Weiser (1976), who reported
liver cholesterol concentrations
this is an unexpected finding,
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a significant reduction in total bile acids of liver, bile and 
small intestine in chronically deficient animals.
Ginter (1975b) has postulated that the site of action of 
ascorbic acid is at the 7oC-hydroxylation of cholesterol. In 
the first experiment, the activity of this enzyme showed a slight 
reduction in the deficient group but by 23 weeks this was no 
longer apparent, an unexpected finding, as it coincides with 
an increase in serum cholesterol. In the second experiment, 
there was a reduced activity in the most deficient group (A) 
at 6 weeks. After further depletion, there was a trend towards 
a diminution in 7ot-hydroxylase activity at both levels of 
deficiency, perhaps indicative that at the higher level of 
supplementation, the effect of the deficiency on cholesterol 
7cL-hydroxylation is only manifest after a longer period of 
depletion. In contrast to these findings, Bjorkhem and Kallner 
(1976) demonstrated a fifteen-fold decrease in the activity 
of this enzyme in chronically deficient female guinea pigs.
It is possible that the sex difference may account for this 
disparity. However, the lack of any consistent or pronounced 
effect on cholesterol 7oC-hydroxylation in the chronically 
treated animals lends support to the concept of a critical 
threshold'level of intake which conceivably varies between 
animals.
Unexpectedly, there was no observable change in 7oL-hydroxylase 
activity in the acutely deficient guinea pigs. This finding is 
difficult to explain but may indicate, as do the chronic 
experiments, that the catabolism of cholesterol may not be the 
only site of action of ascorbic acid. The observed accumulation
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of cholesterol in the liver without any obvious effect on 
cholesterol catabolism is commensurate with the suggested 
interaction with cholesterol biosynthesis (Kallner, 1977).
One problem in the interpretation of the 7ct-hydroxylase data 
is the low activity encountered in the guinea pig, although 
similar levels were reported by Bjorkhem and Kallner (1976).
Hypertriglyceridaemia was apparent in the acutely deficient 
animals, and to some extent in the chronically treated ones; 
this phenomenon has been observed by others and has been 
attributed to a decrease in lipolytic activity (Ginter, 1978). 
Histological sections of the aorta were only examined in 
Experiment 1. There was no evidence of degeneration or lipid 
accumulation. This is contrary to the findings of Sulkin and 
Sulkin (1975)>who reported changes ranging from endothelial 
proliferation to the formation of large musculofibrotic, 
atherosclerotic plaques in animals chronically depleted of 
ascorbic acid for over 100 days. Similarly, Ginter (1978) 
has reported pathological changes in the coronary arteries 
of these animals. The lack of any detectable change is again 
consonant with the concept of a critical threshold level of 
intake.
After'feeding ascorbic acid at 300mg/kg body weight for 
12 weeks, there was no difference in total serum cholesterol 
concentration. There was a reduction in liver cholesterol 
content, coinciding with a small increase in cholesterol 700- 
hydroxylase activity and indicating a possible stimulation of 
cholesterol catabolism; however, serum and biliary bile acids 
were unchanged. Increasing the dose t^o 500mg or lg/kg body
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weight did not influence any of these parameters. Thus, excess 
ascorbate had no marked stimulatory effect on cholesterol 
7oC-hydroxylase activity, a finding in agreement with the view 
of Bjorkhem and Kallner (1976), who have questioned this 
concept. Attempts to demonstrate in vitro stimulation of the 
enzyme system have been unsuccessful (Kritchevsky et al., 1973b), 
although the experimental design of this study has been 
criticised.
Feeding either deficient or supplemental levels of ascorbate 
did not- influence the pattern of bile acids in gall bladder 
bile. Information regarding qualitative changes in biliary 
bile acids in the ascorbate-deficient guinea pig is lacking, 
but in a recent study, Kallner (1977) examined the serum bile 
acid pattern in man after supplementation with ascorbic acid.
His results suggested that there may be a decrease in chenodeo- 
xycholate concentration after discontinuation of the supplements, 
although this is open to interpretation as the individual 
variation between subjects was great. Ginter (1977) showed 
that the formation of gallstones in hamsters could be limited 
by the administration of ascorbic acid. This could also be 
interpreted as indicative of an increase in chenodeoxycholate 
synthesis/ although as Kallner (1977) points out, it could 
also result from a more general effect on the cholesterol: 
bile acid ratio.
As considered earlier, acute ascorbic acid deficiency 
markedly reduces mixed function oxidase metabolism. However, 
the effects of chronic.deficiency on these enzymes has scarcely 
been considered. In the present series of experiments, chronic
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ascorbate deficiency did not result in a reduction of any of 
the parameters of mixed function oxidase metabolism. This is 
contrary to the findings of Bjorkhem and Kallner (1976) who 
reported a 50$ reduction of hepatic cytochrome P-^50 in chroni­
cally deficient female guinea pigs.
An interesting finding, nonetheless, was the apparent 
induction of biphenyl hydroxylase and NADPH-cytochrome creductase 
activities. In the first experiment, the 2-hydroxylase and 
cytochrome c reductase enzymes were elevated at both 12 and 23 
weeks. -In the second experiment, by 12 weeks,biphenyl 2-hydro- 
xylase was slightly induced in the most deficient group and 
biphenyl ^-hydroxylation and cytochrome c reductase were increased 
in both deficient groups.
In Experiment 2, an attempt was made to explain this 
alteration in reductase activity. .It is known that in addition 
to its involvement in drug oxidation, NADPH-cytochrome c 
reductase is an essential component of the enzymic lipid peroxi­
dation system, which is partly responsible for the peroxidation 
of subcellular lipids (Hochstein and Emster, 1963; Orrenius 
et al., 196^; Pederson and Aust, 1972; Pederson et al., 1973). 
the two processes are thus closely related. Normally, induction 
of cytochrome c reductase activity would be expected to be 
associated with an induction in specific mixed function oxidase 
enzymes. Therefore, this observed independent increase in 
cytochrome c reductase activity was speculatively interpreted 
as implying a stimulation of the peroxidative function of the 
reductase, representing an uncoupling of electron transfer 
from cytochrome P-^50 (Suarez et al., 1972). Furthermore,
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_increased biphenyl 2-hydroxylase activity has been suggested 
to be indicative of disturbed hepatic metabolism, associated 
.with degranulation of the endoplasmic reticulum (Parke, 1977).
A marked proliferation of smooth endoplasmic reticulum has 
been observed in guinea pigs suffering from '’marginal'* ascorbate 
deficiency (Sulkin and Sulkin, 1975)» which accords with the 
finding of Experiment 1. It was hypothesised that the associated 
increase in biphenyl 2-hydroxylase and cytochrome c reductase 
activity might be indicative of a derangement in membrane 
structure, induced by ascorbate deficiency and possibly mediated 
by peroxidative damage. However, the results of the lipid 
peroxidation and glucose-6-phosphatase histochemistry studies 
do not support this hypothesis and the finding remains unexplained.
Labadarios (1975) demonstrated the ability of guinea pigs 
to synthesise ascorbic acid de novo when depleted of the vitamin 
and treated with prednisone. This was attributed to the 
induction of a microsomal reductase and confirmed the work of 
Odumosu and Wilson (1973)f who observed the same phenomenon 
in untreated, deficient animals. The present finding of an 
induction of NADPH-cytochrome c reductase suggests that ascorbate 
deficiency might engender an adaptive response,in which there 
is a non-specific induction of microsomal reductases to facilitate 
synthesis of ascorbic acid. It is likely that the individual 
capacity for this response would show-considerable variation 
which could further explain the inter-animal variability of 
response to ascorbate depletion.
These chronic experiments successfully demonstrated a 
discrepancy between changes engendered by either an acute.or
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chronic ascorbate deficiency, again leading one to speculate on 
the existence of a critical threshold concentration of ascorbate, 
beneath which aberrations in mixed function oxidase metabolism 
may occur. In order to confirm this and exclude the possibility 
of a strain variation in response to ascorbate deficiency, the 
acute experiment was carried out.
The results of this experiment confirmed those of previous 
workers,particularly the recent study of Sikic et al. (1977b), 
which also reported at least a 50$ reduction in cytochrome P- 5^0 
content but no change in NADPH-cytochrome c reductase activity. 
However, although p-nitroanisole O-demethylation was slightly 
reduced, biphenyl hydroxylation was unaffected, perhaps indicating 
an effect on a specific type of P-^50. In this way»demethylation 
might be altered whilst hydroxylation (biphenyl and cholesterol) 
remained unchanged. This idea is partially in agreement with 
that of Bjorkhem and Kallner (1976), who speculate that the 
ascorbate-induced defect is specific to the type of cytochrome 
P-450 responsible for cholesterol oxidation. They suggest 
however that ascorbate might be involved in the synthesis or 
breakdown of P-^50 itself, although it is ulikely then to be 
specific to one type of the cytochrome. Furthermore, Rikans 
et al. (1977) were unable to demonstrate any disturbances in . 
the enzymes of haem synthesis in response to ascorbate deficiency. 
The wide variation in individual response to deficiency reduced 
the statistical significance of the results and again emphasises 
the importance of the individual.variation in the level of the 
vitamin required to ensure integrity of metabolism.
Supplemental ascorbic acid, at any of the levels studied,
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had little effect on these parameters of mixed function oxidase 
metabolism. In the first experiment, there was a slight increase 
in biphenyl 2-hydroxylation and in the second, of NADPH-cytochrome 
c reductase activity. Sato and Zannoni (197*0 » using weanling 
guinea pigs,reported an induction of mixed function oxidase 
metabolism on supplementation with up to 200mg ascorbate/kg 
body weight. Conversely Sikic et al. (1977a), in agreement 
with the present data, found no effect of supplemental ascorbate 
in young adult animals. They suggest that the disparity between 
their results and those of Sato and Zannoni might not only be 
accounted for by an age^difference but also by the lack of 
consistency in the route of administration in the latter experi­
ments. The present results also accord with studies carried 
out in man (Wilson et al., 1976), which showed that antipyrine 
and diphenylhydantoin plasma half lives were unaffected by 
"megadoses" of ascorbate of 4-5g per day. Ascorbic acid 
in high concentrations is recognised as a pro-oxidant, thus 
it might be expected to enhance non-enzymic lipid peroxidation 
(Hochstein et al., 196*0. However, in vitro lipid peroxidation 
was unaffected in animals supplemented with lg/kg body weight.
Thus in summary, over a limited range of ascorbic acid 
concentration, there would appear to be some type of dose-response 
relationship in mixed function oxidase metabolism, which affects 
the metabolism of both endogenous substrates such as cholesterol 
and of foreign compounds. Beneath a certain critical level 
of intake and thus of tissue concentration, metabolism may be 
impaired but this level is quite low and may well vary between
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animals. Consequently, the effects of acute deficiency, i.e. 
total depletion,are entirely different from those of chronic 
deficiency, a finding which may have considerable implications 
to man (see final discussion). Supplemental ascorbate does not 
seem to induce mixed function oxidase metabolism, neither does it 
have any pronounced detrimental effect on the parameters of 
cholesterol metabolism measured here.
Chapter k
The Effects of Dietary Iron Deficiency on Cholesterol and 
Foreign Compound Metabolism in the Rat
Introduction
There is a considerable body of epidemiological data 
associating various minerals with the incidence of hyperlipid- 
aemia and coronary heart disease. Total cardiovascular mortality 
has been shown to be substantially higher in populations living 
in areas supplied by soft water than in those living in hard 
water areas (Schroeder i960; Crawford et al., 1968; Crawford 
et al., I971; Crawford, 1972; Masironi et al., 1972). However, 
although some workers have reported higher serum cholesterol 
levels in soft water areas (Anderson et al., 1969; Stitt et al., 
1973)» this is not a universal finding (Elwood et al., 1971; 
Bierenbaum ejt al.,. 1973)* With respect to the specific minerals 
implicated, large supplements of calcium were found to be 
hypercholesterolaemic both in rabbits and in man (Iacono et al., 
I960; Yacowitz et al., 1965; Bierenbaum et al., 1972). Similarly, 
the contribution of magnesium to the protective effect of hard 
water has been considered (reviewed by Seelig and Heggtveit,
197*0-
Attention has also been focussed on several trace minerals. 
Schroeder etal. (1970) suggested that chromium deficiency was 
a causative factor in. atherosclerosis. Vanadium deficiency is 
known to be associated with elevated serum lipid levels (Nielsen 
and Ollerich, 1973; Hopkins and Mohr, 197*+). Silicon is also 
recognised as being hypercholesterolaemic (Schwart,1977)•
A deficiency of copper elevated serum cholesterol concentrations 
in rats and thus led Klevay (1975) to hypothesise that an 
absolute or relative (i.e. a high zinc/copper ratio) deficiency 
of copper might be a major aetiological factor in coronary
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heart disease.
Finally, iron has been considered to play a role in lipid 
metabolism and the incidence of coronary heart disease. A large 
number of studies have demonstrated an association between 
hypolipidaemia, particularly hypocholesterolaemia, and various 
types of anaemia (Fessas et al., 1963; Westerman et al., 196^ +; 
Rifkind and Gale 1967; Bazzano, 1969; Elwood et al., 1970b; 
Westerman, 1975; Seip et al., 1975; Seip and Skrede, 1977)*
It has been suggested that the lower incidence of coronary 
heart disease seen in developing countries might be attributable 
to the greater incidence of anaemia (Bimbaum and Levein, 1961; 
Rifkind and Gale, 1967)* The same authors attributed the sex 
difference in occurrence of coronary heart disease to the lower 
haemoglobin level of premenopausal American women. Evidence in 
support of this derives from several case-control studies,. where 
patients with coronary heart disease were shown to display higher 
haematocrits than their controls (Burch and DePasquale, 1962a; 
Burch and DePasquale, 1962b; DePasquale and Burch, 1963; Mayer, 
1965)• In 1970, Elwood et al., reported a significant correlation 
between serum cholesterol and haemoglobin levels in a large 
group of wornen, which could not be accounted for by the apparent 
dilution;effect due to the increase in plasma volume. Correction 
of the anaemia led to a rise in cholesterol concentration, 
although this was not statistically significant.
Conflicting data have also been presented. Thus, Conley 
et al. (196*+) observed that in a group of 200 patients with 
myocardial infarction, the.mean haemoglobin level was slightly 
less than that of the control group. Initial interpretation
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of results from the Framingham Study (Kannel at al., 1961) 
supported the association but on subjecting the data to further 
analysis, the correlation was not apparent (Truett et al.,
1967). A recent report from the Los Angeles Heart Study (Abu-Zeid 
and Chapman, 1976) showed that neither haemoglobin or haematocrit 
were significantly correlated with the incidence of coronary 
heart disease.
Conversely, in experimental animals such as the rat and 
chick, iron has a hyperlipidaemic effect (Lewis and Iammarino,
1971; Guthrie et al., 197*+; Sherman et al., 1977; Amine and 
Hegsted, 1971)» which, at least in the rat, is also interdependent 
on other trace minerals such as zinc and copper (Klevay, 1973; 
Sourkes et al., 1968; Sherman et al., 1977).
Various mineral deficiencies are also known to influence 
the activity of the mixed function oxidase enzyme system. 
Deficiencies of both calcium (Dingell et al., 1966) and magnesium 
Becking and Morrison, 1970b; Becking, 1976) depress the metabolism 
of various substrates, associated, in the case of magnesium, 
with '-lowered cytochrome P-^50 and NADPH-cytochrome c reductase 
levels. Trace minerals are also of importance. In the rat, 
zinc deficiency reduces the rate of metabolism of various 
compounds such as pentobarbital and aminopyrine, after a prolonged 
period/of depletion, probably via an effect on cytochrome P-^50 
(Becking and Morrison, 1970a). Mixed function oxidase activity 
is reduced by either deficiency or excess of dietary copper 
(Moffitt and Murphy, 1973)* Paradoxically, a dietary deficiency 
of iron is associated with an increased activity of some mixed 
function oxidase enzymes.
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Catz et al. (1970) reported that in adult mice, chronic 
iron deficiency significantly enhanced hexobarbital oxidation 
and aminopyrine N-demethylation, without any effect on aniline 
or benzo apyrene hydroxylation, in vivo metabolism as measured 
by sleeping times, or on cytochrome P-^ +50 content. Becking 
(1972; 1976) reported similar findings with respect to cytochrome 
P-450 content and aminopyrine metabolism in adult male rats 
but observed no change in pentobarbital metabolism in vivo or 
in vitro and an enhancement in both in vivo and in vitro aniline 
metabolism. These workers also fed a high iron diet to rats, 
without.any deleterious effect on mixed function oxidase metabo­
lism. This is in contrast to V/ills (1972), who demonstrated a 
reduction of aminopyrine metabolism in iron-supplemented rats, 
which he attributed to increased lipid peroxidation. In man, 
only one study has examined the effects of iron deficiency on 
mixed function oxidase metabolism; no detrimental effect was 
observed (O 'Malley and Stevenson, 1973) •
Aim of Present Study
The epidemiological studies associating iron deficiency 
with a decreased incidence of coronary heart disease and hyper- 
cholesterolaemia, and its established inductive effect on mixed 
function oxidase metabolism, led to the hypothesis that the 
hypercholesterolaemia might be explained by an induction of 
cholesterol 7*-hydroxylase. A series of experiments were thus 
set up to investigate the effects of iron deficiency in the 
rat on cholesterol and mixed function oxidase metabolism.
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Materials
These were as described in Chapters land 2, with the 
addition of the following: Drabkin's reagent and the carboxy-
methaemoglobin standard (57.2mg/l00ml) were obtained from 
■B.D.H, Ltd.
Methods
These were also as described in Chapters 1 and 2 with the 
addition of the following:
(a) Blood Haemoglobin Concentration
Haemoglobin was determined by the cyanomethaemoglobin 
method. Whole blood is' treated with a reagent containing 
potassium ferricyanide, potassium cyanide and potassium dihydrogen 
phosphate (Drabkin's reagent). The ferricyanide reacts with 
the haemoglobin to form methaemoglobin which in turn reacts with 
the cyanide to form cyanomethaemoglobin, the extinction of which 
can be measured.
A 20^ *1 aliquot of blood was added to 4.0ml' of Drabkin's 
reagent and mixed thoroughly. The tubes were centrifuged at 
2,000 r.p.m. for 10 minutes in a bench centrifuge and after at 
least a further 4 minutes,the extinctions of the supernatants 
were measured at 5*+0nm in the Cecil spectrophotometer. All 
determinations were carried out in duplicate and the extinctions 
of a blank (Drabkin's reagent) and a cyanomethaemoglobin standard 
containing 57/2mg cyanomethaemoglobin/lOOml, equivalent to a 
haemoglobin concentration of 11.5g/100ml, were also measured.
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(b) .Determination.of Haematocrit
The relative volume of red blood cells to plasma was 
determined as follows:
Duplicate heparinised capillary microhaematocrit tubes 
(M.S.E. Ltd., Crawley, Sussex) were three-quarters filled with 
blood, sealed at one end with a sealing material (Cristaseal, 
Hawksley and Sons Ltd., Lancing, Sussex) and centrifuged for 
6 minutes at 12,400 r.p.m. in a microhaematocrit centrifuge 
(M.S.E. Ltd.).
The haematocrit Value was determined as follows:
Haematocrit (ti) = Height of packed red cells (mm)
''' Height of red cells and plasma (mm)
'(c) Determination of Dietary Iron Content
The concentration of iron in both diets was determined 
by atomic absorption spectrophotometry after wet ashing.
Duplicate 0.2g aliquots of each diet were digested with a 
mixture of 5ml of concentrated nitric acid and 1ml of perchloric 
acid in a 25ml conical flask, pre-washed with dilute hydrochloric 
acid. Duplicate blanks,consisting of 6ml of acid mixture only, 
were set up. The mixture, was shaken and left to stand for 15 
minutes and subsequently heated to approximately 100°C on a 
heating block, until the reaction subsided. The heat was 
gradually increased to 200-250°C and digestion continued until 
a white residue remained.
The residue was dissolved in a known quantity of 4.5M 
hydrochloric acid, and the iron content determined by atomic 
absorption spectrophotometry using an IL 353 spectrophotometer'
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(Instrumentation Laboratory Inc., Lexington, Mass.).
Animals
In all experiments, male Wistar albino rats (Porton Strain, 
random bred in closed colony), supplied by the University of 
Surrey Animal Breeding Unit and aged 5 weeks (weighing 80-lC0g), 
were used. The animals were randomly assigned to test (iron- 
deficient) and control groups and housed in polypropylene cages 
with aluminium lids (65cm x 39cm x 20cm) on "Sebital" bedding 
(Plasticos Espanoles, S'.A., Torrelavega, Spain, supplied by 
J. Lillico and Sons), which was changed at weekly intervals .
Animal house conditions were as described in the previous Chapter. 
Prior to the administration of the experimental diets, the 
animals were maintained on Spratts Laboratory Animal Diet No 2. 
for 3-5 days to allow acclimatisation to the powder form of 
diet. The rats were then allowed access to glass-distilled 
water and to the experimental powdered diets, contained in 
stainless steel straight-sided bowls fitted with grids, ad 
libitum. Measurements of body weight (individual) and food 
intake (per cage) were made at regular intervals.
Diets
The iron-deficient diet used by Becking (1972), modified 
from that of McCall et al. (1962) was used. The compositions 
of the basic diet and the vitamin and mineral mixtures used 
are presented in Tables 4.1 - 4.3* The control and iron-deficient 
diets were shown by analysis to contain 223-250ppm and 9-15ppm 
of iron respectively. Diets were prepared, as described in
Table 4.1 Basal Iron-Deficient Diet (Becking 1972)
(g/Kg)
+ Skim Milk 650
** Sucrose 210
4.4.4.
C om Oil 100
Mineral Mix 30
Vitamin Mix 10
Choline 2.2
Fat Soluble Vitamins 0.7ml
(Control diet supplemented with iron as FeSOj^  220ppm (1.1 g/Kg diet)) 
"Marvel" Cadbury Typhoo Catering Services, Boumville, U.K.
++ Tate and Lyle, Croydon, Surrey.
+++ ."Saladin" Van dez> B&rgS and Jurghens Ltd., London.
40mg retinyl palmitate and 5mg ergocalciferol dissolved in 
5ml 50$ <?C-tocopherol in soya oil.
Table 4.2 Mineral Mix (McCall et al., 1962)
(g/Kg)
NaCl 200
NalO, H20 0.022
MnSO^ itH20 10.812
CuSO^ 5H20 2.722
Glucose 786.5
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Table 4.3 Vitamin Mix (McCall et al., 1962)
(gAg)
Pyridoxine 0.5
Calcium Pantothenate 1.2
Riboflavin 0.5
Thiamine HC1 1.0
Nicotinic Acid 1.0
Vitamin K 0.1
p-Aminobenzoic Acid 1.0
Folic Acid 0.1
Biotin 0.02
Inositol 20.0
Vitamin B ^  0.00015
Glucose 974.5
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Chapter 2, at weekly intervals and stored in the dark at 0-4° C
to limit oxidative degradation.
Experiment 1
Six animals were randomly assigned to each of two control 
and two experimental groups. The experimental diets were 
administered for 12 weeks, 6 animals from each group being 
killed after 6 weeks (la) of treatment and the remainder at 
the end of the experiment (lb).
Prior to commencement of the dietary regime and after
under mild ether anaesthesia from the tail vein of each rat 
into a 2ml heparinised tube (Seward Laboratory, London), for 
the determination of haematocrit and haemoglobin concentration.
At 6 and 12 weeks, the animals, which had been allowed 
free access to food prior to this, were killed by cervical 
dislocation between 8.30 and 9*30 am, following exsanguination 
from the abdominal aorta under mild ether anaesthesia. A small 
volume (100^ ,1) of blood was collected as described above, the 
remainder being collected in non-heparinised glass bottles 
for preparation of serum. Livers 'were rapidly excised and 
treated as described in the previous Chapter.
3 weeks of treatment, blood (approximately
Results
Animal Weights and Food Intakes
Thas£ data o*& presented in Figs. 4.1 and 4.2 and Tables 
4.4 and 4.5•
BO
DY
 
WE
IG
HT
 
(g
)
-186-
Fig. ^.1 Growth Curves of Rats Maintained on Iron-Deficient 
(a —— -a ) and Control (•---») Diets (Experiment la)
250
200
150
100
WEEKS
Points represent mean values (n=6 for both groups). 
No significant differences between means.
Fig. k.Z Growth Curves of Rats Maintained on Iron-Deficient  a )
Control (o •) Diets (Experiment lb)
350
300
250
200
K
MW
3om 100
10
WEEKS
Points represent mean values (n=12, both groups at 6 weeks; n ~ 6 , both 
groups at 12 weeks). No significant differences between means.
and
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Table 4.4 Mean Food Intake (g/rat/day) of Control and Iron- 
Deficient Rats (Experiment la)
WEEKS Mean + SEM
1 2 3 4 5 6 Over 6 weeks
CONTROL 10 10 12 13 15 15 12.5 + 0.9
IRON-DEFICIENT 10 10 12 13 13 15 12.2 +0.4
n=6 forboth groups .
Table 4.5 Mean Food Intake (g/rat/day) of Control and Iron- 
Deficient Rats (Experiment lb)
WEEKS Mean+SEM 
Over 
12 weeks1 2 3 4 5 6 7 8 9 10 11 12
CONTROL 7 12 12 14 13 16 16 16 17 18 18 17 14.7+0.9
IRON- 7 
DEFICIENT
11 12 13 11 16 15 15 14 16 18 18 13.8+0.9
1-6 weeks n=12 for both groups
6-12 weeks n=6 for both groups
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In the 6 week experiment (la), there was some indication 
of a slightly decreased rate of growth in the deficient animals, 
although this was not statistically significant and not associated 
with any change in food intake. In the 12 week experiment (lb), 
growth rate and food intake did not significantly differ from 
the controls. The deficient animals from both experiments 
displayed a slight coarsening of the hair and lethargy.
Biochemical Changes Occurring in Animals Fed the Iron-Deficient 
Diet *
Thksiidata ar*. presented in Tables 4.6-4.9.
After 3 weeks of iron depletion in both experiments, haemo­
globin and haematocrit values had fallen to 70-75$ of control.
By 6 weeks they had further decreased to approximately 60$ 
of control; a longer period of depletion did not further diminish 
these parameters. Control values appeared to increase slightly 
over the first 6 weeks, presumably as a function of age.
Serum total cholesterol concentration rose slightly but 
not significantly after 6 weeks, although liver cholesterol 
content was unchanged. Conversely after 12 weeks, serum choles­
terol levels were significantly diminished in the deficient 
animals although again there was no difference in hepatic 
concentration.
Serum total bile acid concentration did not differ from 
controls at either time interval.
Liver weight was significantly decreased at 6 weeks but 
not at 12 weeks. However, the weight of this organ relative to 
body weight was significantly lower at both time intervals.
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Microsomal protein content was unaffected "by treatment.
After 6 weeks, hepatic cholesterol 7oc-hydroxylase activity 
appeared to he lower in the deficient animals, although the 
difference was not statistically significant. Contrary to this, 
after 12 weeks the activity of this enzyme was significantly 
increased in these animals.
Cytochrome P-U50 levels were unaltered after 6 weeks of 
deficiency, although there was an increase in cytochrome b ^
p-Nitroanisole O-demethylase activity was unchanged but biphenyl 
2-hydroxylase appeared slightly elevated in these animals. NADPH- 
cytochrome c reductase activity was not apparently influenced 
by treatment.
After 12 weeks of depletion there was no difference in 
either cytochrome levels but p-nitroanisole O-demethylation and 
biphenyl 2- and ^-hydroxylation were slightly induced, although 
the difference was not statistically significant. Again the 
reductase activity was unaffected.
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Experiment 2
The animals were randomly assigned to a control and experi­
mental group with 15 in each group, each housed in two cages 
containing either 7 or 8 animals.
The experimental procedure was as described for the first 
experiment,except that the animals were bled prior to starting 
the experiment but not after 3 weeks and were killed after 6,8 
and 12 weeks.
Results
Animals Weights and Food Intakes
Thasedata dcsL presented in Fig. 4.3 and Table 4.10.
The growth rate of the deficient animals was significantly 
reduced after 4 weeks, remaining so throughout the experiment. 
This phenomenon was unrelated to any significant alteration in 
food intake. As previously, these animals showed some coarsening 
of the fur and appeared slightly lethargic.
Biochemical Changes Occurring in Animals Fed the Deficient Diet 
Thx-si data &tJL presented in Tables 4.11-4.14.
After 6 weeks of the deficient regime, mean values for 
haemoglobin and haematocrit had fallen to 60-65$ of control, 
further depletion did not result in a‘greater reduction of 
these values.
Serum total cholesterol concentrations were lower at 6 and 
12 weeks, although the differences were not statistically 
significant. Conversely, at 8 weeks, this parameter was signifi-
-196-
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Table 4.10 Mean Food Intake (g/rat/day) of Control and Iron- 
Deficient Rats (Experiment 2)
WEEKS Mean+SEM
1 2 3 4 5 6 7 8 9 10 11 12
Over 
12 weeks
CONTROL 9 12 13 16 17 15 16 16 17 18 17 20 15•5*0.9
IRON- 10 
DEFICIENT
12 13 16 16 15 15 15 16 15 15 17 14.6+0.6
Table 4.11 Effect of Iron-Deficiency on Plasma Haemoglobin
Concentrations and Haematocrit Values, Measured in 
All Animals Prior to Starting the Experiment and in 
Animals Killed During Experiment 2.
WEEKS
0 6 8 12
Haemoglobin
*
T 14.7 + 0.2 9.40 + 0.25c9.77 + 0.41° 9-13 + 0.53°
(g/lOOml)
**
C 14.2 + 0.2 15.2 + 0.2 14.6 + 0.3 1^.7 + 0.3
Haematocrit
*
T 41.9 + 0.5 31.0 + 1.0° 34.1 + 1.2° 32.2 + 2.2°
m C 44.9 + 0.7 45.0 + 0.9 45.1 + 0.^
+ 
1
O
0.5
Results expressed as mean + standard error of mean..
Iron-deficient
Control
n=15 at 0 weeks n=5 at 6,8,12 weeks. c = p<0.001
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cantly increased in the deficient animals. Hepatic concentrations 
of cholesterol were generally uninfluenced by treatment.
Mean serum total bile acid concentration displayed little 
variation from control at any time interval.
Liver weight was significantly reduced by treatmentat 8 
and 12 weeks, although not at 6 weeks. However, the relative 
liver weight was significantly decreased at all 3 time intervals. 
Microsomal protein content was not significantly altered by 
treatment.
In this experiment, cholesterol 7tk-hydroxylase, activity 
showed little variation from control, although when expressed 
as specific activity there was an indication of a slight increase 
in the deficient animals.
Cytochrome P-^50 and b^ levels were slightly but not signifi­
cantly lower in the deficient animals at 6 and 8 weeks, whereas 
at 12 weeks the P-^50 levels were somewhat higher in these 
animals. Cytochrome c reductase activities were unaffected by 
treatment.
After 6 weeks of treatment, there were no changes in the 
activities of the enzymes measured. However p-nitroanisole 
O-demethylation was significantly higher in the deficient animals 
at 8 and 12 weeks. Both 2- and 4- biphenyl hydroxylase activities 
were also greater at 8 weeks but the difference was not statisti­
cally significant. At 12 weeks, there was little variation in 
the activity of either hydroxylase.
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Discussion
The iron-deficient regime caused some reduction in growth 
rate of the rats, although this .finding-was not consistent.
Using similar diets, McCall et al. (1962) and Bailey-Wood et al. 
(1975) observed a decrease in body weight and growth rate whilst 
Becking (1972) reported no change in body weight. The general 
appearance of the animals was not markedly dissimilar to the 
controls, with the exception of a slight coarsening of the coat 
and a mild lethargy. This is in contrast to McCall et al. (19.62') 
and Cusack and Brown (1965) who reported more severe skin, hair 
and behavioral changes.
The degree of deficiency attained in the present experiments 
was not as great as that achieved by other workers. On average, 
haemoglobin concentrations fell to approximately 60$ of control 
after six v/eeks, with no further decrease; other workers have 
achieved decreases of 50-55 *^
The finding of a decrease in liver weight, accords with 
the results of Bailey-Wood et al. (1975)» who did not, however, 
observe the decrease in relative liver weight seen here, presu­
mably because the reduction in body weight of their rats was 
more severe. Conversely, Cusack and Brown (1965) reported no 
change in liver weight.
The changes in total serum cholesterol concentration, 
observed here, were not consistent. In general, there was a 
trend towards a decrease in cholesterol v/ith decreasing haemoglo­
bin levels, but on two occasions, the converse of this was noted. 
Liver cholesterol concentrations did not differ from controls 
at any time. Few studies have examined the effects of nutritional
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iron deficiency on serum lipid concentrations and no data is 
available for hepatic concentrations. Lewis and Iammarino (1971) 
reported a pronounced lipaemia in severely iron-deficient rats, 
associated with an increase in circulating chylomicrons and 
triglycerides, but with no change in cholesterol or phospholipid 
concentrations. Amine and Hegsted (1971) observed a similar type 
of hyperlipidaemia in both rats and chicks but also noted some 
depression in serum cholesterol concentration. These workers 
demonstrated an interaction between the type of dietary fat and 
the iron deficiency; hypertriglyceridaemia only being evident 
when hydrogenated vegetable oil or coconut oil was used and not 
with c o m  oil. This finding would explain the absence of any 
obvious lipaemia in the present series of experiments, where com 
oil was the source of dietary fat. Guthrie et al. (197*0 investi­
gated the effect of maternal iron deficiency during pregnancy 
and/or lactation on the lipid metabolism of both dams and pups.
The dams showed little change in serum triglyceride or cholesterol 
levels but the offspring had elevated serum triglyceride concentra­
tions when iron depletion occurred during pregnancy or lactation 
or during both periods. However, cholesterol levels were elevated 
only in those depleted during both pregnancy and lactation, 
indicating the importance of iron stores in influencing the severity 
of the abnormality in lipid metabolism.
The mechanism accounting for these observed changes in 
lipid metabolism has not been investigated, although Lewis and 
Iammarino (1971) did report a decrease in lipoprotein lipase 
activity, which might account for the observed triglyceridaemia.
In the present study, it was postulated that any change in serum
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cholesterol concentration might result from an alteration in 
its catabolism to bile acids. However, serum levels of bile 
acids were largely unaffected by the deficient regime, although 
there were some changes in cholesterol ^-hydroxylase activity. 
Thus, after 6 weeks of depletion in the first experiment, there 
was an increase in serum cholesterol concentration, associated 
with a decrease in 7^-hydroxylase activity. After 12 weeks, 
despite no further decrease in haemoglobin levels, the pattern 
was reversed i.e. there was a decrease in serum cholesterol 
associated with an increase in cholesterol 7oC-hydroxylation.
In the second experiment however, despite a slight increase 
in serum cholesterol after 6 and 12 weeks of depletion, 7oC-hydro- 
xylase activity only showed a very small increase at 12 weeks.
The observed increase in serum cholesterol at 8 weeks was not 
accompanied by a corresponding decrease in enzyme activity.
These results may be interpreted in several ways. Firstly, 
it is possible that iron deficiency might also influence other 
pathways of cholesterol metabolism, such as its absorption or 
biosynthesis; this would merit further investigation. If the 
deficiency had opposing effects on these pathways, the variable 
results of these experiments and those of previous workers 
might be'explained. Thus, different degrees of deficiency 
might influence serum cholesterol levels by either stimulating 
or inhibiting a particular pathway, although if this were so, 
hepatic cholesterol concentrations might be expected to vary.
An alternative explanation, which would better explain 
the changes in cholesterol 7flC-hydroxylase activity seen here, 
is that iron-deficiency might indirectly affect, cholesterol
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metabolism by influencing other nutrients. Severe iron- 
deficiency in the rat (Vitale et al., 1966) and in man (Velez 
et al. f 1966) is known to induce folate deficiency, which in 
turn may reduce mixed function oxidase metabolism (Labadarios,
1975; Labadarios et al., 1978). Various authors have reported 
considerable interactions between iron and other trace minerals 
such as zinc and copper. Iron deficiency has been shown to 
lead to an increase in hepatic copper content (Sourkes et al.,
1968; Symes et al., 1969) and as the corollary to this, a dietary 
deficiency of copper results in increased hepatic iron concentra­
tions (Frieden, 1971)* Klevay (1973) has demonstrated hyperlipid- 
aemia in rats fed diets with a high zinc/copper ratio. However 
Sherman et al. (1977) demonstrated, in rats bred from iron- 
deficient dams,a hyperlipaemia which was associated not only 
with a decreased liver iron level but also with a decreased 
zinc/copper ratio, a finding opposed to that of Klevay. In a 
recent study, Allen and Klevay (1978) reported an increase in 
plasma cholesterol concentration, associated with an increased 
appearance of newly synthesised labelled cholesterol in plasma, 
in response to copper deficiency. They postulated that copper 
might act via an effect on lipoprotein or bile acid metabolism.
Thus the'observed modulatory effect of iron deficiency on 
cholesterol metabolism might result indirectly from its effect 
on hepatic concentrations of copper. In subsequent investigations, 
it would therefore be of interest to compare the effects of 
iron and copper deficiency on cholesterol metabolism, particularly 
with respect to cholesterol 7<x.-hydroxylase activity. It could 
be envisaged that copper status, particularly at the microsomal
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level, might vary with different degrees of iron deficiency and 
thus variably affect cholesterol 7<*--hydroxylase activity.
The effects of iron deficiency on mixed function oxidase 
metabolism seen here are not totally in accord with those reported 
by other workers. Generally,there was an increase in the meta­
bolism of p-nitroanisole and biphenyl, although the magnitude 
of the effect was small, particularly for the latter substrate.
As discussed earlier, this increase has been observed by other 
workers (Catz et al., 1970; Becking, 1972). The variable 
sensitivity of specific reactions to iron deficiency, as seen 
here,was also noted by Becking (1972). In rats, aromatic ring 
hydroxylations were more sensitive to the deficiency than 
aminopyrine N-demethylation. This author also speculates that 
the relative increase in copper content of the liver might 
influence these oxidative reactions, an idea consonant with 
that discussed above.
The relative increase in metabolism is difficult to explain. 
Labbe and Finch (1977) have shown that the activity of ^ -aminole­
vulinic acid dehydratase, an enzyme of haem biosynthesis, is 
incresed in dietary iron deficiency. One might postulate that 
an increased synthesis of cytochrome P-450 might explain the 
increase in mixed function oxidase metabolism. However, in the 
present experiment, in common with those of previous workers, 
levels of cytochrome P-450 and b^ and of NADPH-cytochrome c 
reductase were not markedly altered, although the cytochromes 
were slightly decreased in the second experiment.
Bailey-Wood et al. (1975) have suggested that the competition
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by various organs for the limited available iron may reflect the 
metabolic capacity of the organ. This postulate explains their 
findings and those of Dallmnan and Goodman (1-971)» which showed 
a normal inductive response of hepatic microsomes to phenobarbi- 
tone treatment.
Becking (1972) suggested that the increased metabolism 
might be due to an alteration in substrate binding to cytochrome 
P-450 or on the rate of reduction of the P-^O/substrate complex. 
He later expanded this hypothesis (Becking, 1976), by suggesting 
that the iron released from the liver during deficiency might 
alter the liver microsomal oxidation/reduction potential. This 
would result in a more rapid reduction of oxidation of the 
P-450/substrate complex and consequently an increased rate of 
metabolism. This hypothesis would be consonant with an increased 
rate of cholesterol jK-hydroxylase activity.
Becking (1976) has also speculated on the importance of 
iron stores in controlling the rate of hepatic mixed function 
oxidase metabolism. He suggested that the relative ratio of 
ferric/ferrous iron might be relevant, as the ferric ions in 
ferritin (approximately 20$) inhibited aniline hydroxylation 
and aminopyrine N-demethylation in vitro, whereas ferrous ions 
stimulated these enzymes. Similarly, ferric ions inhibited 
cytochrome P-^50 activity in vitro whereas ferrous ions stimulated 
the enzyme (Fouts and Pohl, 1971)•
It could be that the intracellular ferric/ferrous .ion 
ratio is critical in the control of mixed function oxidase 
metabolism. Thus the lesser degree of deficiency achieved in 
the present experiments might be associated with a different
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ratio of ferric/ferrous ions, due to a differing degree of 
depletion of iron stores, which could thus affect the metabolism 
of various substrates. Variations in this ratio might then 
also be important in controlling the activity of cholesterol 
7<A-hydroxylase, hence offering a further explanation for the 
variable effects on serum cholesterol concentration.
In conclusion, dietary iron deficiency appeared to have a 
variable influence on serum cholesterol concentrations, associated 
with changes in cholesterol 7^-hydroxylase activity. This 
variability could be explained by an interaction with other 
trace nutrients, particularly copper, as this is known to 
influence both cholesterol and mixed function oxidase metabolism.
A further plausible explanation is that of the ferric/ferrous 
iron ratio, related to the degree of deficiency. If the degree 
of depletion had been more severe, iron stores would have been 
further depleted and the rate consequently reduced. As a result, 
stimulation of the mixed function oxidase system and perhaps 
of cholesterol 7c**-hydroxylase would be likely to occur. Thus, 
the possible involvement of iron stores in the control of 
cholesterol 7ob-hydroxylase activity would merit further study.
Chapter 5
General Discussion
The studies described in this thesis were designed to gain 
further insight into the interactions between certain dietary 
components and bile acid metabolism, and their relationship to 
the pathogenesis of atherosclerosis. As the results have been 
discussed in detail within each of the previous chapters, only 
the principal findings will be considered here.
Dietary Lipid and Cholesterol Metabolism
Firstly, under the experimental conditions employed, choles­
terol 7<*-hydroxylase activity was significantly reduced in the 
fat-fed animals compared with the controls. Thus, the observed 
hypocholesterolaemic action of polyunsaturated fats cannot be 
attributed to an induction of bile acid synthesis. The effects 
of dietary fat modification on other aspects of cholesterol 
metabolism, such as its absorption and synthesis have already 
been investigated by previous workers but an area meriting 
further study is that of cholesterol transport via lipoproteins. 
In view of the recent publications concerning high density 
lipoprotein cholesterol, (see Chapter 1), it would seem important 
to examine the influence of dietary lipid on this lipoprotein.
The activity of cholesterol 7<*-hydroxylase was marginally 
lower in the rabbits given the polyunsaturated fat diet compared 
with those given saturated fat. As discussed earlier, the 
former diet might be expected to have a higher peroxide content, 
which could adversely affect microsomal metabolism by damaging 
the endoplasmic reticulum membranes. The influence of peroxide 
content of the diet and of dietary antioxidants on cholesterol 
’fci-hydroxylase activity would merit further investigation.
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The higher 7°C-hydroxylase activities in the chow-fed control 
animals compared, with those fed semi-synthetic diets, confirm 
the suggestion of previous authors that animals given unrefined 
diets display higher activities of this enzyme.
In both groups of rabbits on the high fat regimes there was 
an increase in cytochrome P-450 and b^ concentrations accompanied 
by decreased mixed function oxidase enzyme activities. Several 
explanations for this anachronism may be postulated; 1) A high 
level of dietary fat, independent of the degree of saturation, 
may inhibit a specific type of P-450 whilst inducing the bulk of 
the cytochrome. To test this hypothesis, a wider range of 
substrates should be examined. As fatty acids are known substrates 
of cytochrome P-450 and are metabolised by (A -oxidation, it would 
also be of interest to separate the cytochrome(s) by SDS-gel 
electrophoresis, after feeding diets containing variable types 
and quantities of fat, in order to ascertain if there were any 
specific inductions or inhibitions of different P-450 types.
2) The fats might bind to cytochrome P-450 and competitively 
inhibit the metabolism of exogenous substrates. The metabolism 
of fatty acids by cytochrome P-^50 via 0 -oxidation occurs particu­
larly in conditions where the animal has high circulating levels 
of ketone bodies. It is thus likely that when fat intake is high, 
metabolism of fatty acids via this pathway would be induced; 
therefore it would be of interest to measure 6)-oxidation under 
the experimental condition employed here. 3) It is also possible 
that a high level of dietary fat might unfavourably influence 
the composition of the microsomal membrane, thereby modifying 
metabolism; this possibility will be further considered below.
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Ascorbic Acid and Cholesterol Metabolism
Secondly, further insight has been gained into the involvement 
of ascorbic acid in the metabolism both of cholesterol and of 
foreign compounds. In the guinea pig, there appears to be a 
threshold level of intake for ascorbic acid which plays some 
part in the control of cholesterol catabolism to bile acids; 
there is probably considerable variation in this requirement 
between individual animals. The level of intake below which 
abberratiohs in cholesterol metabolism become apparent in the 
guinea pig is very low. Therefore, it would seem important 
to determine this level of requirement in man, in order to 
confirm the contention of Ginter (1977)» that a seasonal deficiency 
of ascorbic acid is of prime importance in the pathogenesis of 
hypercholesterolaemia. Although several human studies have 
now been carried out (Fix et al., 1974s Kothari and Jain, 1977; 
Kallner, 1977; Ginter, 1977)» none are sufficiently extensive 
to define the range of intakes required in man to prevent 
hypercholesterolaemia. Rigorous dietary control would be 
necessary in such a study, in order to eliminate variability 
due to other dietary components such as lipid.
The results of the present study also indicate that in 
contrast to the effects of acute ascorbate deficiency, chronic 
deficiency has little effect on foreign compound metabolism, 
although again there may be a threshold level of requirement.
This finding may also be of significance in man, as it has been 
suggested that drug metabolism may be impaired in the elderly 
or institutionalised populations (Zannoni, 1977)» where ascorbate 
intake may be low and subclinical deficiencies apparent (Booth
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and Todd, 1972). This assumption has been made on the basis 
of data emanating from studies in acutely deficient experimental 
animals. However, as the chronic deficiency state is closer 
to the human situation, the present results would suggest that 
drug metabolism is unlikely to be impaired in these people. 
Furthermore, when ascorbic acid was given at "megadose" levels 
no adverse effect on mixed function oxidase metabolism was 
observed.
The only alteration in mixed function oxidase metabolism 
in response to chronic ascorbate deficiency was the apparent 
induction of NADPH-cytochrome c reductase activity and to some 
extent of biphenyl 2-hydroxylase. However, although tentative 
explanations for this have been put forward (see Chapter 3)» 
this finding remains unexplained.
Dietary Iron and Cholesterol Metabolism
Thirdly, in consideration of the role of dietary iron in 
cholesterol metabolism, the results from the present study are 
equivocal. Although iron deficiency modified cholesterol 
7<*.-hydroxylase activity, the effect was not consistent. This 
could either be interpreted as being related to the degree of 
depletion of iron stores, or to interactions with other trace 
minerals such as copper. Both possibilities require further 
investigation, as discussed in Chapter 4-.
Relevance of Experimental Findings to Man
Thus, the nutrients examined here all interact with mixed 
function oxidase enzymes which control the metabolism of
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endogenous and exogenous compounds. However, when each nutrient 
is considered in isolation, the effects on the microsomal enzymes 
are small. Thus in attempting to assess the importance of these 
findings in man, two questions must be asked: 1) What is their 
relevance in terms of recommendations made to man? and 2) If 
an experimental model were established, in which all three 
nutrients and perhaps others such as fibre were modified, would 
the observed effect on metabolism be more dramatic and more 
closely represent that seen in man?
Recommendations with respect to dietary lipid are probably 
of most importance and are certainly most controversial. The 
present results fail to explain the hypocholesterolaemic effects 
of polyunsaturated fatty acids and lend support to the doubts 
recently expressed concerning the "lipid hypothesis" (McMichael, 
1976; Mann, 1977; Kummerow, 1977; Cole, 1977; Kaunitz, 1977) • 
Despite the prevailing uncertainties and scepticism regarding 
the efficacy and mechanism of dietary fat modification and 
regulation of lipid metabolism, various official bodies,both 
in this country and the United States (see Chapter 1), have 
made statements of nutrition policy. These have gradually 
become more positive regarding the recommended intakes for total, 
saturated and polyunsaturated fats.
Thus, in the United Kingdom, the D.H.S.S. (1974) were only 
able to recommend a reduction in total fat intake; however by 
1977, the Royal College of Physicians did recommend an increase 
in the ratio of polyunsaturated to saturated fat. Similarly, 
in the.United States, the American Medical Association (1972) 
made a conservative statement, recommending dietary lipid
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modification only for persons falling into risk categories. 
Nevertheless, in the Dietary Goals proposed by the Senate Select 
Committee (1977), stringent "blanket" recommendations have been 
made for the whole population. These include a reduction of 
total fat intake to 30$ of total energy and of cholesterol to 
3C0mg per day and modification of the type of fat such as to 
provide equal proportions of saturated, monounsaturated and 
polyunsaturated fatty acids. These recommendations have been 
criticised by Harper (1978) and Reiser (1978); both authors 
refute the idea of mass recommendations, suggesting that to 
date, only individual treatment of patients with proven abnorma­
lities of lipid metabolism is justified. The present results 
expand and support this view; although it is apparent that a 
deficiency or excess of the nutrients studied may influence 
cholesterol metabolism, at this stage the evidence is insufficient 
for these blanket recommendations.
The answer to the second question, i.e."is the human disease 
of atherosclerosis the result of an interaction of both excesses 
of and deficiencies of particular nutrients, together with other 
environmental factors such as smoking and pollution and possibly 
stess?",can only be speculative. Atherosclerosis is now considered 
to be a raultifactorial disease; the results of the present 
study support this, as all three nutrients examined influenced 
bile acid metabolism and the degree of cholesterolaemia, which 
is an accepted risk factor for atherosclerosis. In this study 
and in those of previous workers, these nutrients have all been 
shown to interact with cytochrome P-450. Both the synthesis 
and catabolism of cholesterol are dependent on P-450 and the
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desaturation of fatty acids is regulated by a microsomal enzyme 
system in which cytochrome b^, which is closely coupled to 
cytochrome P-450 (Schenkman et al., 1976), acts as the electron 
donor (Oshino et al., 1971; Oshino and Omura, 1973)• Furthermore, 
various other factors which are associated with hyperlipidaemia 
and atherosclerosis also interact with this cytochrome. For 
instance, high levels of carbon monoxide, which are associated 
with an increased incidence of atherosclerosis in experimental 
animals (Astrup et al., 1970) and in man (Astrup et al., 1966), 
inhibit normal cytochrome P-450 hydroxylations (Orrenius. and 
Emster, 1964) . Similarly, the excessive amounts of vitamin 
D often ingested by Western populations (Kuramerow et al., 1976), 
are known to cause vascular hypercalcification (Seelig, 1969;) 
hypercholesterolaemia and atherosclerosis (Parke et al., 1978) 
in experimental animals. Vitamin D£ displays strong affinity 
binding for cytochrome P-450 (Cinti et al., 1976) and has been 
shown to decrease cholesterol 7^-hydroxylase activity in vitro 
(Rush, 1978). Oestrogens have been suggested as being protective 
against atherosclerosis on the basis of evidence that the 
susceptibility of women to cardiovascular disease increases 
after natural or surgical menopause (Oliver and Boyd, 1959;
Kannel et'al., 1976) and that diet-induced atheroma in animals 
can be retarded by oestrogen administration (Wissler and Vesse- 
linovitch, 197*0 and again, oestrogens are metabilised by P-450 
and could thus induce its^synthesis.
Thus, many of the factors influencing atherosclerosis also 
influence or interact with cytochrome P-450. One could hypothesise
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that this cytochrome plays a central role in the pathogenesis 
of this disease. In accordance with this, Stier (1976) has 
suggested that changes in the lipid environment of the endoplasmic 
reticulum membrane, induced by diet or exposure to chemicals, 
could lead to an uncoupling of the cytochrome P-450 system such 
that the cytochrome would subsequently act as a peroxidase.
The process of lipid peroxidation results in the release of 
various reactive oxygen species such as hydroperoxides, which 
are known to inactivate enzyme systems associated with damage 
to endoplasmic reticulum membranes (Hrycay and O'Brien, 1971)* 
These workers also showed that microsomal damage,induced by 
agents such as thiols or proteases, led to the conversion of 
P-450 to P-420, with a concomitant enhancement of peroxidase 
activity. Thus, it could be envisaged that a vicious cycle of 
uncontrolled membrane oxygenation might occur, both in the liver 
and at other sites, notably the arterial walls. Either (1) 
the endoplasmic reticulum could be adversely affected by diet 
or foreign chemicals, thus resulting in decoupling of the 
flavoprotein reductase-cytochrome-P-450 system such that the 
cytochrome would act as a peroxidase or (2) lipid peroxidation 
might be initiated, leading to membrane damage and conversion 
of P-450' to the peroxidase,resulting in further release of 
peroxides.
In this context, the three nutrients selected for investiga­
tion in the present study all influence lipid peroxidation 
(Wills, 1969; Rowe and Wills, 1976; Wills, 1972) and interact 
with each other in this process (Fujita, 1977; Hammer and Wills, 
1978). Therefore it is possible that polyunsaturated fatty acids,
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ascorbic acid and iron are vital to the structural.and functional 
integrity of the endoplasmic reticulum membranes and their asso­
ciated enzymes, over a limited range of concentration. Divergence 
from these critical concentrations could result in membrane 
damage and consequently inhibition of normal cytochrome P-450- 
mediated reactions, including cholesterol 7^-hydroxylation; 
pathological changes might then ensue. In man,the situation is 
likely to be highly complex, owing to numerous other factors 
which could also interact with the cytochrome, as discussed 
earlier.
In summary then, it is suggested that cytochrome P-450 
could play a central role in the pathogenesis of atherosclerosis, 
which might be twofold. Abnormalities in diet and exposure to 
environmental contaminants could influence membrane integrity 
and inhibit the P-450-mediated oxidation of cholesterol, possibly 
leading to hypercholesterolaemia. Secondly, peroxidation might 
be engendered as a result of this damage, leading to a cycle of 
uncontrolled release of reactive oxygen species, perpetuating 
the damage both at the hepatic level and possibly affecting 
the integrity of the arterial walls. Thus, further investigation 
of the interaction of diet and foreign chemicals with this 
enzyme system is required, in the hope that further knowledge 
in this respect will give greater insight into prophylactic 
measures which could be adopted in atherosclerosis.
References
-220-
R E P . E R E . N C E S
Abu-Zeid, H.A.H. and Chapman, J.M. (1976). J. chron. Dis.,
29,395.
Agradi, E., Spagnuolo, C. and Galli, C. (1975)* Pharmac. Res. 
Commun., £,469*
Ahrens, E.H. (1957). Am. J. Med., 22,928.
Ahrens, E.H. (1976). Ann. intern. Med., 35,37.
Aldersberg, D. (1951)* Am. J. Med., 11,600 .
Ali, S.S., Kuksis, A. and Beveridge, J.M.R. (1966). Can. J. 
Biochem., 44,1377*
Allen, K.G.D. and Klevay, L.M. (1978). Life Sci., 22,1691*
American Medical Association (1972). Preventative Medicine,1,559*
Amine, E^K. and Hegsted, D.M. (1971)• 'J- Nutr., 101,1575*
Anderson, J.T., Grande, P. and Keys, A. (1958). Fedn. Proc., 
17,468.
Anderson, J.T., Grande, P., Matsumoto, Y. and Keys, A. (1963)*
J. Nutr., 79,349.
-221-
Anderson, T.W., leRiche, W.H., Mackay, J.S. (1969). New Engl.
J. Med., 280,805.
Andrews, J . and Brook, M. (1966). Lancet, 1,1350.
Angelin, B. (1977)* Acta med. Scand., Suppl. 610.
Anitschkow, N. and Chalatow, S. (1913). Zentrabl. Allg. Pathol., 
24,1. (cited by Kottke and Subbian, 1978).
Antonis, A. and Bersohn, I. (1962). Am. J. clin. Nutr., 11,142.
Armstrong, .M.L. (1976).. In Atherosclerosis Reviews. Editors; 
Paoletti, R. and Gotto, A.M. vol. 1, p. 137, New York,
Raven Press.
Armstrong, M.L., Waner, E.D. and Connor, V/.E. (1970) . Circulation 
Res., 22,59.
Arrington, L.R., Platt, J.K. and Franke, D.E. (1974). J. Anim. 
Sci., 38,76.
Astrup, P., Hellung-Larsen, P., Kjeldsen, K., Mellemgaard, K. 
(1966). Scand. J. clin. Lab. Invest., 18,450.
Astrup, P., Kjeldsen, K. and Wanstrup, J. (1970). Ann, N. Y.
Acad. Sci. U.S.A., 174,294.
-222-
Atkin, S.D., Palmer, E.D., English, P.D., Morgan, B., Cawthome, 
M.A. and Green, J. (1972). Biochem. J., 128,237.
Avignon, J. and Steinberg, D. (1965). J. Clin. Invest., 44,1845.
Bailey-Wood, R., Blayney, L.M., Muir, J.R. and Jacobs, A. (1975)* 
Br. J. exp. Path., 56,193«
Baird, I.M., Howard, A.N., Hughes, R.E. and Wilson, H.K. (1976). 
Unpublished Data (cited by Hughes, 1977)*
Bajwa, G.S., Morrison, L.M. and Ershoff, B.H. (1971)* Proc. Soc. 
exp. Biol. Med., 138,975«
Baker, E.M., Hammer, D.C., March, S.C., Tolbert, B.M. and Canham, 
J.E. (1971a). Science, 173,826.
Baker, E.M., Hodges, R.E., Hood, J. Sauberlich, H.E., March, S.C. 
and Canham, J.E. (1971b). Am. J. clin. Nutr., 24,444.
Balasubramaniam, S. and Mitropoulos, K.A. (1975)• Biochem. Soc. 
Transac., 2»964.
Balasubramaniam, S., Goldstein, J.L., Faust, J.R. and Brown, M.S.
(1976). Proc. Natn. Acad. Sci. U.S.A., £3,2564.
Balasubramaniam, S ., Mitropoulos , K.A. and Myant, N .B. (1973) •
-223-
Eur. J. Biochem., 34,77.
Balasubramaniam, S., Mitropoulos, K.A. and Myant, N.B. (1975)•
In, advances in Bile Acid Research. Editors: Matem, S., 
Hackenschmidt, J., Back, P. and Gerok. W. Vol. 3» P* 61, 
Stuttgart, F.K. Schattauer Verlag.
Balmer, J. and Zilversmit, D.B. (1974). J. Nutr., 104,131?.
Bannerjee, S. and Singh, H.D. (1958). biol. Chem., 233.336.
Bamdt, R., Blankenhom, D.H., Crawford, D.W. and Brooks, S.H.
(1977)* Ann. Intern. Med., 86,139»
Barnes, S. and Chitranukroh, A. (1977)* Ann. clin. Biochem., 
14,235-
Barr, D.P., Russ, E.M. and Eder, H.A. (1951)* Am. J. Med.,11,
480. ■
Basu, T.K. (1977). Chem.-Biol. Interact., 16,247.
Bazzano, G. (1969). Archs intern. Med., 124,710.
Becker, R.R., Burch, H.B., Salomon, L.L., Venkitasubramanian, T.A. 
and King, C.G. (1953). J* Am. chem. Soc., 75,2020.
Becking, G.C. (1972). Biochem. Pharraac., 21,1585.
-224-
Becking, G.C. (1976). Fedn. Proc., 35.2480.
Becking, G.C. and Morrison, A.B. (1970a). Biochem. Pharmac., 
19,895.
Becking, G.C. and Morrison, A.B. (1970b). Biochem. Pharmac.,
19,2639.
Beher, W.T., Casazza, K.K., Beher, M.E., Filus, A.M. and Bertasius, 
J. (1970). Proc. Soc. exp. Biol. Med., 134,595*
Beke, R., De Weerdt, G.A., Parijs, J., Huybrechts, W. and Barbier, 
F. (1976). Clinica Chim. Acta, 70,197.
Benditt, E.P. (1977). Am. J. Path., 86,693.
Benditt, E.P. and Benditt, J.M. (1973). Proc. natn. Acad. Sci. 
U.S.A., 20,1753.
Bergstrom, S. (1952). Kgl. Fysiolgrafiska Sallskapets Forhand-
lingar (Lund) 22,1. (cited by Dietchsky and Wilson,1970c).
Berseus, 0., Danielsson, H. and Einar-sson, K. (1969). In Methods 
of Enzymology. Editors: Colowick, S.P. and Kaplan, N.O.
Vol. 15, P*555» New York and London, Academic Press.
Best, M.M., Duncan, D.H., VanLoon, E .J. and Wathen, J.D. (1955)•
Am. J. Med., 19,61. ' •
Beveridge, J.M.R., Connell, W.F., Mayer, G.A., Firstbrook, J.B. 
and Dewolfe, M.S. (1955)• J* Nutr., 56,311.
Beveridge, J.M.R., Connell, W.F., Mayer, G.A. and Haust, H.L.
(I960). J. Nutr., 21,6l.
Bhattacharyya, A.K., Connor, W.E. and Spector, A.A. (1972). J. 
clin. Invest., 51,2060.
Bielski, B.H.J., Richter, H.W. and Chen, P.C. (1975)* Ann. N. Y. 
Acad. Sci., 258,231.
Bierenbaum, M.L., Fleischman, A.I., Dunn*, J.P., Hay ton, T., 
Pattison, D.C. and Wilson, P.B. (1973)* Am. J. publ.
Hlth., 62,169.
Bierenbaum, M.L., Fleischman, A.I. and Raichelson, R.I. (1972). 
Lipids,
Birkner, H.J. and Kern, F. (1974). Gastroenterology, 67,237. 
Bimbaum', M. and Levein, C.D. (1961). N.Y. St. J. Med., 61,4213. 
Bjorkhem, I. (1973). Eur. J. Biochem., 40,415.
Bjorkhem, I. and Danielsson, H. (1970). Eur. J. Biochem., 17,450.
Bjorkhem, I. and Danielsson, H. (1974). Analyt. Biochem., 59,508.
-226-
Bjorkhem, I. and Danielsson, H. (1975)* Eur. J. Biochem., 53,63.
Bjorkhem, I. and Kaliner, A. (1976). J. Lipid Res., 17,360.
Bjorkhem, I., Blomstrand, R. and Svensson, L. (1978). J. Lipid 
Res., 19,359•
Bjorkhem, I., Danielsson, H. and Gustafsson, J. (1973)* FEBS 
Lett., 31,20.
Bjorkhem, I., Danielsson, H. and Wikvall, K. (1974). Biochem. 
biophys. Res. Commun., 61,934.
Bligh, E.G. and Dyer, W.J. (1959). Can. J. Biochem. Physiol., 
22,911.
Bloch, K., Berg, B.N. and Rittenberg, D. (1943). J . biol. Chem., 
149,511.
Bolker, H.I., Fishman, S., Heard, R.D.H., 0'Donnell, V.J., Webb, 
J.L. and V/ill is, G.C. (1956). J. exp. Med., 103,199 •
Bondjers G. and Bjorkerund, S . (1977)• Expl. Molec. Path., 26,341.
Booth, J.B. and Todd, G.B. (1972). Geriatrics, 27,130.
Borgstrora, B. (1969). J. Lipid Res., 10,331.
-227-
Boyd, E.M. Dobos, I. and Taylor, F. (1970). Chemotherapy, 15,1*’
Boyd, G.S., Brownie, A.C., Jefcoate, C.R. and Simpson, E.R.
(1971)* Biochem. J., 125,IP*
Boyd, G.S., Grimwade, A.M. and Lawson, M.F. (1973)* Eur. J. 
Biochem., 2Z,334.
Boyd, G.S., Scholan, N.A. and Mitton, J.R. (1969). Adv. exp. Med. 
Biol., 4,443.
Briggs, M. (1976). Lancet, 1,154.
Bronte-Stewart, B., Keys, A., Brock, J.F., Moodie, A.D., Keys,
M.H. and Antonis, A. (1955)• Lancet, 2,1103*
Bronte-Stewart, B., Roberts, B. and Wells, V.M. (1963). Br. J. 
Nutr., 17,61.
Brown, H.B. , deV/olfe, V.G. , Naito, H.K., Harper, W.J. and 
Palmquist, D.L. (1976). J. Am. diet. Ass., 69,235*
Brov/n, M.S. and Goldstein, J.L, (1974). Science, N.Y., 185,61.
Brown, M.S. and Goldstein, J*L. (1976). New Engl. J. Med., 294, 
1386.
Brown, M.S., Faust, J.R. and Goldstein, J.L. (1975)* J* clin.
Invest., 55,783•
Brown, R.G. (1973)* J. Am. med. Ass., 11,1529>
Browne,M.J.G. and Boyd, G.S. (1974). Eur. J. Biochem., 44,37.
Brunner, D., Altman, S., Loebl, K. and Schwartz, S. (1962). J. 
Atheroscler. Res., 2,424.
Burch, G.E. and dePasquale, N. (1962a). Am. J. med., 32,l6l.
Burch, G.E. and dePasquale, N. (1962b). J. Am. med. Ass., 180,63
Burkitt, D.P., Walker, A.R.P. and Painter, N.S.J. (1974). J. Am. 
med. Ass., 229,1068.
Bums, J.J. (1957)* Nature, 180,553.
Bums, J.J., Peyser, P. and Moltz, A. (1956). Science, 124,1148.
Byers, S.0. and Friedman, M. (1958). Proc. Soc. exp. Biol. Med.
98,523.
Campbell, T.C. (1977). Clin. Pharmac. Ther., 22,699.
Campbell, T.C. and Hayes, J.R. (1974). Pharmac. Rev., 26,171.
-229-
Campbell, T.C. and Hayes, J.R. (1976). Fedn. Proc., 35.2470.
Carlson, L.A. and Bottiger, L.E. (1972). Lancet, 1,865*
Carlson, L.A., Oro, L. and Ostman, J. (1968). Acta Med. Scand., 
183,457*
Carroll, K.K. (1978). Nutr. Rev., 36,1.
Carroll, K.K. and Hamilton, R.M.G. (1975)* J* Fd. Sci., 40,18.
Carroll, K.K., Giovannetti, P.M., Huff, M.W., Moase, 0., Roberts,
D.C.K. and/Wolfe, B.M. (1978). Am. J. clin. Nutr., 31,1312.
Castelli, W.P., Doylk, J.T., Gordon, T., Hames, C.G., Hjortland, 
M.C., Hulley, S.B., Kagan, A. and Zukel, W.J. (1977)* 
Circulation, 51,767.
Caster, W.O., Wade, A.E. , Greene, F.E. and Meadows, J.S. (1970a). 
Life Sci., 2»181-
Caster, W.O., Vfade, A.E., Norred, W.P. and Borgmann, R.E. (1970b). 
Pharmacology, 2»i77*
Caster, W.O., Wade, A.E., Greene, F.E. and Meadows, J.S. (1968). 
Fedn. Proc.., 27,549.
Catz, C.S., Juchau, M.R. and Yaffe, S.J. (1970). J. Pharmac. exp.
-230-
Ther., 174,197*
Century, B. (1973)* J* Pharmac. exp. Ther., 185,135*
Century, B. and Horwitt, M.K. (1968). Fedn.Proc., 27,349*
Chang, M.L.V/. and Johnson, M .A . (1976). J. Nutr., 106,1562.
Chaplin, M.D* and Mannering, G.J. (1970). Molec. Pharmac., 6,631*
Chatterjee, G.C. (1967). In The Vitamins. Editors: Sebrell, W.H. 
and Harris, R.S. vol. 1, p.399, New York and London,
Academic Press.
Cinti, D.L., Golub, E.E. and Bronner, F. (1976). Biochem. Biophys. 
Res. Commun., 72,546.
Clarkson, T.B., Pritchard, R.W., Lofland, H.B. and Goodman, H.O.
(1962). Circulation Res., 11,400.
Clarkson, T.B*, King, J.S., Lofland, H.B., Feldner, M.A. and 
Bullock, B.C. (1973). J* molec. Path., 13,267*
Clarkson, T.B.-, Prichard, R.W., Bullock, B.C., St. Clair, R.W., 
Lehner, N.D.M., Jones, D.C., V/agner, W.D. and Rudel, L.L. 
(1976). Expl. molec. Path., 24,264.
Cole, T.J. (1977). Lancet, 1,1199*
-231-
Comai, K. and Gaylor, J.L. (1973)* J* bio1. Chem., 248,4947.
Conley, C.L., Russell, R.P., Thomas, C.B. and Tumulty, P.A. (1964). 
Archs intern. Med., 113,170.
Conney, A.H. (1967)* Pharmac. Rev., 19,317.
Conney, A.H., Pantuck, E.J., Kuntzman, R., Kappas, A., Anderson, 
K.E. and Alvares, A.P. (1977)• Clin. Pharmac. Ther., 
•22,707.
Connor, W.E., Hodges, R.E. and Bleiler, R.E. (1961) . J. clin. 
Invest., 40,894. 
Connor, W.E., Witiak, D.T., Stone, D.B. and Armstrong, M.L. (1969)* 
J. clin. Invest., 48,1363*
Corey, J.E., Hayes, K.C., Dorr, B. and Hegsted, D.M. (1974). 
Atherosclerosis, 19,119.
Crawford, G.P.M., Warlov/, C.P., Bennett, B., Dawson, A.A., Douglas, 
A.'G.,'Kerridge, D .?. and Ogstrom, C. (1975)* Atheroscle­
rosis , 21,451.
Crawford, M .D . (1972). Proc. Nutr. Soc., 31,347. 
Crawford, M.D., Gardner, J.J. and Morris, J.N. (1968). Lancet, 
1,827.
Crawford, M.D., Gardner, J.J. and Morris, J.N., (1971). Lancet, 
2,327.
Creaven, P.J., Parke, D.V. and Williams, R.T. (1965). Biochem.
J. 25,879.
Cusack, R.P. and Brown, W.D. (1965)• J. Nutr., 86,383.
Dalderup, L.M., Stockmann, V.A., Rechsteiner-de Vos, H.L. and 
van der Slikke, G.J. (1965)• Neth. J. Nutr., 26,245.
Dallman, P.R. and Goodman, J.J. (1971). J« Cell Biol., 48,79.
Danielsson, H. (1972). Steroids, 20,63*
Daoud, A.S., Jarmolych, J., Fritz, K. and Augustyh, J. (1974). 
Circulation, 50,202.
Davies, J.E.W. and Hughes, R.E. (1977). Br. J. Nutr., 38,299*
Dayton, S., Chapman, J.M., Pearce, M.S. and Popjak, G.W. (1970). 
Ann. intern. Med., 72,97.
deGroot, A.P., Luyken, R. and Pikaar, N.A. (1963). Lancet, 2,303
Denbesten, L., Reyna, R.H., Connor, W.E. and Stegink, L.D. (1973) 
J. clin. Invest., 52,1384.
-233-
Denson, K.W. and Bowers, E.F. (1961). Clin. Sci., 21,157*
DePasquale,-..N.P. and Burch, G.E. (1963)* J. Am. med. Assoc., 
182,142.
D.H.S.S. (1974). Diet and Coronary Heart Disease. Report of the 
advisory panel of the Committee on Medical Aspects of 
Food Policy (Nutrition). H.M. Stationary Office.
Dickerson, J.W.T.,. Basu,T.K. and Parke, D.V. (1971)* Proc. Nutr. 
Soc., 30,27A.
Dietchsky, J.M. (1968). Gastroenterology, 47,286.
Dietchsky, J.M. and Wilson, J.D. (1970a). New Engl. J. Med., 
282,1128.
Dietchsky, J.M. and Wilson, J.D. (1970b) . New Engl. J.Med., 
282,1179.
Dietchsky, J.M. and Wilson, J.D. (1970c). New Engl. J. Med.,
282, 1241.
Dingell, J.V., Joiner, P.D. and Hurwitz, L. (1966). Biochem. 
Pharmac., 15. m.
Dixon, R.L., Shultice, R.W. and Fouts, J.R. (I960). Proc. Soc. 
exp. Biol. Med., 103,333*
-234-
Drill, V.A. (1952). Pharmac. Rev. 4,1.
Drury, R.A.B. and Wallington, E.A. (1967). Carleton's Histological 
Techniques, 4th ed., pp. 129 and 296, New York: Oxford 
University Press.
Eastwood, M.A. and Hamilton, D. (1968). Biochim. biophys. Acta, 
152,165.
Einarsson, K. and Hellstrom, K. (1972). Eur. J. clin. Invest., 
2,225.
Einarsson, K. and Johansson, G.(1968). FSBS Lett., 1,219.
Einarsson, K., Hellstrom, K. and Kallner, M. (1974). J. clin. 
Invest., 54,1301.
Elwood, P.O., Bainton, D., Moore, F., Davies, D.F., Wakley, E.J., 
Langmen, M. and Sweetnam, P. (1971). Br. Med. J., 2,362.
Elwood, P.O., Hughes, R.E. and Hurley, R.J. (1970a). Lancet, 
2,1197.
Elwood, P.O., Mahler, R., Sweetnam, P., Moore, F. and Welsby, E. 
(1970b). Lancet, 1,589.
Eneroth, P., Hellstrom, K. and Rhyage, R. (1964). J. Lipid Res.,
■5.2*5.
-235-
Engelberg, D. and Newman, B.A. (1943). J. Am. med. Ass., 122,116?.
Epstein, F.H., Block, W .D., Hand, E.A. and Francis, T. (1959).
Am. J. Med., 26,39*
Epstein, F.H., Ostrander, J.L.D., Johnson, B.C., Payne, M.W.,
Hayner, N.S., Keller, J.B. and Francis, T. (1965)• Ann. 
intern. Med., 62,1170.
Ernster, L. and Orrenius, S. (1965). Fedn. Proc., 24,1190.
Eskelson, C.D., Jacobi, H.P. and Fitch, D.M.-(1973). Physiol.
Chem. Phys., 5>319.
Estabrook,■ R»W., Werringloer, J., Hrycay, E.G., O'Brien, P.J.,
Rahimtula, A.D. and Peterson, J.A. (1975)• Biochem. Soc. 
Trans.,
Ewing, A.M., Freeman, N.K. and Lindgren, F.T. (1965). Adv. Lip.
Res., 2,25.
Fessas, P., Stamatoyannopoulos, G. and Keys, A.. ■ (1963) • Lancet, 
1,1182.
Fisher, M.M., Kakis, G. and Yousef, I.M. (1976). Lipids, 11,93 *
Fix, A.J., Davis, J.A. and Copenhaver, J.H. (1974). Nebraska
-236-
Med. J . , 59,343.
Forfar, J.O. and Thompsett, L. (1959). Adv. Clin. Chem., 2,167.
Fouts, J.R. and Pohl, R.J. (1971)• J . Pharmac. exp. Ther., 179,91*
Fredrickson, D.S., Levy, R.I. and Lees, R.S. (1967). New Engl.
J. Med., 276,34,94-, 148,215,273.
Frieden, E. (1971)* Adv. Chem., 100,292.
Friedman, R.J., Moore, S., Singal, D.P. and Gent, M. (1976).
Archs Path. Lab. Med., 100,189.
Friend, B. (1967). Am. J. clin. Nutr., 20,907.
Fry, J.R. and Bridges, J.W. (1977)* In Progress in Drug Metabo­
lism. Editors* Bridges, J.W. and Chasseaud, L.F. vol. 2, 
p.73i London, New York, Sydney, Toronto, Wiley-Interscience.
s.
Fujita, T. (1978). Jap. J. Pharmac., 27,914.
Funch, J.P., Krogh, B. and Dam, H. (I960). Br. J. Nutr., 14,355*
Fyfe, T., Dunnigan, M.G., Hamilton, E. and Rae, R.J. (1968).
J. Atheroscler. Res., 8,591.-
Gatenby-Davies, J.D. and Newton, J. (1974). Am. J. clin. Nutr., 
22,1039.
Gerson, T., Shorland, F.B. and Adams, Y. (1961). Biochem. J., 
81,534.
Gielen, J.E.,' Van Cantfort, J. and Kremers, P. (1976). Archs 
Toxicol., 36,255.
Gielen, J.E., Van Cantfort, J., Robaye, B. and Renson, J. (1969)• 
C.R. Acad. Sci. Paris, 269,731. (cited by Mayer, 1976).
Gielen, J.E., Van Cantfort, J., Robaye, B. and Renson, J. (1975)* 
Eur. J. Biochem., H A  1.
Gigon, P.L., Gram, T.E. and Gillette, J.R. (1969) • Molec. Pharmac.
5.109.
Gillette, J.R., Davis, D.C. and Sasame, H.A. (1972). A. Rev. 
Pharmac., 12,57.
Ginter, E. (1973)* Science, 179, 702.
Ginter, E. (1975a). The Role of Vitamin C in Cholesterol Catabo- 
“ lism and Atherogenesis Veda, Vydaatelstvo Slovenskej 
Akademie Vied, Bratislava.
Ginter, E. (1975b). Ann. N.Y. Acad. Sci., 258,410.
-238-
Ginter, E. (1976)* Food Chem., 1,23- 
Ginter, E. (1977)* Experentia, 33,716.
Ginter, E. (1978). Second International Symposium on Vitamin C,
Rio de Janeiro, Brazil.
Ginter, E. and Nemec, R. (1969). J. Atheroscler. Res., 10,273.
Ginter, E. and Zloch, Z. (1972). Int. J.'-Vit. Nutr. Res., 42,72.
Ginter, E., Bilistics, L. and Cerven, J. (1965). Physiologia 
bohemoslov., 14,466.
Ginter, E., Bobek, P. and Ovecka, M. (1968). Int. Z. Vit. 
forschung, 38,104.
Ginter, E. , Cema, 0., Budlovsky, J. Balaz, V. , Hruba, F., Roch,
V. and Sasko, E. (1977). Int. J. Vit. Nutr. Res., 47,123.
Ginter, E., Cerven, J., Nemec, R. and Mikus, L. (1971). Am. J. 
Clin. Nutr., 24,1238.
Ginter, E., Kajaba, I, and Nizner, 0. (1970). Nutr. Metab., 12,76.
Ginter, E., Nemec, R. and Bobek, P. (1972). Br. J. Nutr., 28,205*
Ginter, E., Ondreicka, R., Bobek, P. and Simko, V. (1969). J* Nutr. 
99,261.
-239-
Glaumann, H. and Dallner, G. (1968). J. Lipid Res., 2»720*
Gloraset, J.A. (1968). J. Lipid Res., 2»155«
Goldsmith, G.A., Hamilton, J.G. and Miller, N.O. (I960). Archs 
intern. Med., 105,512.
Gordon, H., Lewis, B., Tales, L. and Brock, J.F. (1957)* Lancet, 
2,1299.
Gordon, T., Castelli, V7.P. Hjortland, M.C., Kannel, W.B. and .
Dawber, T.R. (1977). Am. J. Med., 62,707.
Gore, I., Fujinami, T. and Shirahama, T. (1965). Archs Path., 
80,371.
Gortner, W.A. (1975)• Cancer Res., 35,3246.
Gotto, A.M., Yeshurun, D. and DeBakey, M.E. (1976). J. chron. 
Dis., 29,677.
Gram, T.'E., Guarino, A.M., Schroeder, D.H., Davis, D.C., Reagan, 
R.C. and Gillette, J.R. (1970). J. Pharm. exp. Ther., 
175,12.
Grande, F. (1967). Am. J. clin. Nutr., 20,176.
Grande, F. (1974). S.A. Med. Journal, 48,1660.
-240-
Grande, F., Anderson, J.T. and Keys, A. (1970). Am. J. clin.
Nutr., 23,1184.
Groen, J., Tijong, B.K., Kamminga, C.E. and Willebrands, A.F. 
(1952). Voeding, 12,556.
Grundy, S.M. (1975)* J* clin. Invest., 55,269.
Grundy, S.M . and Ahrens, E.H. (1969). J. Lipid Res., 10,91.
Grundy, S.M. and Ahrens, E.H. (1970). J. clin. Invest., 49,1135.
Grundy, S.M., Ahrens, E.H. and Miettlnen, T.A. (1965) • J* Lipid 
Res., 6,397•
Guchait, R., Guha, B.C. and Ganguli, N.C. (1963). Biochem. J., 
86,193*
Gundermann, K., Degkwitz, E. and Staudinger, H. (1973)* Hoppe- 
Seyler's Z. Physiol. Chem., 354,238.
Gustafsson, B.E. and Norman, A.' (1969). Br. J. Nutr. 23,429.
Guthrie, H.A., Froozani, M., Sherman, A.R. and Barron, G.P. (1974). 
J. Nutr., 104,1273*
Gutstein, W.H., Lazzarini-Robertson, A. and LaTaillard, J.A.
(1963). Am. J. Path., 42,61.
-241-
Hamilton, R.M.G. and Carroll, K.K. (1976). Atherosclerosis, 24,47.
Hammer, C.T. and Wills, E.D. (1978). Biochem. J.,174,585.
Harper, A.E. (1978). Am. J. clin. Nutr., 31,310.
Hashim, A., Arteaga, S.A. and van Itallie, T.B. (I960). Lancet, 
1,1105-
Haslewood, G.A.D. (1967)• Bile Salts, Londons Methuen and Co. Ltd.
Hattersley, N.G. (1975)- Ph.D. Thesis, University of Edinburgh.
Hattersley, N.G. and Boyd, G.S. (1975)- FEBS Lett., 53,80.
Haust, H.L. and Beveridge, J.M.R. (1958). Archs Biochem, 78,367.
Haust, M.D. and More, R.H. (1972). In The Pathogenesis of
Atherosclerosis. Editors: Wissler, R.W. and Geer, J.C. 
p.l, Baltimore, Williams and Wilkins.
Hegsted, D.M., McGandy, R.B., Myers, M.L. and Stare, F.J. (1965)- 
Am. J. clin. Nutr., 17,281.
Helin, P., Lorenzen, I., Garbarsch, C. and Matthiessen, M.E.
(1971)- Atherosclerosis, 13,319.
Hellstrom, K. (1965)- Acta Physiol. Scand., 63,21.
Hellstrom, K. and Lindstedt, S. (1966). Am. J. clin. Nutr., 18,46.
Hermus, R.J.J. (1975)• Experimental Atherosclerosis in Rabbits
on Diets with Milk Fat and Different Proteins. Agric. Res. 
Rep. (Versl. Landbouwk. Onderz.) 838.
Hietanen, E., Laitinen, M., Yainio, H. and Hanninen, 0. (1975)* 
Lipids, 10,467•
Hildebrandt, A. and Estabrook, R.W. (1971)* Archs Biochem. 
Biophys., 143,66.
Hill, P. and Wynder, E.L. (1976). J. Am. diet. Ass., 68,25.
Hochstein, P. and Emster, L. (1963)* Biochem. biophys. Res. 
Commun., 12, 388.
Hochstein, P., Nordenbrand, K. and Emster, L. (1964). Biochem. 
biophys. Res. Commun., 14,323-
Hodges, R.A., Salel, A.F., Dunkley, W.L., Zelis, R., McDough,
-P.F., Clifford, C., Hobbs, R.K., Smith, L.M., Fan, A., 
Mason, D.T. and Lykke, C. (1975) •. Am. J. clin. Nutr., 
28,1126.
Hodges, R.E., Krehl, W.A., Stone, D.B. and Lopez, A. (1?67) •
Am. J. clin. Nutr., 20, 198.
Hofmann, A.F. (1967). Gastroenterology, 52,4.
-243-
Holtzman, J.L., Gram, T.E., Gigon, P.L. and Gillette, 
Biochem. J., 110,407«
Hopkins, L.L. and Mohr, H.E. (1974). Fedn. Proc., 22
Hornig, D. and Weiser, H. (1976). Experentia, 32,687
Hornig, D., Weiser, H., Weher, F. and Wiss, 0. (1973) 
Vitam. Forsch., •a ,28.
Howard, A.N., Gresham, G.A., Jones, D. and Jennings, 
J. Atheroscler. Res., 2*330.
Hrycay, E.G. and O ’Brien, P.J. (1971). Archs Biochem 
147,28.
Huff, M.W., Hamilton, R.M.G. and Carroll, K.K. (1977) 
rosis, 28,187•
Hughes, R.E. (1976). J. Hum. Nutr., 30,315.
Hughes, R.E. (1977)» Food Chem.,2,119.
Hughes, R.E. and Jones, P.R. (1971). Br. J. Nutr., 2
Iacono, J.M., Mueller, J.F. and Ammerman, C.B. (I960) 
Proc., 19,15.
J.R. (1968).
1773^
Int. Z.
.W. (1965).
Biophys., 
Atheroscle-
Fedn.
-2*J4-
Imai, Y. and Sato, R. '(197*0 • Biochem. biophys. Res. Coramun, 60,8.
Iwamoto, K., Ozawa, N., Ito, F., Okamoto, N. and Watanabe, J. 
(1976). Chem. pharm. Bull., Tokyo, 24,2014.
Jackson, R.L., Morrisett, J.D. and Gotto, A.M. (1976) . Physiol. 
Rev., 56,259.
Jackson,' R.L., Taunton, O.D., Morrisett, J.D. and Gotto, A.M. 
■'(1978). Circulation Res., 42,447.
Jencks, W.P., Hyatt, M.R., Jetton, M.R., Mattingly, T.W. and 
Durrum, E.L. (1956). J. clin. Invest., 9,980.
Jenkins, D.J.A., Newton, C., Leeds, A.R. and Cummings, J.H.
(1975)• Lancet, 1,1116.
Johansson, G. (1970). Eur. J. Biochem., 17,292.
Jolliffe, N. (1961). Metabolism, 10,497.
Judd, P.A., Kay, R.M. and Truswell, A.3. (1975)* Froc. Nutr.
Soc., 35,71A.
Judd, P.A., Kay, R.M. and Truswell, A.S. (1977). Nutr. Metab. 21 
(Suppl. 1), 84.
-245-
Kallner, A. (1977)• Acta Med. Scand., 202,283*
Kannel, W.B., Castelli, W.P., Gordon, T. and McNamara, P.M.
(1971)* Ann. intern. Med., 74,1.
Kannel, W.B., Dawber, T.R., Friedman, G.D., Glennon, W.E. and 
McNamara, P.M. (1964). Ann. intern. Med., 61,888.
Kannel, W.B., Dawber, T.R., Kagan, A., Revotskie, N. and Stokes, J.
(1961). Ann. intern. Med., 55,33.
Kannel, W.B., Hjortland, M.C., McNamara, P.M. Gordon, T. (1976) . 
Ann. intern. Med., 85,447.
Kaplan, J.A., Cox, G.E. and Taylor, C.B. (1963). Archs Path.,
Kappas, A., Anderson, K.E., Conney, A.H. and Alvares, A.P. (1976).
Clin. Pharmac. Ther., 20,643*
Kaschnitz, R. (1970). Hoppe-Seyler1s Z. Physiol. Chem., 351,771*
Kato, H., Tillotson, J., Nichaman, M.Z., Rhoads, G.G. and Hamilton, 
H.B. (1973)* Am. J. Epidemiol.,97,372.
Kato, R. (1977). Xenobiotica, Z»25*
Z^ ,359
Kato, R. and Gillette, J.R. (1965) . J. Pharm. exp. Ther., 150, 
279.
-246-
Kato, R., Chiesara, E. and Yassanelli, P. (1962). Biochem. 
Pharmac. 11,211.
Kato, R., Takanaka, A. and Takayanaghi, M. (1968). Jap. J. 
Pharmac., 18,482.
Kaunitz, H. (1977). Cherny. Ind., 76l.
Kay, R.M. and Truswell, A.S. (1974). Proc. Nutr. Soc., 34,17A.
Keith, M.O. and Pelletier, 0. (1974). Am. J. clin. Nutr., 27,368.
Keys, A. (Editor) (1970). Circulation, 40., Supplement 1.
Keys, A., Anderson, J. T. and Grande, F. (1957) • Lancet, 2,959*
Keys, A., Anderson, J.T. and Grande, F. (1965)• Metabolism, 14, 
747.
Keys. A., Anderson, J.T., Mickelson, 0., Adelson, S.F.and 
Fidanza, F. (1956). J. Nutr., 59,39*
Keys, A., Kimura, N., Kusukawa, A., Bronte-Stev/art, B., Larsen,
N., and Keys, M.H. (1958). Ann. intern. Med., 48,33*
Keys, A., Taylor, H.L., Blackburn, H., Brozek, J., Anderson, J.T. 
and Simonson, E. (1963). Circulation, 28,331.
-247-
Kim. J.J., Hamilton, R.M.G. and Carroll, K.K. (1976). Can. J. 
Biochem., 54,272.
Kirk, J.E. (1973)* In Monographs on Atherosclerosis. Editors:
Kirk, J.E., Kritchevsky, D., Pollack, O.J. and Simms, H.S. 
vol.3» p.4, Basel, S. Karger.
*
Klevay, L.M. (1973)* Am. J. clin. Nutr., 26,106o.
Klevay,' L.M. (1975)* Am. J. clin. Nutr., 28,764.
Kothari, L.K. and Jain, K. (1977)* Acta biol. hung., 28,111. 
Kottke, B.A. (1969). Circulation, 46,13.
Kottke, B.A. and Subbiah, M.T.R. (1978). Mayo Clin. Proc., 53,35.
Krebs, H.A. (1953). Proc. Nutr. Soc., 12,237.
Kritchevsky, D. (1969). Ann. N.Y. Acad. Sci., 162,80;
Kritchevsky, D. (1970). Am. J. clin. Nutr., 23,1105*
Kritchevsky, D. (1974). In Advances in Drug Research. Editors:
Harper, N.J. and Simmons, A.B. vol.9» P«^l» London, New 
York and San Francisco, Academic Press.
Kritchevsky, D. (1976). Am. J. Path., 84,615.
-248-
Kritchevsky, D. and Story, J.A. (1974). J. Nutr., 104,458. 
Kritchevsky, D. and Tepper, S.A. (1968). J. Atheroscler. Res.,
8,317.
Kritchevsky, D., Casey, R.P. and Tepper, S.A. (1973a). Nut. Rep. 
Int., 2,61.
Kritchevsky, D., Tepper, S.A. and Story, J.A. (1973b). Lipids, 
8,482.
Kritchevsky, D., Tepper, S.A. and Story, J.A. (1977a). Nut. Rep. 
Int., 15,65.
Kritchevsky, D., Tepper, S.A., Williams, D.E. and Story, J.A. 
(1977b). Atherosclerosis, 26,397.
Krumdieck, C. and Butterworth, C.E. (197*0. Am. J. clin. Nutr.,
22,866.
Kudchodkar, B.J., Horlick, L. and Sodhi, H.S. (1976). Atheroscle­
rosis, 23,239.
Kudchodkar, B.J., Sodhi, H.S. and Horlick, L. (1973)* Metabolism, 
22,155.
Kummerovv, F-A. (1977). Fats and Health 1 (Butter Information 
Council Publication).
Kummerow, F.A., Cho, B.H.S., Huang, W.Y-T., Imai, H., Kamio, A., 
Deutsch, M.J. and Hooper, V/. M. (1976). Am. J. clin. 
Nutr., 29,579.
Kuntzman, R. (1969). A. Rev. Pharmac., 2*^1.
Labadarios, D. (1975)• Ph.D. Thesis, University of Surrey.
Labadarios, D., Dickerson, J.W.T., Parke, D.V., Lucas, E.G. and 
Obuwa, G.H. (1978). Br. J. clin. Pharmac., j>,l67«
Labbe, R.F. and Finch, C.A. (1977). Biochem. Med., 18,323*
Lahiri, S. and Bannerjee, S. (1956). Proc. Soc. exp. Biol.
Med., 91,583*
Lambert, G.F., Miller, J.P., Olsen, R.T. and Frost, D.V. (1958). 
Proc. Soc. exp. Biol. Med., 97,544.
Lancet (Editorial) (1975). 2,398.
Lancet (Editorial) (1977). 1,887*
LaRusso, N.F., Korman, M.G., Hoffman, N.F. and Hofmann, A.F.
(1974). New Engl. J. Med., 291,689.
Leibman, K.C. and Estabrook, R.W. (1971). Molec. Pharmac.,
-250-
Levin, W.f Ryan, D., West, S.B. and Lu, A.Y.H. (1974). J. biol. 
Chem., 249,1747.
Levy, R. S., Lynch, A.C., McGee, E.D. and Mehl, J.W. (1967). J. 
Lipid. Res., 8,483.
Lewis, B. (1976). The Hyperlipiodaemias: Clinical and Laboratory 
Practice. (Chapter 6) Oxford, London, Edinburgh and 
Melbourne: Blackwell Scientific Publication.
Lewis, B. and Myant, N.B. (1967). Clin. Sci., 32,201.
Lewis, M. and Iammarino, R.M. (1971). J. Lab. clin. Med., 78,547.
Linden, V. (1974). Br. Med. J., 2»647*
Lindgren, F.T., Nichols, A.V. and Freeman, N.K. (1955). J* Phys. 
Chem., 59,930.
Lofland, H.B., Clarkson, T.B. and Goodman, H.O. (1961).. Circ. 
Research, 9,919.
Lowry, O.H., Rosenbrough, N.J., Farr, A.C. and Randall, R.J. 
(1951). J. biol. Chem., 193,265.
Lu, A.Y.H. (1977). Fedn. Proc., 21-2^60.
Lu, A.Y.H. and Coon, M.J. (1963). J. biol. Chem., 2*4-3.1331 •
-251-
Lu, A.Y .H. and Levin, W. (1974). Biochim. biophys. Acta, 344,205.
Lu, A.Y.H., Kuntzman, R. West, S.B., Jacobsen, M. and Conney, A.H. 
(1972). J. biol. Chem., 247,1727.
Luft, D., Degkwitz, E., HSchli-Kaufman-, L. and Staudinger, H.
(1972). Hoppe-Seyler*s Z. Physiol. Chem., 353,1420.
Lutton, C. (1976). Digestion, 14,342.
Lutton, G. and Chevallier, F. (1972). Biochim. biophys. Acta, 
280,116.
Lutton, C. Matha, D. and Chevallier, F. (1973)* Biochim. biophys. 
Acta, 306,483.
Macdonald., I. (1967). Am. J. clin. Nutr., 20,345.
Macdonald, I. (1972). Clin. Sci., 43,265.
Mahler, H.R. and Cordes, E.H. (1966). Basic Biological Chemistry, 
p.594, New York and London: Harper and Row.
Malmros, H. (1950). Acta Med. Scand., Suppl. 246,137*
Malmros, H. and V/igand, G. (1959). Lancet, 2,74?.
-252-
Mann, G.V. (1977)* New Engl. J.- Med., 297,644.
Marchand, F. (1904). Ueber Arteriosklerosis. Mtlnch. Med. Wschr., 
j>l,770 • (cited by Hermus 1975) •
Marshall, W.J. and McLean, A.E.M. (1969)* Biochem. J., 115,27P*
Marshall, W.J. and McLean, A.E.M. (1971)* Biochem. J., 122,569*
Masironi, R. (1970). Bull. Wld. Hlth. Org., 42,103.
Masironi, R., Miesch, A.T., Crawford, M.D. and Hammilton, E .I.
(1972). Bull. Wld. Hlth. Org., 4Z,139*
Mason, H.S. (1957)* Adv. Enzymol., 19,179*
Mathur, K.S., Khan, M.A. and Sharma, R.D. (1968). Br. Med. J., 
1,30.
Mattson, F.H. , Erickson, F.A. and Kligman, A.M. (1972). Am. J. 
clin. Nutr., 25,589.
Mayer, D. (1975). In Advances in Bile Acid Research. Editors:
Matem, S., Hackenschmidt, J., Back, P. and Gerok, W. vol.3, 
p*53# Stuttgart, F. K. Schattauer Verlag.
Mayer, D. (1976). Archs Toxicol., 36,267.
-253-
May er, D. and Mayer, G. (1975)* Z. Em&hrWiss. 13,158.
Mayer, G.A. (1965). Can. med. Ass. J., 93,1151*
McCall, M.G., Newman, G.E., O'Brien, J.R.P., Valberg, L.S. and 
Witts, L.J. (1962). Br. J. Nutr., 16,297-
McGill, H.C.- (1968). Lab. Invest., 18,560.
McGovern, R.F. and Quackenbush, K.W. (1973). Lipids, 8,470.
McIntyre, N. and Isselbacher, K.J. (1973). Am. J. clin. Nutr., 
26,647-
McLean, A.E.M. and Marshall, W.J. (1970). Scand. J. clin. Lab. 
Invest., 25, Suppl. 113,9-
McMichael, J., (1976)• Lancet, 2, 56?.
Mellon, W.S., Witiak, D.T. and Feller, D.R. (1978). Biochem. 
Pharmac., 27,1055.
Mendez, J., Tejada, C. and Flores, M. (1962). Am. J. clin.
Nutr., 10,403-
Mengel. C.E. and Green, H.L. (1976). Ann. intern. Med., 84,4?0. 
Mgbodile, M.U.K. and Campbell, T.C. (1972). J. Nutr., 102,53.
-254-
Mgbodile, M.U.K., Hayes, J.R. and Campbell, T.C. (1973). Biochem. 
Pharmac., 22,1125.
Middleton, C.C., Clarkson, T.B., Lofland, H.B. and Pritchard,
R.W. (1967). Archs Path., 82,145-
Miettinen, T.A., Pelkonen, R., Nikkilae, E.A. and Heinonen, 0.
(1967)- Acta. Med. Scand., 182,645.
Miller, G.J. and Miller, N.E. (1975)- Lancet, 1,16.
Miller, N.E., F^rde, O.H., Thelle, D.S. and Mjjz(s, O.D. (1977). 
Lancet, 1,965-
Minick, C.R. and Murphy, G.E. (197**)- In Arterial Mesenchyme
and Arteriosclerosis. Editorsi Wagner, W.D. and Clarkson, 
T.B. p.355, New York, Plenum Publishing Corporation.
Miranda. C.L. and Webb, R.E. (1973)- J- Nutr.. 103,1425.
Mitropoulos, K.A. and Balasubramaniam, S. (1972). Biochem. J. 
128,1.
Mitropoulos, K.A. and Myant, N.B. (1967). Biochem. J .. 103,472.
Mitropoulos, K.A., Balasubramaniam, S. and Myant, N.B. (1973)* 
Biochim. biophys. Acta, 326,428.
-255-
Mitropoulos, K.A., Suzuki, M., Myant, N.B. and Danielsson, H.
(1968). FEBS Lett., 1,13*
Mitton, J.R., Scholan, N.A. and Boyd, G.S. (1971)* Eur. J. 
Biochem., 20,509.
Moffitt, A.E. and Murphy, S.D. (1973). Biochem. Pharmac., 22, 
1463.
Moore, j.H. (1967). Br. J. Nutr., 21,207.
Moore, J.H. and Williams, D.L. (1964). Br. J. Nutr., 18,253.
Moore, R.B., Anderson, J.T., Taylor, H.L., Keys, A. and Frantz, 
I.D. (1968). J. clin. Invest., 42,1517•
Morgan, B., Heald, M., Atkin, S.D. and Green, J. (197**). Br.
J. Nutr., 22,447.
Morin, R.J. (1972). Lancet, 1,594.
Morrisett, J.D., Jackson, R.L. and Gotto, A.M. (1975). A. Rev. 
Biochem., 44,183.
Mosbach, E.H. , Rothschild, M.A. and Bekersky, I. (1971) • J* 
clin. Invest., 50,1720.
Murphy, G.M., Billing, B.H. and Baron, D.N. (1970). J. clin.
-256-
Path., 22,594.
Myant, N.B. and Mitropoulos, K.A. (1977)• J. Lipid Res., 18,135-
Myaniskova, I.A. (1947). Voenno-Morskoi Med. Akad. Leningrad, 
8,140. (cited by Turley et al., 1976).
Nambisam, B. and Kurup, P.A. (1975)* Atherosclerosis, 22,447-
Nandi, B.K., Majumder, A.K., Subramaniam, N. and Chatterjee, I.B.
(1973). J. Nutr., 103,1088.
Nash, T. (1953). Biochem. J., 22,416.
Nestel, P.J., Havenstein, N., Scott, T.J. and Cook, L.J. (197**). 
Aust. N.Z.J. Med., 4,497•
Nestel, P.J., Havenstein, N. Whyte, H.M., Scott, T.J. and Cook, 
L.J. (1973). New Engl. J. Med., 288,379.
Netter, K.J. and Seidal, G. (1964). J. Pharmac. exp. Ther. , 
146,61.
Niehaus, C.E., Wotton, R., Lewis, J . Nicoll, A., Williams, B., 
Coltart, D.J. and Lewis, B. (1977). Lancet, 2,469-
Nielsen, ?.H. and Ollerich, D.A. (1973)- Fedn. Proc., 32,929-
-257-
Nikkila, E. (1953). Scand. J. clin. Lab. Invest., 2» Suppl.8.
Nishikimi, M. and Udenfriend, S. (1977)* Trends Biochem. Sci., 
2,11.
Nockels, C.F. (1973). Poult. Sci., *>Z,373*
Norman, A. and Sjovall, J. (1958). J. biol. Chem., 233,872. 
Norred, :W.P. and Wade, A.E. (1972). Biochem. Pharmac., 21,2887.
Odumosu, A. and Wilson, C.W.M. (1973). Nature (London), 242,519.
Oliver, M.F. and Boyd, G.S. (1959). Lancet, 2,690.
Olsson, A.G* (1975). Acta. Med. Scand. Suppl. 581.
O'Malley, K. and Stevenson, I.H. (1973). J« Pharm. Pharmac.,
22,339.
Omura, T. and Sato, R. (1962). J. biol. Chem., 237,1375.
Omura, T. and Sato, R. (1964). J. biol. Chem., 239,2370>
Orrenius, S. and Emster, L. (1?64). Biochem. biophys. Res. 
Commun., 16,60.
-258-
Orrenius, S., Dallner, G. and Emster, L. (1964). Biochem. 
biophys. Res. Commun., 14. 329.
Oshino, N. and Omura, T. (1973). Archs Biochem. Biophys., 157,
395-
Oshino, N., Imai, Y. and Sato, R. (1971)- J. Biochem., Tokyo ,
62,155-
Ottolenghi, A. (1959). Archs Biochem. Biophys., 79,355.
Page, I.H., Stare, F.J., Corcoran, A.C., Pollack, H. and Wilkinson, 
C.F. (1957). Circulation, 16,163.
Parke, D.V. (1977). In Principles of Surgical Oncology. Editor: 
Raven, R. pp.113-156. London, Plenum Press.
Parke, D.V.’, Sacra, P.J. and Thornton, P.C. (1978). Brit. J. 
Pharmac., 63,346P.
Pauling, ;rL.. (1968). Proc. natn. Acad. Sci. U.S.A., 67,1643.
Pederson, T.C. and Aust, S.D. (1972). Biochem. biophys. Res. 
Commun., 48,789*
Pederson, T.C., Beuge, J.A. and Aust, S.D. (1973). J* biol.
Chem., 248,713**.
-259-
Peterson, V.E., Crapo, P.A., Weiniger, J., Ginsberg, H. and 
Olefsky, J. (1975)• Am. J. clin. Nutr., 28,584.
Pinter, K.G., Hamilton, J.G. and Goldsmith, G.A. (1964). J. clin. 
Invest., 43,1251*
Pool, W.R., Newmark, H., Dalton, C., Banziger, R.P. and Howard, 
A.N. (1971)* Atherosclerosis, 14,131.
Portman, O.W. (1970). Adv. Lip. Res., 8,41.
.. . ' ' j ' . '
Portman, O.W. and Murphy, P. (1958). Archs Biochem. Biophys., 
26,367.
Preiss, B. and Block, K, (1964). J. biol. Chem., 239,85.
Prichard, R.W. (197**). Expl. Molec. Path., 20,407.
Quintao, E ., Grundy, S.M. and Ahrens, E.H. (1971). J* Lipid 
Res., 12,233-
Raicht, R.F., Cohen, B.T., Shefer, S. and Mosbach, E.H. (1975)- 
Biochim. biophys. Acta, 388,374.
Reiser, R. (1978). Am. J. clin. Nutr., 31,865.
-260-
Remmer, H. (1972). Eur. J. clin. Pharmac., ^,116.
Rhead, W.J. and Schrauzer, G.N. (1971). Nutr. Rev., 29,262.
Rifkind, B.M. and Gale, M. (1967). Lancet, 2,640.
Rikans, L.E., Smith, C.R. and Zannoni, V.G. (1977). Biochem.
Pharmac., 26,797.
Rizek, R.L., Friend, B. and Page, L. (197**). J. Am. Oil Chem. 
Soc., 21,244.
Robbins, K.C. (1961). Fedn. Proc., 20,272.
Roberts, J.C. and Straus, R. (1965). Comparative Atherosclerosis.
New York, Harper and Row.
Robertson, T.L., Kato, H., Gordon, T., Kagan, A., Rhoads, G.G., 
Land, C.E., Worth, R.M., Belsky, J.L., Dock, D.S., 
Miyanishi, M. and Kawamoto, S. (1977). Am. J. Cardiol., 
29,244.
Rokitansky, K. (1852). A Manual of Pathological Anatomy, vol.4, 
pp.261-272, London, Sydenham Society, (cited by Kottke 
and Subbiah, 1978).
Rosenfeld, R.S., Zumoff, B. and Heilman, L. (1967). J. Lipid 
Res., 8,16.
-261-
Ross, R. and Glomset, J. A. (1976). New Engl. J. Med., 295,420. 
Ross, R. and Harker, L. (1976). Science, 193,1094.
Ross, R., Glomset, J. A. and Harker, L. (1977)* Am. J. Path.,
86,675-
Rowe, L. and Wills, E.D. (1976). Biochem. Pharmac., 25,175.
Royal College of Physicians of London and British Cardiac Society.
(1976) . Jl. R. Coll. Physcns. Lond., 10,213*
Rudel, L.L. and Morris, M.D. (1973)- Lipid Res., 14,3646.
Rudel, L.L., Morris, M.D. and Felts, J.M. (1972). J. clin.
Invest., 51,2686.
Rush, R. (1978). Personal Communication.
Ryan, D., Lu, A.Y.H., Kawalek, J. West, S.B. and Levin, W. (1975). 
Biochem. biophys. Res. Commun., 64,1134.
Sabine, J.R. (1977). Cholesterol. (Chapter 8.) New York and 
Basle: Marcel Dekker Inc.
Sachs, B.A. and Weston, R.C. (1956). Archs intern. Med., 97,738.
-262-
Sacks, F. M., Castelli, W.P., Donner, A. and Kass, E.H. (1975)* 
New Engl. J. Med., 292,1148.
Salel, A.F., Hodges, R.E., Dunkley, W.L., Sodhi, H.S., Clifford, 
C., Kraus, J.F., Borhani, N.O. and Mason, D.T. (1977)*
In Advances in Heart Disease. Editor: Mason, D.T. vol.l, 
p.295* New York, San Francisco and London, Grune and 
Stratton.
Samuel, P. and Shalchi, O.B.j (1964). Circulation, 29,24.
Sato, P.H. and Zannoni, V.G.■(197*0 • Biochem. Pharmac. 23,3121.
Schenkman, J.B., Jansson, I. and Robie-Suh, K.M. (1976). Life 
Sci., 19,611.
Schrauzer, G.N. and Rhead, W.J. (1973). Int. J. Vit. Res., 43, 
201.
Schroeder, H.A. (I960). J. Am. med. Ass., 172,1902.
Schroeder, H.A., Nason, A.P. and Tipton, I.H. (1970). J. chron. 
Dis., 23,123•
Schwartz, K. (1977)* Lancet, 1,454.
Scott, D. (1958). Acta Med. Scand., 162,69.
-263-
Scott, R.F., Daoud, A.S. and Florentin, R.A. (1972). In The 
Pathogenesis of Atherosclerosis. Editors: Wissler, R.W. 
and Geer, J.C. p.120, Baltimore, Williams and Wilkins.
1
Scrimshaw, N.S. and Guzman, M.A. (1968). Lab. Invest., 18,623. |
i
1
I
Seelig, M.S. (1969). Ann. N.Y. Acad. Sci., 14?,539. 1
Seelig, M.S. and Heggtveit, H.A. (197*0« Am. J. clin. Nutr., ?
2Z.59.
Seip, M. and Skrede, S., (1977)• Scand. J. Haemat., 19,503. j
Seip, M., Skrede, S., Bjerve, K.S., Hovig, T. and Gaarder, P.I. |
(1975)* Scand. J. Haemat., 12,272. j
\
Select Committee on Nutrition and Human Needs, U.S. Senate. )
(1977)- Dietary Goals for the United States. U.S. Govern­
ment Printing Office. (cited by Lancet (Editorial) 1977)*
Shefer, S., Hauser, S., Bekersky, I. and Mosbach, E.H. (1969)* j
J. Lipid Res., 10,646.
Shefer, S., Hauser, S., Bekersky, I. and Mosbach, E.H. (1970);
J. Lipid Res., 11,404.
Shefer, S., Hauser, S. and Mosbach, E.H. (1968). J. Lipid Res.,
2 >328.
-264-
Shefer, S., Hauser, S. and Mosbach, E.H. (1972). J. Lipid Res., 
12,69.
Sherman, A.R., Guthrie, H.A. and Wolinsky, I. (1977). Proc. Soc. 
exp. Biol. Med., 156,396.
Siekevitz, P. (1963)* A. Rev. Physiol., 25,15.
Sikic, B.I., Mimnaugh, E.G. and Gram, I.E. (1977a). Biochem. 
Pharmac., 26,2037.
Sikic, B.I., Mimnaugh, E.G., Litterst, C.L. and Gram, T.E• (1977^)* 
Archs Biochem. Biophys., 179,663.
Sinnett, P.F. and Whyte, H.M. (1973). J* chron. Dis., 26,265.
Siperstein, M.D. and Chaikoff, I.L. (1952). J. biol. Chem.,
198,93.
Siperstein, M.D. and Fagan, V.M. (1966). J. biol. Chem., 241,602.
Siperstein, M.D. and Murray, A.W. (1955)• J. clin. Invest., 
24,1449.
Siperstein, M.D., Chaikoff, I.L. and Reinhardt, W.O. (1952).
J. biol. Chem., 198,111.
Sirtori, C.R., Agradi, E., Conti, F., Mantero, 0. and Gatti, E.
-265-
(1977). Lancet, 1,275*
Skipski, V.P. (1972). In Blood Lipids and Lipoproteins. Editor: 
Nelson, G.J. p.**76, New York, London, Sydney, Toronto,
Wiley Interscience.
Slater, G., Mead, J., Dhopeshwarker, G., Robinson, S. and Alfin- 
Slater, R.B. (1976). Nut. Rep. Int., 14,249.
Slater, T.F. and Sawyer, B.C. (1971). Biochem. J., 123,805.
Snog-Kjaer, A., Prange, I. and Dam, H. (1956). J. gen. Microbiol., 
14,256.
Sodhi, H.S. and Kudchodkar, B.J. (1973). Clinica chim. Acta, 
40,161.
Sodhi, H.S., Kudchodkar, B.J., Borhani, N. and Mason, D.T. (1977)* 
Artery, 2>120*
Sokoloff, B., Hori, M v, Saelhof, C.L., Wrzolek, T. and Imai, T. 
(1966). J. Am. Geriat, Soc., 14,1239.
Sorenson, D.I., Devine, M.M. and Rivers, J.M. (197**). J* Nutr., 
104,1041.
Sourkes, T.L., Lloyd, K. and Bimbaum, H. (1968). Can. J.
Biochem., 46,267.
-266-
Spittle, C.R. (1971). Lancet, 2,1280.
Spitzer, N., Newcombe, T.-F. and Noyes, W.D. (1966). New Engl.
J. Med., 274,772.
Spritz, N. and Mishkel, M.A. (1969). J. clin. Invest., 48,78.
Spritz, N., Ahrens, E.H. and Grundy, S. (1965)• J. clin. Invest., 
44,1482.
Stamler, J. (1967). Lectures in Preventive Cardiology, p.63,
New York: Grune and Stratton.
Stamler, J.D., Berkson, M. and Lindberg, H.A. (1972). In The 
Pathogenesis of Atherosclerosis. Editors: Wissler, R.W. 
and Geer, J.C. p.41, Baltimore, Williams and Wilkins.
Stein, E.A., Mendelsohn, D., Fleming, M., Barnard, G.D., Canter, 
K.J., du Toit, P.S., Hansen, J.D.L. and Bersohn, I.
(1975)* Am. J. clin. Nutr., 28,1204.
Stein, H.B., Hasan, A. and Fox, I.H. (1976). Ann. intern. Med., 
84,385.
Stier, A. (1976). Biochem. Pharmac., 25>109.
Stitt, F.W., Clayton, D.G., Crawford, M.D. and Morris, J.N.
(1973)• Lancet, 1,122.
-267-
Stone, I. (1965)« Am. J. phys. Anthrop., 22,83* (cited by Hughes, 
1977).
Story, J.A., Tepper, S.A. and Kritchevsky, D. (197**) • Biochem. 
Med., 10,214.
Story, J.A. Tepper, S.A. and Kritchevsky, D. (1976). Fedn. Proc., 
;25.294 (abs.).
Strand, 0. (1963). J. Lipid Res., 4,305-
Strobel, H.W., Lu, A.Y.H., Heidema, J. and Coon, M.J. (1970).
J. biol. Chem., 245,4851.
Strong, J.P., Eggen, D.A. and Oatmann, M.C. (1972). In The
Pathogenesis of Atherosclerosis. Editors: Wissler, R.W. 
and Geer, J.C. p.20, Baltimore, Williams and Wilkins.
Strother, A., Throckmorton, J.K. and Herzer, C. (1971). J*
Pharmac. exp. Ther., 179,490•
Suarez, K.A., Carlson, G.P., Fuller, G.C. and Fausto, N. (1972). 
Toxic, apl. Pharmac., 23,171.
Suld, H.M., Staple, E. and Gurin, S. (1962). J. biol. Chem.,
22Z.338.
Sulkin, N.M. and Sulkin, D.K. (1975)• Ann. N.Y. Acad. Sci., 2581 
317.
-268-
Swell, L., Boiter, T.A., Field, H. and Treadwell, C.R. (1954).
Proc. Soc. exp. Biol. Med., 86,295*
Symes, A.L., Sourkes, T.L., Youdhim, M.B.H., Gregoriadis, G. and 
Bimbaum, H. (1969) • Can. J. Biochem., 47,999.
Testa, R., Canestri, C. and Oldani, C. (1975). J* Pharm. Pharmac., 
22,699 •
Thiele, E.R. and Huff, J.W. (i960). Archs Biochem. Biophys., 
88,203.
Thiffault, C., Belanger, M. and Pouliot, M. (1970). Can. med.
Ass. J., 103,165.
Thomas, P.E., Lu, A.Y.H., Ryan, D., West, S.B., Kawalek, J. and 
Levin, W . (1976). Molec. Pharmac., 12,746.
Trowell, H. (1972). Am. J. clin. Nutr., 25,926.
Truett, J., Comfeld, J. and Kannel, W. (1967). J. chron. Dis., 
20,511.
Truswell, A .S. (1968). Lancet, 2,684.
Truswell, A.S. and Kay, R.M. (1976). Lancet, 1,367.
Turley, S.D., West, C.E. and Horton, B.J. (1976). Atherosclerosis,
22.3 5^.
Uchida, K., Nomura, Y., Kadowaki, M., Takeuchi, N. and Yamamura, Y.
(1977). Jap. J. Pharmac., 22,193*
Van Cantfort, J. (1973)* Memoire Present^ pour l*obtention du
’ grade de docteur en sciences biomedicales experimantales, 
Universite de Liege, (cited by Myant and Mitropoulos, 
1977).
Van Cantfort, J. (197*0« J* Interdiscip. Cycle Res., £,80.
Van der Hoeveh, T.A. and Coon, M.J. (197*0 * J.'biol. Chem., 2*^ 9, 
6302.
Veen-Baignt, M.J., Ten Cate, A.R., Bright-See, E. and Rao, A.V.
(1975). Ann. N.Y. Acad. Sci., 258,339.
Velez, H., Restrepo, A., Vitale, J.J. and Hellerstein, E.E.
(1966). Am. J. clin. Nutr., 19,27.
Velican, C. and Velican, D. (1976). Atherosclerosis, 23,3^5*
Vergroesen, A.J. (1972). Proc. Nutr. Soc., 31,323.
Vesselinovitch, D., Wissler, R.W., Hughes, R. and Borenszlajn, J.
(1976). Atherosclerosis, 23,155.
Vesselinovitch, D., Wissler, R.W., Fisher-Dzoga, K., Hughes, R.H. 
and Dubien, L. (1974). Atherosclerosis, 19,259.
Virchow, R.L.K. (1856) Cellular Pathology as Based Upon Physio­
logical and Pathological Histology. (Translated from the 
second German edition by F. Chance) New York, Dover 
Publications, 197.1* ’Pp230-25^«
Vitale, J.J., Restrepo, A., Velez, H., Riker, J.B. and Hellerstein, 
E.E. (1966). J. Nutr., 88,315.
Vitler, R.W. (1967). In The Vitamins. Editors: Sebrell, W.H. 
and Harris, R.S. vol. 1, p.501, New York and London,
Academic Press.
Wachstein, M. and Meisel, E. (1956). J. Histochem. Cytochem., 
4,592.
Wada, F. and Usami, M. (1977). Biochem. biophys. Acta, 482,261.
Wada, F., Hirata, K., Nakao, K. and Sakanoto, Y. (1969) • J« 
Biochem., Tokyo, 66,699.
Wada, F., Shibata, H., Goto, M. and Sakamoto, Y. (1968). Biochim.
biophys. Acta, 162,518.
Wade, F., Usami, M., Goto, M. and Hayashi, T. (1971). J. Biochem 
Tokyo, 70,1065.
Wade, A.E. and Norred, W.P. (1976). Fedn. Proc., 35,2475.
Wade, A.E-., Wu, B.C. and Smith, P.B. (1972). J. pharm. Sci., 
61,1205.
Wahlefeld, A.W. (1974). In Methods of Enzymatic Analysis. Editor 
Bergmeyer, H.U. 2nd English edition. New York and London, 
Academic Press.
Walker, G.R., Morse, E.H. and Oversley, V.A. (i960). J. Nutr., 
22,317.
Watson, E. (i960). Clinica chim. Acta, £,637*
Webb, R.E. and Miranda, C.L. (1973)* Fd. Cosmet. Toxic., 11,63.
Wiech, N.L., McGandy, R.B. and Hegsted, R.M. (1967)• Fedn. Proc. 
26,489.
Weight, M.H., Kotze, J.D., de Klerk, W.A. and V/eight, N. (1974). 
Int. J. Biochem., £,287.
Weis, H.J. and Dietchsky, J.M. (1969)• J. clin. Invest., 48,2398
-272-
Westerman, M.P. (1975). Br. J. Haemat., 31,87.
Westerman, M.P., Pierce, L.E. and Jensen, W.N. (1964), Blood, 
2£,200.
W-H.O. (1958). Classification of Atherosclerotic Lesions. W.H.O. 
Technical Report Series 143. Geneva.
Wigand* G. (1959). Acta Med. Scand., 166, Suppl. 351.
Williams, R.J. and Deason, G. (1967). Proc. natn. Acad. Sci.
U.S.A., £2,1638.
Willis, G.C. (1957). Can. med. Ass. J., 2Z*-1*06-
Willis, G.C. and Fishman, S. (1955) • Can. med. Ass. J., 72,500.
Wills, E.D. (1969). Biochem. J. 113,333.
Wills, E.D. (1972). Biochem. Pharmac., 21,239.
Wilson, J.D. (1961). J. Lipid Res., 2,350.
Wilson, J.D. (1962). Am. J. Physiol., 202,1029.
Wilson, J.D. (1964). J. Lipid Res., £,409.
Wilson, J.D. and Lindsay, C.A. (1965). J* clin. Invest., 44,1805. '
-273-
Wilson, J.T., Van Boxtel, C.J., Alvan, G. and Sjoqvist, F. (1976). 
J. clin. Pharmac., 16,265.
Windaus, A. (1910). Hoppe-Seyler’s Z. physiol. Chem., 67,174.
Wissler, R.W. and Vesselinovitch, D. (1968). Ann. N.Y. Acad.
Sci., 149,907.
Wissler, R.W. and Vesselinovitch, D. (1974). In Atherosclerosis.
Editors: Schettler, G. and Weizel, A. vol.3, p.747- Berlin.
Wissler, R.W. and Vesselinovitch, D. (1977)* In Modem Concepts 
of Cardiovascular Diseases. Editor Yu, P.N. vol.156, 
p.27, Texas, American Heart Association, Inc.
Wood, J.D. and Migicovsky, R.B. (1958)- Can. J. Biochem. Physiol., 
M ^ 3 3 .
Wood, P.D.S., Lee, Y.L. and Kinsell, L.W., (1967). Fedn. Proc., 
26,261.
Wood, P.D.S., Shioda, R. and Kinsell, L.W. (1966). Lancet, 2,604.
Worcester, N.A., Bruckdorfer, K.R. and Yudkin, J. (1975)• Proc. 
Nutr. Soc., 34,125a .
Worth, R.M., Kato, H., Rhoads, G.G., Kagan, A. and Syme, S.L.
(1975)* Am. J. Epidemiol., 102,481.
-274-
Yacowitz, H., Fleischman, A.I. and Bierenbaum, M.L. (1965). Br. 
Med. J., 1,1352.
Yerushalmy, J . and Hilleboe, H.E. (1957)* N.Y. St. J. Med., 
£Z>2343.
Yeshurun, D., Gotto, A.M. and Taunton, O.D. (1976). Clin. Res., 
24,373A.
Yew M.L.S. (1973)- Proc. natn. Acad. Sci. U.S.A., 70,969.
Yew, M-L.S. (1975)- Ann. N.Y. Acad. Sci., 258,451.
Yudkin, J. (1957). Lancet, 2,155* '
Yudkin, J. (1963). Lancet, 1,1335*
Yudkin, J. (1966). Angiology, 17,127.
Yudkin, J. (1972). Proc. Nutr. Soc., 31,331.
Yudkin, J. and Roddy, J. (1964). Lancet, 2,6.
Zannoni, V.G. (1977). Acta Vitaminol. Enzymol., 31,17.
Zannoni, V.G. and Lynch, M.M. (1973)* Drug Metab. Rev., 2,57•
-275-
Zannoni, V.G. and Sato, P.H. (1975)- Ann. N.Y. Acad. Sci., 258, 
119.
Zannoni, V.G. and Sato, P.H. (1976). Fedn. Proc. ££, 2464.
Zannoni, V.G., Flynn, E.J. and Lynch, M. (1972). Biochem. 
Pharmac., 21,1377-
